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Abstract 
 
Data from this thesis has extended our understanding of the molecular epidemiology and 
transmission of Mycobacterium tuberculosis in the Midlands. A novel DNA fingerprinting 
method called Mycobacterial Interspersed Repetitive Units containing Variable Number 
Tandem Repeats (MIRU-VNTR) typing provided equivalent results when compared to the 
current gold standard for DNA fingerprinting (IS6110 RFLP). To improve our understanding 
of TB in the Midlands, MIRU-VNTR typing was then developed to be assayed by non-
dHPLC for the first time. Using this high-throughput rapid method a prospective and 
universal typing study was undertaken. This work identified the predominance of the Euro-
American and East African Indian global clades in the Midlands and linked them to particular 
human population groups using novel software based on names. DNA fingerprinting also 
discovered the most prevalent single strain in the Midlands. This strain is geographically 
restricted to the West Midlands within the UK and globally. From this geographical 
association, we have called this strain the “Mercian” strain. The Mercian strain was not 
associated with patients who originated from the Indian Sub-Continent but was significantly 
associated with UK-born, Black Caribbean patients in Wolverhampton. These findings show 
that strains have been imported into the Midlands from around the world and there has also 
been continued transmission of these and other strains which may have been present in the 
Midlands for years. Molecular tools developed in this thesis will have regional, national, and 
international impact on TB control.  
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1.1. GLOBAL EPIDEMIOLOGY 
Mycobacterium tuberculosis is the single leading global cause of infectious disease. There 
were an estimated 9.4 million incident cases of TB world-wide in 2008 of which 80% were in 
22 countries (Figure 1.1). South-East Asia has the highest total number of cases (35% of 
global total) whereas rates in Sub-Saharan Africa are nearly twice that in South-East Asia at 
over 350 cases per 100,000 population. Of the 15 countries with the highest estimated TB 
incidence rates, 13 are in Africa with half of all new cases in six Asian countries - 
Bangladesh, China, India, Indonesia, Pakistan, and the Philippines. There were 1.3 million 
deaths caused by TB in 2008 with more than two billion people infected. The overall global 
TB incidence rate is very slowly decreasing at a rate of less than 1% each year. However, the 
slow decline in incidence rates is offset by global population growth. (World Health 
Organisation, 2009). 
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Figure 1.1.  Estimated global TB incidence rates, 2008. 
 
Figure from (World Health Organisation, 2009) 
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1.1.1. UK epidemiology 
In the UK, the number of clinical cases reached an all-time low in 1987 with 5,085 cases. 
However, since then, the numbers of cases have slowly and consistently increased by 
approximately 2-3% each year with 9,040 cases in 2009 representing a national rate of 14.6 
cases per 100,000 population (Figure 1.2). Just over half of all patients in 2009 were male 
(4,980/8,987, 55%) and patients aged 15-44 years old accounted for 60% of cases 
(5,425/9,040)  (Health Protection Agency, 2010).  
 
 
 
Figure 1.2  Tuberculosis case reports and rates in the UK, 2000-09. 
 
Figure from (Health Protection Agency, 2010) 
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1.1.2. Midlands epidemiology 
The Health Protection Agency (HPA) Midlands Regional Centre for Mycobacteriology 
(MRCM) laboratory receives specimens and positive cultures from >35 National Health 
Service (NHS) laboratories in the West and East Midlands for mycobacterial identification, 
speciation, drug sensitivity testing, and DNA fingerprinting. The Midlands region of the UK 
encompasses the West and East Midlands (Figure 1.3) which had a total population of 5.4 and 
4.4 million people respectively in 2009 (Office for National Statistics, 2010). 
 
In 2009, there were 1,564 clinical cases (16.0 per 100,000) in the Midlands region of the UK 
with 1,018 cases (18.7) in the West Midlands and 546 (12.3) in the East Midlands. Only 
London accounted for a higher proportion of all cases in the UK in 2009 with 3,440/9,040 
(38%) and a rate of 44.4 per 100,000. There has been a 45% increase in case numbers in the 
West Midlands with a 29% increase in the East Midlands since 2000 (Figure 1.4). In London, 
there has been a 30% increase in case numbers since 2000. Birmingham is the largest city in 
the Midlands with a total population of one million and 429 cases (42.4 cases per 100,000) in 
2009 (Personal Communication, Helen Bagnall, HPA West Midlands Regional Surveillance 
Unit) (Office for National Statistics, 2003). 
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Figure 1.3.  Map of the administrative geography of the United Kingdom. 
The West Midlands is highlighted in green and the East Midlands in blue (adapted from 
http://en.wikipedia.org/wiki/File:Map_of_the_administrative_geography_of_the_United_Kin
gdom.png). 
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Figure 1.4.  Tuberculosis case reports and rates in the East and West Midlands, 
England, 2000-2009. 
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1.2. THE AETIOLOGICAL AGENT OF TUBERCULOSIS 
The clinical disease of tuberculosis is caused by various members of the M. tuberculosis 
complex (MTBC) and comprises M. tuberculosis, Mycobacterium africanum, Mycobacterium 
bovis, Mycobacterium bovis BCG, Mycobacterium microti, Mycobacterium canettii, 
Mycobacterium pinnipedii, Mycobacterium caprae, and the recently proposed Mycobacterium 
mungi (Table 1.1)  (Brosch et al., 2002;Alexander et al., 2010). The members of the MTBC 
display different phenotypic traits including colony morphology, biochemical profiles, and 
host ranges (Levy-Frebault and Portaels, 1992) but the complex represents extreme genetic 
homogeneity when compared with other bacterial species with <0.03% synonymous 
nucleotide variation within the complex (Sreevatsan et al., 1997). 
 
M. tuberculosis is the predominant cause of tuberculosis in humans with 5,014/5,075 (99%) 
of culture positive human cases of tuberculosis in the UK caused by M. tuberculosis in 2009, 
25/5,075 (0.5%) were identified with M. bovis and 36/5,075 (0.7%) with M. africanum. 
(Health Protection Agency, 2010).  
 
Species Predominant host 
M. tuberculosis Humans, domesticated animals 
M. africanum Humans and primates 
M. bovis Cattle and wild animals 
M. bovis BCG Vaccine strain 
M. microti Rodents/voles 
M. canettii Humans in Africa 
M. pinnipedii Seals 
M. caprae Goats 
M. mungi Banded mongoose 
 
Table 1.1.  Members of the M. tuberculosis complex and host specificity.  
 
BCG: Bacillus Calmette-Guèrin. List created from (Liebana et al., 1996;van Soolingen et al., 
1997;Aranaz et al., 1999;Alexander et al., 2010) 
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1.3. PATHOGENESIS  
In all individuals infected with M. tuberculosis, the primary outcome of infection with M. 
tuberculosis is not disease but containment and latency as 90% will never develop any 
clinical, active disease (Kaufmann, 2001). Therefore, most individuals infected with M. 
tuberculosis mount an immune response that is sufficient to prevent disease.  The current 
global transmission and epidemiology of M. tuberculosis in humans is a reflection of the 
continuous interaction between the host and strain over many bacterial and human generations 
but understanding the extent to which M. tuberculosis has adapted to the human host still 
remains to be fully elucidated. 
 
Infection with M. tuberculosis in humans occurs by airborne transmission between close 
contacts. It is estimated that one untreated smear-positive patient results in about 10 
secondary infections annually (Styblo, 1980). About 10 percent of immunocompetent people 
infected with TB develop the disease with persons that do not develop active disease within 
two years of acquisition having a 10% lifetime risk of developing TB (Sutherland, 1976). 
Disease presentation varies between patients which suggests that host factors play a 
significant role in an individual‟s susceptibility to infection and disease. Several studies have 
proposed a role for variation in host genetics which contribute to susceptibility to TB but 
verification of these proposed genetic mechanisms in different global human populations has 
not always been achieved (Stein, 2011). 
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The other 90% of persons infected with TB that do not progress to active disease will never 
develop active or infectious disease but will remain latently infected without complete 
eradication of M. tuberculosis. The major predisposing factor in progression to active disease 
is the interaction between M. tuberculosis and the host immune response as host co-factors 
that reduce immunosuppression such as co-infection with HIV increase the 10% lifetime risk 
to a 10% risk for each year of life (Kaufmann, 2001). 
 
There are two forms of tuberculosis: TB affecting the lungs (respiratory disease) and TB 
causing infection elsewhere in the body (non-respiratory disease). Most patients with TB in 
the UK present with respiratory disease (4,851/8,968, 54%) (Health Protection Agency, 
2010). M. tuberculosis is an intracellular pathogen that in respiratory disease is found 
primarily in the alveolar macrophage. Thus, the focus of the pathogenic properties of M. 
tuberculosis is based on the interaction with the hostile environment of the host alveolar 
macrophage and the exposed cell surface of the mycobacterial cell (McDonough et al., 1993). 
 
Airborne droplets containing M. tuberculosis are inhaled and can reach the pulmonary alveoli 
(Figure 1.5). M. tuberculosis then infects and can replicate within the alveolar macrophage. 
From this, a granulomatous lesion can develop which if the host is immunocompetent will 
contain and limit the mycobacteria. Within a granuloma, there is a highly heterogeneous 
immune cell population containing a variety of different T cell populations, B cells, 
macrophages at different stages of maturation, fibroblasts, and dendritic cells. If the cellular 
immune response is altered, then the granuloma may no longer be able to contain and limit 
spread of the mycobacteria. The granuloma liquefies and mycobacteria are released not only 
within the lung but can disseminate to other extra-pulmonary sites via the lymphatic system 
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and blood, resulting in miliary (disseminated) disease, extra-pulmonary tuberculosis, or 
meningitis (Kaufmann, 2002;Donoghue, 2009). 
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Figure 1.5.  The development of tuberculosis. 
 
Small droplet nuclei (1-5 μm) containing M. tuberculosis are deposited in the alveoli (1). 70% 
of individuals exposed are not infected (2) but 30% are infected (3). Infection is contained in 
90% of those infected (latent infection) (4). The remaining 10% will develop progressive 
primary tuberculosis (5). Extensive dissemination (6) to various organs can result in miliary 
TB. People with latent TB infection have a 10% lifetime risk of re-activation and post-
primary tuberculosis (7). 50% of re-activations occur during the first two years of primary 
infection. The risk of re-activation in HIV-infected individuals is approximately 10%/year. 
Massive lymphohaematogenous dissemination during re-activation (8) can also result in 
miliary tuberculosis (progressive post-primary miliary tuberculosis). Re-infection with a new 
strain of M. tuberculosis (9) can occur and the cycle is repeated. *Important in endemic areas. 
†Organ-restricted tuberculosis with adequate host immunity. MTB=miliary tuberculosis, 
TB=tuberculosis, TNF=tumour necrosis factor (Sharma et al., 2005). 
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1.4. TRANSMISSION 
The airborne transmission of tuberculosis by droplet nuclei was confirmed by the infection of 
71/77 guinea pigs that were housed above a ward for TB patients and exposed to airborne 
bacilli generated by these patients over a 2-year period. Infection was detected by tuberculin 
skin testing and confirmed by culture and histological examination of lung, spleen, and lymph 
node tissue (Riley, 1957). 
 
The infectiousness of a patient with respiratory disease can be determined by the smear 
microscopy status of the patient. Non-respiratory disease is generally accepted as a form of 
TB which represents acquisition of M. tuberculosis with a low risk of onward transmission to 
another patient. 
 
The oldest and most widely used technique for primary identification of the presence of acid-
fast bacilli is the microscopic examination of a sputum specimen by specific stains, either 
auramine-phenol for examination of specimens or Ziehl-Neelsen for positive cultures 
(Ulukanligil et al., 2000;Murray et al., 2003). The presence or absence of acid-fast bacilli in a 
sputum specimen indicates the degree of infectiousness of the patient. A survey of 1,532 
children in Bedfordshire in the UK between 1945 and 1952 showed that 244/374 (65.2%) 
children in contact with sputum smear positive culture positive patients showed evidence of 
recent infection using the tuberculin skin test whereas only 61/228 (27.8 %) of children in 
contact with smear negative culture positive showed evidence of recent infection (Shaw and 
Wynn-Williams, 1954). Therefore, contacts of patients with smear positive culture positive 
tuberculosis were at least twice as likely to be infected with tuberculosis when compared to 
contacts of patients with smear negative culture positive tuberculosis. It was estimated that 
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patients with smear-positive disease expectorate 10
8
-10
10
 bacilli daily (Pottenger, 1948), or 
10
6
-10
7
 AFB per ml of sputum, while smear-negative sputum contains <10
3
 bacilli per ml of 
sputum (Yeager, Jr. et al., 1967). However, it is not known how many bacilli must be inhaled 
to contract M. tuberculosis as this is very likely to be highly variable between individuals. It is 
known that the likelihood of infection depends on the intensity, frequency, and duration of 
exposure (Ewer et al., 2003). 
 
Current guidelines in the UK assess the smear status of an individual patient as part of 
infection control assessments to determine whether a patient requires hospital isolation in a 
single bed negative pressure room. Sputum smear status also determines whether enhanced 
contact screening using Interferon Gamma Release Assays (IGRA) and chest X-rays are 
required in contact tracing investigations (National Institute for Clinical Excellence, 2011). 
Within the UK in 2009, a sputum smear microscopy result was known for 2,790/4,851 (58%) 
pulmonary cases with 1,579/2,790 (57%) smears positive for acid-fast bacilli. Of these 1,579 
smear positive cases, 1,389/1,579 (89%) were culture positive (Health Protection Agency, 
2010). 
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1.5. CLINICAL DIAGNOSIS OF ACTIVE DISEASE 
The classic signs and symptoms of active TB are malaise, weight loss, fever and night sweats 
with a cough that may induce haemoptysis in a small proportion of cases (Brandli, 1998). 
Upon presentation, an initial chest X-ray is taken and if this suggests TB then at least three 
sputum samples including one early morning sample are obtained and referred for 
microbiological culture and microscopy. If sputum samples are not spontaneously produced 
then sputum induction or bronchoscopy and lavage in adults is carried out with safe induction 
of sputum in children or a gastric lavage. Samples should be obtained before the initiation of 
therapy if the patient has clinical signs and symptoms conducive with a diagnosis of TB and 
therapy should be started before microbiological results are known (National Institute for 
Clinical Excellence, 2011). The confirmation of a clinical case is achieved by identifying M. 
tuberculosis by microbiological culture. 
 
Microbiological diagnosis is based on initial smear microscopy to detect acid fast bacilli 
(AFB), culture using liquid and solid media, isolate identification, and drug sensitivity testing. 
There have been various recent developments to improve the microscopic identification of M. 
tuberculosis in the 21
st
 century. Light emitting diodes are now used as alternative light 
sources to replace expensive mercury lamps which can enable microscopy to be readily 
applied in high burden areas (Hung et al., 2007). Mobile phone digital cameras have been 
utilised to enable the transmission of slide images to trained personnel at a central location 
(Breslauer et al., 2009), and automated slide scanners are being developed by the WHO 
Foundation for Innovative New Diagnostics. 
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Culture has traditionally used a solid egg-based medium such as Lowenstein-Jensen (LJ) 
media which contains a variety of supplements and selective agents to inhibit growth of rapid-
growing non-mycobacteria and enhance mycobacterial growth. Culture on LJ slopes can be 
slow with a recommended incubation time of up to three months for all specimens. To reduce 
the time taken to obtain a positive culture, more sensitive and rapid radiometric culture 
systems were introduced. To reduce exposure to hazardous reagents used by the radiometric 
culture systems, fluorescence-based liquid media culture systems were developed.  
 
A multi-centre study compared radiometric culture (BACTEC 460 TB System), fluorescent 
detection using Mycobacteria Growth Indicator Tubes (MGIT), and solid media in the 
isolation of 180 mycobacterial isolates from 1,500 specimens which included 113 M. 
tuberculosis complex and 67 nontuberculous mycobacteria (NTMs) When a combination of 
liquid and solid media was used, it was shown that fluorescent MGIT plus solid media 
detected 156/180 (86.7%) of the isolates which was statistically non-inferior to radiometric 
BACTEC plus solid media which recovered 168/180 (93.3%) of all AFB. A combination of 
the two liquid media together detected 171/180 (95%) of all isolates which was significantly 
different when compared to MGIT plus solid media but not when compared to BACTEC plus 
solid media. The two liquid media systems greatly reduced the time to detection of M. 
tuberculosis complex which was 9.9 days with MGIT, 9.7 days with BACTEC, and 20.2 days 
with solid media. From this, the MGIT system was shown to be a beneficial alternative to the 
radiometric cultivation system since it removed the need for the use of hazardous reagents 
(Pfyffer et al., 1997). However, there are instances where isolates will only be identified on 
solid LJ media so for optimal rates of isolation both types of culture media still need to be 
used. 
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1.5.1. Identification 
Mycobacterial isolates were traditionally identified via a series of biochemical tests which 
examined growth on different substrates and also growth at different temperatures. The M. 
tuberculosis complex can be phenotypically distinguished from NTMs by growth only at 
37 C, no growth in the presence of ρ-nitro benzoic acid or thiacetazone, preference for an 
aerobic atmosphere, lack of pigmentation in light or dark and the ability to hydrolyse Tween. 
M. bovis has similar characteristics except that it cannot hydrolyse Tween (Cowan and Steele, 
1993).  
 
Genotypic tests for identification of positive cultures using the Polymerase Chain Reaction 
(PCR) have been developed. Two commercially available assays are the Innogenetics 
InnoLipa and Hain LifeScience Genotype assay (Richter et al., 2003;Tortoli et al., 2003). 
These two assays both employ PCR-based amplification and reverse line hybridisation to 
detect single nucleotide polymorphisms (SNPs) in the 16S-23S rRNA spacer region or 23S 
rRNA, gyrB, and M. bovis BCG RD1 (region of difference 1) respectively. These two tests 
can identify individual members of the M. tuberculosis complex and most of the common 
NTMs. 
 
1.5.2. Drug Sensitivity Testing 
There are three phenotypic methods that are used in Europe which follow guidelines and 
definitions set out by the WHO: the absolute concentration method; the resistance ratio 
method; and the proportion method (Canetti et al., 1969). In the absolute concentration 
method, two dilutions of each drug are used in two separate solid or broth cultures. 
Susceptibility is defined as the lowest concentration of the drug that inhibits growth and 
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results in less than 20 colonies. This essentially calculates the minimal inhibitory 
concentration (MIC) for an isolate. Drug concentrations and inoculum sizes must be carefully 
standardised. The resistance ratio method is a further development of the absolute 
concentration method where the MIC for a susceptible reference strain is compared to the 
MIC of the specimen isolate (MIC for test isolate is divided by MIC for reference strain). If 
the ratio is two or less, the isolate is fully susceptible. If the ratio is eight or more, the isolate 
is highly resistant. Within the resistance ratio method, low-level or intermediate resistance is 
difficult to quantify accurately and the inoculum size again needs to be standardised 
(Drobniewski et al., 2007).  
 
In the proportion method, each isolate is grown on drug-containing and drug-free media and 
the proportion of drug-resistant mutants is calculated from the total colony count on the drug-
free media. This proportion varies with different antibiotics. For both isoniazid and 
rifampicin, the proportion is 1%. If more than 1% of the total colony count on drug-free 
media grows on drug-containing media, then the isolate is resistant. The proportions set 
correlate with an effective clinical outcome. The widely used broth-based BD MGIT system 
uses a modified proportion method (Drobniewski et al., 2007). 
 
As for culture and isolation, solid media has been traditionally used with liquid media systems 
recently introduced which have been shown to reduce the turn-around times to obtain 
antibiotic sensitivity data (Tortoli et al., 2002). The WHO has a global network of 20 supra-
national laboratories that provide drug sensitivity testing for all first line agents and second 
and third line agents as well and these laboratories participate in global surveillance of drug 
resistance (Wright et al., 2009). 
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There have been several novel assays recently developed as part of global efforts to produce 
drug sensitivity testing that can be implemented in high-burden areas. The microscopic-
observation drug-susceptibility assay uses a micro-titre plate format to identify rifampicin 
resistance within seven days (Moore et al., 2006). Phage-based assays have also been 
developed for the identification of rifampicin resistance as well (Wilson et al., 1997).  
 
1.5.3. Direct identification and Drug Sensitivity Testing from specimens by Nucleic 
Acid Amplification 
It is possible to directly identify M. tuberculosis complex DNA present in specimens using 
PCR-based amplification of species specific DNA sequences. However, a systematic review 
of rapid diagnostic tests for the detection of tuberculosis infection from 212 studies published 
between 1975 and 2003 found that TB-PCR is a reliable method for positively identifying 
tuberculous disease but that sensitivity is too poor to be able to accurately exclude disease, 
especially in smear-negative disease where clinical diagnosis may be absolutely dependent on 
microbiological examination (Dinnes et al., 2007). 
 
A recently developed nucleic acid amplification test is the Cepheid Gene Xpert MTB/RIF 
assay which aims to overcome these technical challenges and reduce the requirement for 
highly skilled personnel such that this assay can be a rapid on-demand, “near-patient 
technology”. This assay can simultaneously detect M. tuberculosis DNA and mutations which 
confer rifampicin resistance in a sputum specimen within two hours. It has been shown to 
exhibit at least 98.2% sensitivity in smear-positive culture-positive cases and at least 72% 
sensitivity in smear-negative culture-positive cases (Helb et al., 2010;Boehme et al., 2010). 
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Rapid identification of resistance to rifampicin and isoniazid can also be detected 
genotypically using nucleic acid amplification tests such as those commercially supplied by 
InnoLipa and Hain LifeScience (Ling et al., 2008;Hillemann et al., 2005;Morgan et al., 
2005;Telenti et al., 1997). Sensitivity and specificity is greatest for detection of mutations 
conferring rifampicin resistance with reduced values for isoniazid and the two other first-line 
agents. Mutations conferring resistance to 2
nd
-line therapeutic agents can also now be detected 
as well (Hillemann et al., 2009). 
 
1.5.4. Treatment 
There are four first-line antibiotics used for the treatment of uncomplicated tuberculosis in the 
UK: isoniazid, rifampicin, ethambutol, and pyrazinamide. Within the UK, patients with active 
disease are prescribed six months of isoniazid and rifampicin supplemented in the first two 
months with pyrazinamide and ethambutol whilst latently infected patients can be treated with 
three months isoniazid and rifampicin or six months of isoniazid. Treatment of latent infection 
with six months of isoniazid or rifampicin and isoniazid for three months is considered in 
patients <35 years old, HIV positive, or Healthcare Workers (National Institute for Clinical 
Excellence, 2011). 
 
The development of the current first line therapy of four drugs was achieved by studies 
carried out by the TB Units of the British Medical Research Council (MRC) around the world 
between 1946 and 1986. There were four milestones between 1970 and 1976 that generated 
the current standardised therapy of four first line antibiotics: addition of rifampicin or 
pyrazinamide to the current regimen in 1970 (streptomycin and isoniazid) substantially 
reduced the subsequent relapse rate; inclusion of rifampicin and pyrazinamide shortened 
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treatment length to six months; and it was shown that the sterilising activity of pyrazinamide 
was confined to the first two months of treatment whereas rifampicin exhibited sterilising 
activity throughout the intensive and continuation phase which in turn created the current 
modern short-course therapy regimen (Fox et al., 1999). 
 
The most important determinant for success of therapy is the development of drug resistance. 
The known targets for each for each of the four first line drugs and the genetic location of 
mutations that confer drug resistance are listed in Table 1.2. However, not all mutations that 
confer resistance have been fully elucidated. 
 
Drug 
Known or 
probable targets 
Mutations in genes 
conferring resistance 
Function of gene 
 
Rifampicin 
 
RNA synthesis 
 
rpoB 
 
DNA-dependent RNA 
polymerase (β subunit) 
 
 
Isoniazid 
 
Mycolic acid 
biosynthesis 
 
katG 
inhA/mabA 
ahpC 
 
Catalase/peroxidase 
Fatty-acid biosynthesis 
Alkylhydroperoxide C 
reductase 
 
 
Ethambutol 
 
Cell wall synthesis 
 
embA,B,C 
 
Lipoarabinomannan and 
arabinogalactan synthesis 
 
Pyrazinamide 
 
Pyrazinamidase 
 
pncA + others 
 
Pyrazinamidase 
 
 
Table 1.2  Molecular detection of drug resistance in M. tuberculosis 
 
Table from Drobniewski et al., 2007. 
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M. tuberculosis isolates that are resistant to both isoniazid and rifampicin are defined as 
multidrug-resistant TB (MDR-TB). Resistance to isoniazid and rifampicin, plus any 
fluoroquinolone and at least one of three injectable
 
second-line drugs (amikacin, kanamycin, 
or capreomycin) is defined as extensively drug resistant TB (XDR-TB) (Centers for Disease 
Control and Prevention (CDC)., 2006). There were an estimated 440,000 global cases of 
MDR-TB in 2008 resulting in 150,000 deaths. Of all global incident cases of TB it is 
estimated that 3.6% are MDR-TB. Almost half of all MDR-TB cases are estimated to be 
present in China and India (World Health Organisation, 2010a). In the UK in 2008, the level 
of isonizaid resistance was 6.9% of all new cases while rifampicin mono-resistance and 
MDR-TB rates were 1.4% and 1.2% respectively (Health Protection Agency, 2010). Eight 
XDR-TB cases have been reported in the UK between 1995 and 2008 which accounted for 
8/678 (0.9%) of all MDR-TB cases reported in this time period (Abubakar et al., 2009). 
 
1.5.5. Immunological diagnosis of latent disease 
Identification and prophylactic treatment of latently infected patients before active disease 
develops is important in “ring-fencing” an outbreak and preventing further transmission. The 
traditional method of identifying infection with M. tuberculosis was via sub-cutaneous 
injection of purified protein derivative (PPD) as the tuberculin skin test (TST) and analysis of 
the host response. However, TST has limited specificity as it cannot identify M. tuberculosis 
infection in individuals who have been previously vaccinated with the BCG vaccine or 
infected with environmental mycobacteria. 
 
Two sensitive enzyme-linked immunosorbent assays (ELISAs) have been developed that can 
detect T cells present in whole blood specimens with specific antigens for M. tuberculosis that 
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are absent from Mycobacterium bovis BCG and most environmental mycobacteria. These two 
tests are the Oxford ImmunoTec T-SPOT®.TB (Ewer et al., 2003;Lalvani et al., 2001) and 
Cellestis QuantiFERON
®
-TB Gold (Mazurek et al., 2001). 
 
These two ELISAs detect the production of interferon-gamma in whole blood from patients 
that is incubated with two antigens expressed by M. tuberculosis: early secretory antigenic 
target-6 (ESAT-6) and culture filtrate protein-10. These two antigens are secreted by all M. 
tuberculosis and M. bovis strains but are absent in all M. bovis BCG vaccine strains and from 
most NTMs (Mazurek et al., 2005;Andersen et al., 2000). T-SPOT®.TB enumerates the 
actual number of IFN-y releasing T-cells after antigen incubation whereas QuantiFERON
® 
Gold measures the amount of released IFN-y. From this, these two ELISAs are termed 
interferon gamma release assays (IGRA). 
 
1.5.6. Vaccination and screening 
The only currently available vaccine against M. tuberculosis is the M. bovis BCG strain. 
Albert Calmette and Camille Guérin produced this vaccine by culturing M. bovis in bile for 13 
years with passaging every two weeks for a total of 230 passages to produce the M. bovis 
BCG vaccine strain in 1921. During this time, the virulence of the passaged strains was 
measured in several animal species and was found to progressively decrease with continued 
passaging (Behr, 2002). The BCG vaccine has been administered to more than three billion 
individuals worldwide and primarily protects children from meningeal and miliary 
tuberculosis. However, protection of adults from pulmonary tuberculosis varies considerably 
from 80% in the UK to no protection in South India (Colditz et al., 1994). Notably, the 
countries with the highest disease burden generally exhibit a low protective efficacy of BCG. 
Chapter 1 
 24 
Exposure to environmental mycobacteria may provide natural protection or may impair the 
protection afforded by BCG (Collins and Kaufmann, 2001). To develop an improved vaccine, 
there are currently 11 new candidate vaccines in clinical trials (Kaufmann et al., 2010). 
 
All school pupils in the UK were routinely vaccinated with the BCG vaccine until 2005 when 
the national policy was changed to neonatal
 
BCG vaccination for high risk groups and at pre-
employment screening
 
for individuals entering "at risk" occupations. The UK policy was 
changed as BCG is not very effective in older children and adults with at best 75% protection 
for 15 years. Repeat vaccinations do not provide any extra benefit. Since 1987 in the UK 
cases rates in UK-born people aged 15-30 declined to reach less than two cases per 100,000 
population per year. This is the sole population group who were protected by routine BCG 
vaccination in early teenage life. From this, it has been calculated that approximately 10,000 
vaccinations were required to prevent a single case of TB with adverse events outweighing 
the benefits received from vaccination (Davies, 2009). 
 
New immigrants identified with active TB who have recently arrived in the UK do not present 
immediately after arrival as only 1,039/4,929 (21%) patients were diagnosed within two years 
of arrival in the UK with 2,209/4,929 (45%) patients presenting within five years; 1,198/4,929 
(24%) presented with tuberculosis within five and nine years after entry and 1,522/4,929 
(31%) had been in the UK for ten or more years before diagnosis (Figure 1.6). The median 
duration of stay in the UK before diagnosis of tuberculosis was four years with an 
interquartile range of 1-13 years (Health Protection Agency, 2010). 
 
Chapter 1 
 25 
The current national UK policy for screening of recently arrived immigrants involves port-of-
entry identification and screening with chest X-rays for immigrants who have originated from 
countries with a TB incidence rate of >40 cases per 100,000 population and intend to stay in 
the UK for >6 months. The aim of this policy is to detect active pulmonary tuberculosis and 
not individuals who are latently infected. This policy would need to be altered if identification 
of latent infection was an aim as well. A recent UK multicentre cohort study of 1,229 
immigrants aged 35 years or younger screened for latent tuberculosis infection by the IGRA 
test from three centres in the UK, showed that the current UK policy would fail to detect 71% 
of individuals latently infected (Pareek et al., 2011). Two more sensitive and cost effective 
strategies were proposed which increased the threshold incidence rate for screening to either 
150 or 250 cases per 100,000 population. These alternative strategies would have identified 
92% of individuals with latent infection. 
 
Figure 1.6.  Non-UK-born tuberculosis case reports by time since entry to the UK to 
tuberculosis diagnosis, UK, 2008. 
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1.6. DNA FINGERPRINTING AND MOLECULAR EPIDEMIOLOGY 
DNA fingerprinting is an essential tool in public health control efforts for tuberculosis as 
identification of indistinguishable strains in ≥2 patients with supporting conventional 
epidemiological data confirms that transmission has occurred and that a cluster of cases has 
been detected. Matching strains identified in epidemiologically linked patients reflect recent 
transmission and rapid progression from infection to active disease (Alland et al., 1994;Small 
et al., 1994). DNA fingerprinting can also be used to identify laboratory cross-contamination 
events where bacilli are unintentionally transferred from positive specimens into negative 
specimens during laboratory investigations and also determine whether two or more episodes 
of active TB disease in an individual represents endogenous re-activation with the previous 
strain or re-infection with a new exogenous strain. DNA fingerprinting methods can also 
provide new insights in the global epidemiology and phylogeny of TB. 
 
1.6.1. Phage typing 
The first genotypic typing method for M. tuberculosis utilised mycobacteriophages specific 
for the M. tuberculosis complex. There have been over 250 mycobacteriophages identified 
from many reservoirs including environmental, animal, and human specimens. A standardised 
methodology for the typing of M. tuberculosis using a panel of 12 mycobacteriophages was 
published by the WHO in 1975 (Rado et al., 1975). Phage typing was a valuable 
epidemiological tool for cluster investigation with large-scale international surveys 
identifying that there were striking geographic variations in mycobacteriophage susceptibility 
between the strain classifications of type A, type B, type C or intermediate. Type A strains 
predominated in Hong Kong, type B strains were more common in northern Europe, and of 
the strains from Madras in the south of India, over 40% were of the intermediate type. 
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Although phage typing provided the first insights into strain transmission and global 
epidemiology, no further increase in differentiation was achieved and it was eventually 
superseded by the development of the analysis of the genomic position and copy number of 
insertion sequences in 1993 (Grange et al., 1976;McNerney, 1999). 
 
1.6.2. IS6110 Restriction Fragment Length Polymorphism typing 
Insertion sequences (IS) are mobile genetic elements (0.8-2.5 kb in length) that contain 
inverted repeated DNA sequences at each end and a translated transposase which makes the 
sequence mobile (McAdam et al., 1990;Thierry et al., 1990a). ISs differ from transposons as 
they only transfer genes necessary for their own replication. More than 16 different ISs in five 
IS families have been reported in mycobacteria (McAdam et al., 1990). The IS6110 element 
is a member of the IS3 family which are the most widely spread group of ISs in bacteria. The 
IS3 family have been found in more than 24 different genera. IS6110 is apparently specific to 
M. tuberculosis when analysed by Southern blotting but cross-reactivity between 
mycobacterial species has been shown when fragments amplified by PCR were compared 
between mycobacterial species (Kremer et al., 1999;McHugh et al., 1997). 
 
Epidemiologic studies of the M. tuberculosis complex were greatly improved by the analysis 
of IS6110 by Restriction Fragment Length Polymorphism (RFLP). This is a nucleic acid 
hybridisation technique that analyses the copy number and location of IS6110 genomic DNA 
fragments digested by a restriction enzyme (Figure 1.7). Most strains contain 6-15 copies of 
IS6110 with the highest number approaching 30 copies (Cowan and Crawford, 2002). Various 
groups independently identified IS6110 with an internationally standardised protocol for 
RFLP published in 1993 that described the use of a common 245 bp probe that hybridises to 
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IS6110 fragments digested with PvuII (Thierry et al., 1990b;Zainuddin and Dale, 
1989;Eisenach et al., 1988;van Embden et al., 1993). 
 
The application of IS6110 RFLP to initial investigations of outbreaks showed that this 
technique was useful in cluster investigations as it exhibited epidemiologically correct 
clustering of related isolates and differentiation of non-related isolates (Edlin et al., 1992;van 
Soolingen et al., 1991a;Hermans et al., 1990). M. tuberculosis clinical isolates were highly 
polymorphic when analysed by IS6110 RFLP whilst in vitro studies demonstrated that 
transposition of IS6110 is an extremely rare event (van Soolingen et al., 1991b). In a 
subsequent study that typed strains from 544 patients with persistent culture positive TB, it 
was estimated that the half-life of changes in the RFLP banding pattern was at least 3.2 years 
(95% CI, 2.1-5.0) (de Boer et al., 1999). The half-life was defined as the average time 
required for 50% of IS6110 patterns to gain or lose one band. Since the rate of change was not 
rapid it was accepted that the “molecular clock” of IS6110 RFLP typing was appropriate as an 
accurate marker of transmission. 
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Figure 1.7  IS6110 RFLP genotyping.  
Mycobacterial DNA is digested with the restriction enzyme PvuII. The IS6110 probe 
hybridizes to IS6110 DNA to the right of the PvuII site in IS6110. The size of each 
hybridising fragment depends on the distance from this site to the next PvuII site in adjacent 
DNA, as reflected by gel electrophoresis of the DNA fragments. The horizontal lines in the 
middle indicate the extent of the distribution of fragments in the gel, including PvuII 
fragments that do not contain IS6110. A probe specific to IS6110 is used to detect IS6110 
containing fragments. Figure adapted from Barnes and Cave, 2003. 
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The mechanism of IS6110 transposition around the M. tuberculosis complex genome is not 
fully understood. Transposition does involve excision from the current site of integration and 
one of three possible mechanisms. Transposition can either be conservative where IS6110 is 
excised and inserted into a new site or replicative where IS6110 is duplicated. Homologous 
recombination between two IS6110 elements can delete intervening genomic DNA. IS6110 
transposition usually has a negative effect on the destination gene due to the disruption of 
gene coding or promoter DNA (McEvoy et al., 2007). 
 
IS6110 RFLP has been utilised in large-scale population based studies on the transmission 
dynamics of M. tuberculosis with the first studies undertaken in New York, Switzerland, San 
Francisco, and Denmark/Greenland (Yang et al., 1994;Alland et al., 1994;Small et al., 
1994;Genewein et al., 1993). The two US studies found that even with apparently efficient 
tuberculosis-control programmes, recent transmission was unexpectedly high and accounted 
for 30-40% of all new cases with TB transmission evidently not under control. The European 
study found that there was significant transmission between human populations resident in 
Denmark and Greenland. 
 
The country with the greatest experience of IS6110 RFLP typing is the Netherlands with more 
than 24,000 strains typed since 1993 (Schurch et al., 2011). The first nationwide study of 
4,266 cases from 1993 through 1997 found that 1,493/4,266 (35%) of all cases could be 
attributed to recent transmission. Demographic risk factors for active transmission of 
tuberculosis in the Netherlands included male sex, urban residence, Dutch or Surinamese 
nationality, and long-term residence in the Netherlands (van Soolingen et al., 1999). 
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Within the UK, there have been two large-scale population-based studies that have utilised 
IS6110 RFLP typing. The first study examined 2,042 isolates from Greater London between 
1995 and 1997 and estimated the rate of recent transmission within this time period as 14.4%. 
A later study looked at M. tuberculosis isolates from across England in 1998 and estimated an 
unadjusted rate of recent transmission as 12.2% with an adjusted estimate of 27.6% taking 
into account missed cases and study duration (Love et al., 2009;Maguire et al., 2002). 
 
1.6.3. Spacer Oligotyping (Spoligotyping) 
Spoligotyping as a typing method for M. tuberculosis strains was first published in 1997 
(Kamerbeek et al., 1997). Spoligotyping was the first genotypic method that enabled the 
simultaneous detection and strain differentiation of M. tuberculosis directly in clinical 
specimens without the need for culture. This method is based on a DNA polymorphism 
identified within the Direct Repeat (DR) locus of M. tuberculosis. This region contains 
multiple, conserved 36-bp DRs that have unique, individual spacer sequences ranging from 
34-41 bp in length interspersed between each DR. M. tuberculosis strains vary in the number 
and presence or absence of DRs (Figure 1.8) (Groenen et al., 1993;Hermans et al., 1991). 
This variation is probably caused by homologous recombination between DRs with 
reassortments caused by transposition of IS6110 into the DR locus (Groenen et al., 1993).  
PCR analysis of the DR locus was originally by “Direct Variable Repeat PCR” with the 
technique enhanced and data analysis simplified by the development of detection via reverse 
hybridisation to probes against 43 selected individual spacer regions covalently bound to a 
nylon membrane. The variation in presence or absence of spacer regions provides different 
hybridisation patterns. Each spacer region has a complementary oligonucleotide probe on the 
nylon membrane so the technique is called spacer oligotyping or spoligotyping. M. 
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tuberculosis and M. bovis exhibit characteristically different spoligopatterns such that 
spoligotyping can differentiate between the two members of the M. tuberculosis complex. M. 
bovis strains characteristically lack the final four spacer sequencers 39-43 (Kamerbeek et al., 
1997). When strain patterns obtained from spoligotyping were compared to IS6110 RFLP 
patterns in a study of 167 patients from three London hospitals in 1997, it was found that 
strains clustered by spoligotyping could be distinguished by IS6110 RFLP, with RFLP 
demonstrating a generally higher level of differentiation. Spoligotyping is particularly useful 
for subtyping isolates with low copy numbers of IS6110 (<5) as these strains exhibit a falsely 
high rate of clustering by RFLP (Goyal et al., 1997). 
 
The DR locus of M. tuberculosis has subsequently been assigned to a common family of 
repetitive DNA sequences called the clustered regularly interspaced short palindromic repeat 
(CRISPR) family that are present among archaea and bacteria but are absent in eukaryotes or 
viruses. There are also CRISPR-associated (cas) genes that are located directly adjacent to 
CRISPR loci. These genes may be involved in DNA metabolism or gene expression (Jansen 
et al., 2002). Further studies have shown that together the cas genes and CRISPR loci may 
provide defence mechanism against bacteriophages (Barrangou et al., 2007;Sorek et al., 
2008). 
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Figure 1.8  Spoligotyping. 
The chromosomes of M. tuberculosis H37Rv and M. bovis BCG contain 48 and 41 DRs, 
respectively (depicted as rectangles), which are interspersed with unique spacers varying in 
length from 35 to 41 bp. The (numbered) spacers used correspond to 37 spacers from M. 
tuberculosis H37Rv and six from M. bovis BCG. The site of integration of insertion element 
IS6110 is depicted. (B) Principle of in vitro amplification of the DR region by PCR. Any DR 
in the DR region may serve as a target for these primers; therefore, the amplified DNA is 
composed of a mixture of a large number of different-size fragments. Shown is the 
combination of fragments that would be produced by in vitro amplification of a DR target 
containing only five contiguous DRs.  (C) Hybridisation patterns (spoligotypes) of amplified 
mycobacterial DNAs of 35 M. tuberculosis and five M. bovis strains (Kamerbeek et al., 
1997). 
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Spoligotyping is not as discriminatory as IS6110 RFLP and is not used as a single first-line 
DNA fingerprinting method but as a complementary method to IS6110 RFLP  (Kremer et al., 
2005a). Since spoligotyping is a fast and robust genotyping technique it has been applied in 
multiple studies of M. tuberculosis complex strains around the world. Spoligotyping data 
from many studies have been consolidated into the “fourth international spoligotyping 
database (SpolDB4) for classification, population genetics and epidemiology” (Brudey et al., 
2006). This database contains spoligotyping data from 39,295 strains in 122 countries. There 
are a total of 5,309 individual spoligopatterns with 1,939/5,309 shared by more than one 
isolate and 3,370 orphan types. Using a mixed expert-based and bioinformatic approach, 62 
global clades have been identified. This database has been used to construct a global 
phylogenetic relationship for M. tuberculosis and has led to insights into global strain 
transmission and migration. 
 
There have been eight major M. tuberculosis spoligotyping clades identified: Beijing; Central 
Asian Strain (CAS); East-African Indian (EAI); Haarlem; Latin American and Mediterranean 
(LAM); X; and T. Each clade appears to be associated with prevalence in specific 
geographical continents (Figure 1.9): the Beijing strain represents about 50% of the strains in 
Far-East Asia and is emerging in Russia; CAS in the Middle-East/South Asia and specifically 
in India; EAI in Central/South-East/Far-East-Asia, the Middle East, and Oceania (Figure 
1.10). The presence of Haarlem in Europe and also Central America/Caribbean suggests that 
there is a link with historical European colonisation. LAM is present in South America, 
coastal regions in the Mediterranean and the Caribbean (Figure 1.11). The X family in North 
America and Central America could be linked to Anglo-Saxon ancestry but is also currently 
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correlated with African-Americans. T “ill-defined” T family is found on all continents as 
strains are designated as “T” by default (Brudey et al., 2006). 
 
 
 
Figure 1.9.  Percentage of main spoligotyping-defined MTBC genotype families within 
SpolDB4. 
 
Region abbreviations: AFR = Africa; CAM = Central America; EUR = Europe; FEA = Far-
East Asia; MECA = Middle-East and Central Asia; NAM = North America; OCE = Oceania; 
SAM = South America. Genotype family abbreviations: CAS = Central Asian Strain; EAI = 
East African Indian; LAM = Latin American Mediterranean (Brudey et al., 2006). 
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Figure 1.10.  World maps showing the global distribution of Beijing, EAI, and CAS. 
 
The diameter of each circle shows the absolute numbers and the colour represents proportions 
of total strain numbers within each country. The maps were built using an updated SpolDB4 
on 14
th
 September 2005, on clusters of the 50 most frequent shared types for a total of n = 
17,212 isolates (Beijing n = 4,042, EAI n = 1,684, CAS n = 1,022) (Brudey et al., 2006). 
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Figure 1.11.  World maps showing the global distribution of M. bovis, Haarlem, and 
LAM. 
 
The diameter of each circle shows the absolute numbers and the colour represents proportions 
of total strain numbers within each country. The maps were built using an updated SpolDB4 
on 14
th
 September 2005, on clusters of the 50 most frequent shared types for a total of n = 
17,212 isolates (M. bovis n = 3888, LAM n = 3400, Haarlem n = 3176) (Brudey et al., 2006).  
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Spoligotyping can be transferred to a high-throughput automated suspension array system 
(Luminex) by coupling the spacer oligonucleotides to 43 different microspheres which each 
contain slightly different proportional mixtures of two fluorochromes that enable the 
multiplex analysis of all 43 spacer oligonucleotides in a single well. Two lasers are used for 
detection: the first laser excites the fluorochromes within the microsphere which identifies the 
exact microsphere type and then a second laser excites a reporter molecule bound to the 
hybridised PCR product which enables quantification of the exact number of hybridised 
microspheres within seconds. The automated system definitively separates positive (present) 
and negative (absent) spacer regions without any overlap. The US CDC now routinely use the 
Luminex system to spoligotype all M. tuberculosis strains referred in the US (Cowan et al., 
2004). The multiplex capacity of the Luminex system has been utilised to develop an 
extended spoligotyping spacer set containing an additional 25 spacers to make a total of 68 
spacer regions analysed. This enhanced spoligotyping panel has been used to further 
reconstruct and refine the global phylogenetic scenario for M. tuberculosis (Zhang et al., 
2010). Matrix-assisted laser desorption ionisation-time of flight mass spectrometry (MALDI-
TOF MS) has also been used to increase the through-put of spoligotyping  (Honisch et al., 
2010). 
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1.6.4. MIRU-VNTR typing 
 
Variable number of tandem repeat (VNTR) sequences are multiple independent genetic loci 
found in at least 40 locations across the M. tuberculosis genome. Each locus contains 
repetitive DNA sequences that can differ in the number of repeats between strains (Figure 
1.12 and Figure 1.13) (Supply et al., 2000). 
 
Figure 1.12.  MIRU-VNTR typing. 
 
Two example MIRU-VNTR loci are shown (ETR-A and ETR-B) in three example strains. 
Each locus is amplified by PCR using primers specific for the flanking region up- and down-
stream of the repetitive DNA sequences. Variation in the number of repeats results in varying 
sizes of PCR amplicons. From the sized PCR amplicon, the number of repeats at each locus 
can be calculated and concatenated to form the complete MIRU-VNTR profile. 
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Figure 1.13 MIRU-23 alleles analysed by agarose gel electrophoresis. 
The MIRU-23 locus in ten different M. tuberculosis strains was amplified by PCR and 
separated by agarose gel electrophoresis. Each strain had a different allele value which ranged 
from 1-10 repeats. The two markers used were a 50 bp and 100 bp molecular markers. The 
positive control was H37Rv. 
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VNTRs were first described in M. tuberculosis in 1994 through determination of the 
mechanism of isoniazid resistance caused by variations in the katG gene. Variation in the 
katG gene in both isoniazid sensitive and resistant strains was found to be caused by varying 
numbers of a 75-bp repeat sequence (Zhang and Young, 1994). VNTR loci were first used in 
human gene mapping and identification, forensic analysis and paternity testing (Jeffreys et al., 
1985). VNTRs have been described in or applied to other members of the M. tuberculosis 
complex including: M. africanum (Frothingham et al., 1999); M. bovis (Skuce et al., 2002); 
M. canettii (Fabre et al., 2004); M. caprae (Prodinger et al., 2005); and M. pinnipedii (Moser 
et al., 2008). VNTRs have also been identified in NTMs including: Mycobacterium avium 
(Bull et al., 2003); Mycobacterium intracellulare (Ichikawa et al., 2010); Mycobacterium 
leprae (Groathouse et al., 2004); and Mycobacterium marinum/Mycobacterium ulcerans 
(Stragier et al., 2005). Other bacterial species that also possess VNTRs including include: 
Bacillus anthracis (Jackson et al., 1997), Staphylococcus aureus  (Hardy et al., 2004), and 
Clostridium difficile (Marsh et al., 2006). The number of repeats in each VNTR locus is 
calculated by PCR and fragment sizing. Each allele is then concatenated to form a VNTR 
profile (i.e. 42235) which can then be compared to other profiles to identify matches (Figure 
1.12). 
 
The first analysis of available M. tuberculosis H37Rv genome sequences before publication of 
the complete genome sequence identified two types of VNTR loci in a total of 11 tandem 
repeat loci. There were five major polymorphic tandem repeat (MPTR) loci that contained 15-
bp repeats with substantial sequence variation in adjacent copies and six exact tandem repeat 
(ETR) loci that contained largely identical DNA repeats. Seven loci (one MPTR locus and all 
six ETR loci) exhibited length polymorphisms that were caused by insertions or deletions of 
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tandem repeats and so could be analysed by agarose gel electrophoresis without requirement 
for elucidation of the full DNA sequence (Frothingham and Meeker-O'Connell, 1998). VNTR 
typing by PCR is a rapid and reproducible method that can be performed on crude DNA 
extracts and the data produced is digital which simplifies the comparison of large numbers of 
strains. From this it was proposed that VNTR typing in M. tuberculosis could be a useful 
alternative fingerprinting method to IS6110 RFLP. However, a subsequent study showed that 
the discriminatory power of the ETR loci did not match that exhibited by IS6110 RFLP 
(Kremer et al., 1999). The publication of the whole genome of M. tuberculosis H37Rv (Cole 
et al., 1998) enabled further genomic studies which identified additional mycobacterial 
interspersed repetitive units (MIRU) loci containing VNTRs (MIRU-VNTR) that increased 
the discriminatory power of VNTR typing in M. tuberculosis such that it began to approach 
that exhibited by IS6110 RFLP (Mazars et al., 2001;Smittipat and Palittapongarnpim, 2000). 
 
MIRU-VNTR typing using 12 loci was shown to be very stable and reproducible. In a study 
of 123 serial isolates from 56 patients over six years, 55/56 (98.2%) patients had identical 12 
locus MIRU-VNTR profiles whereas 11/56 (19.6%) of patients had varying RFLP profiles 
(Savine et al., 2002). Two studies of historically distant BCG strains from around the world 
showed that only one locus (ETR-D/MIRU-04) exhibited wide variation between BCG strains 
(Supply et al., 2000). 
 
Variations in VNTR loci may be caused by an increase or reduction in the number of tandem 
repeats by slipped-strand mispairing (Levinson and Gutman, 1987). It is thought that slippage 
during DNA replication in the template DNA strand reduces the number of repeats and 
increases repeat number if slippage occurs in the replicated strand. A recent study that 
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analysed the number of repeats per locus in >400 isolates indicated that there appears to be a 
general global trend towards reduction in the number of repeats in modern M. tuberculosis 
strains (Arnold et al., 2006). Although in a closed population in South Africa where multiple 
MIRU-VNTR profiles arose from a single ancestral genotype, MIRU-VNTR variation was 
hypothesised to have occurred in both directions which resulted in an increase or decrease in 
the number of repeats (Warren et al., 2004). 
 
MIRU-VNTR typing has been used to: identify a variant Beijing strain in New York (Bifani 
et al., 1999); identify laboratory contamination (Gascoyne-Binzi et al., 2001); subdivide 
clusters containing isolates with few copies of IS6110 (Barlow et al., 2001); and identify 
mixed infections (Shamputa et al., 2006). 
 
The Beijing strain is one of the most prevalent global clades of M. tuberculosis and it was 
initially thought that the development of a rapid highly discriminatory method such as MIRU-
VNTR in combination with spoligotyping would greatly enhance epidemiological studies of 
this strain (Sola et al., 2003;van Soolingen et al., 1995). However, subsequent studies have 
shown that the internationally recommended VNTR loci set did not provide sufficient 
differentiation of the Beijing strain. Additional VNTR loci can provide further differentiation 
(Nikolayevskyy et al., 2006). Many of these additional hypervariable VNTR loci have been 
excluded from other studies as their stability and reproducibility have been questioned 
(Supply et al., 2006). The true epidemiological significance of the apparent enhanced 
discrimination offered by additional VNTR loci has not been fully evaluated as many of these 
studies have focussed solely on strain differentiation and lack the associated epidemiological 
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data that could confirm the relevance of the enhanced differentiation (Mokrousov et al., 
2009;Dou et al., 2009;Hanekom et al., 2008;Wada et al., 2007). 
 
The exact function of VNTR loci in M. tuberculosis is not well understood as most loci are 
located in non-coding regions. For those VNTR loci that are located within an open reading 
frame (ORF), several proposed possible functions include: a source of antigenic variation; 
regulation of gene expression; differential translation of genes; or acting as structural 
components in genome organisation (Supply et al., 1997). 
 
VNTR loci in M. tuberculosis are similar to short sequence repeats in other bacteria which 
can modulate gene expression (van Belkum, 1999). In a comparison of the differences 
between protein expression between H37Rv and CDC1551 grown in vitro, differences in 
protein expression were found in only 15/1,750 (0.85%) of all soluble protein fractions 
identified by 2D electrophoresis (Betts et al., 2000). Although in vivo gene expression may 
vary between strains, this remarkable similarity suggested that the patterns of gene regulation 
in M. tuberculosis are highly conserved (Brosch et al., 2001). 
 
Of the current recommended set of 24 MIRU-VNTR loci, 11 have repeat units which are a 
multiple of three basepairs. Therefore, variations in these loci will not disrupt ORFs. Most 
loci (15) are located within putative genes but only four loci are located in genes with a 
defined function (Le Fleche et al., 2002). The leuA gene in M. tuberculosis encodes alpha-
isopropylmalate synthase (α-IPMS) which is a key enzyme in the first step of the leucine 
biosynthetic pathway. The primary substrates for α-IPMS are alpha-ketoisovalerate and acetyl 
CoA. The leuA gene contains a VNTR locus with a 57 bp repeat motif. A recent study on the 
Chapter 1 
 45 
effect of low (2 repeats) or high (14 repeats) allele number in the leuA gene found that this 
variation in repeat number affected protein structure and function.  The strain with 14 repeats 
tolerated wider pH and temperature ranges and exhibited a higher affinity for alpha-
ketoisovalerate and acetyl CoA (Yindeeyoungyeon et al., 2009). A different study on the 
formamidopyrimidine (faPy)-DNA glycosylase (Mtb-fpg1) that corrects oxidative damage in 
purines and pyrimidines showed that an increased number of tandem repeats in an upstream 
region upregulated the expression of the Mtb-fpg1 gene (Olsen et al., 2009). A similar 
relationship was identified with VNTR3690 and the lpdA gene (Akhtar et al., 2009). 
 
1.6.5. SNPs, Regions of Difference, and Whole Genome Analysis 
The first differences in the genome content of different members of the M. tuberculosis 
complex, M. bovis BCG, and several NTMs were initially identified by subtractive 
hybridisation. This showed that there were three large chromosomal regions present in 
virulent M. bovis that were absent in a M. bovis BCG vaccine strain. Southern hybridisation 
identified the presence of all three regions in virulent M. tuberculosis H37Rv and the M. 
tuberculosis Erdman strain but these regions could not be detected in M. avium or M. 
smegmatis. These large chromosomal regions (9.3-10.7-kb) were termed genomic regions of 
difference (RD) (Mahairas et al., 1996). 
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1.6.6. Identification of three Principal Genetic Groups based on SNPs in katG and gyrA 
The first differences due to SNP variations in M. tuberculosis were identified by analysis of a 
total of two megabases of DNA sequence data in 26 regions which identified three principal 
genetic groups (PGG) based on two SNPs in genes encoding for catalase-peroxidase (katG) 
and subunit A of the DNA gyrase gene (gyrA) (Figure 1.14). Group 1 and 3 organisms were 
found to be evolutionarily distinct with group 1 or 2 strains but not group 3 organisms 
associated with large clusters of cases. This study suggested that M. tuberculosis is evolving 
toward a state of reduced transmissibility or virulence (Sreevatsan et al., 1997). 
 
Figure 1.14.  Initial evolutionary scenario for M. tuberculosis complex organisms based 
on three SNP genotypes.  
 
The precursor of M. tuberculosis complex organisms was characterised by SNPs present in 
katG codon 463 (Leu) and gyrA codon 95 (Thr) (Sreevatsan et al., 1997). 
 
1.6.7. The complete genome sequence of M. tuberculosis and other mycobacteria 
Whole genome analysis of M. tuberculosis was greatly enhanced by the publication of the 
complete genome sequence of M. tuberculosis laboratory strain H37Rv in 1998. It was found 
that the entire genome is 4,411,529 bp long, contains about 4,000 genes, and has a very high 
GC content (Cole et al., 1998). Comparison of H37Rv and complete genome sequences of 
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clinical M. tuberculosis strains that were subsequently characterised have shown that SNPs 
are rare and insertion or deletion events are the principal source of genomic variation. 
Insertion and deletions are caused by insertion sequences, expansion or reduction in repetitive 
DNA sequences or replication errors (Fleischmann et al., 2002). 
 
The complete genome sequence of M. marinum was published in 2008. This mycobacterial 
species has a broad host range and is a ubiquitous pathogen of fish and amphibians and is 
related to M. tuberculosis. The chromosomal genome of M. marinum was found to be 
6,636,827-bp long with a 23-kb plasmid present also. M. marinum has been widely used as a 
model to study M. tuberculosis pathogenesis and comparison of these two complete genomes 
identified an average amino acid homology of 85% which indicated that both species have a 
recent common genetic ancestor. It was hypothesised that M. marinum has retained more of 
the genetic content of the common ancestor compared to the reductive evolution and 
adaptation undergone by M. tuberculosis within the human host (Stinear et al., 2008). M. 
leprae has undergone even further genomic reduction when compared to the M. tuberculosis 
genome (4.41 Mb) as the genome is only 3.27 Mb long with less than half of the M. leprae 
genome containing functional genes (Cole et al., 2001). 
 
Within the M. tuberculosis complex, various insights have been achieved by the analysis of 
complete genome sequences. M. tuberculosis H37 was first isolated in 1905 and was noted for 
its virulence in the guinea pig model which was used in the classification of “human 
tuberculosis” in the early 20th century. Serial passage of H37 through media at different pH 
levels dissociated this strain into two variants that have different colony morphologies: 
virulent H37Rv (rough) and attenuated H37Ra (smooth) (Steenken et al., 1934;Bifani et al., 
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2000). These two strains have been widely used in studies of mycobacterial virulence. 
However, it is only relatively recently that the genetic basis for the phenotypic difference 
between H37Rv and H37Ra laboratory strains has been elucidated (Brosch et al., 1999;Lee et 
al., 2008;Zheng et al., 2008). Complete genome sequences have also enabled the 
differentiation of the original and current modern M. bovis BCG vaccine strains (Seki et al., 
2009;Brosch et al., 2007;Pym et al., 2002), and the construction of a new evolutionary 
scenario for the appearance of M. tuberculosis and M. bovis. 
 
1.6.8. M. tuberculosis can be divided into ancestral and modern lineages 
A study of 20 variable RDs generated from insertion/deletion events were analysed in 100 
strains of the M. tuberculosis complex including M. tuberculosis, M. africanum, M. canettii, 
M. microti, and M. bovis (Figure 1.15). RDs are generated primarily by IS6110 insertion, 
subsequent homologous recombination and excision of intermediary DNA that occur in a 
unidirectional manner. It was discovered that these events had occurred in common progenitor 
strains defined by the presence or absence of a M. tuberculosis specific deletion called 
“TbD1”.  This single region was used to divide the M. tuberculosis complex into ancestral 
(TbD1 is present) and modern (TbD1 absent) strains. Modern strains include major global 
clades such as the Beijing and Haarlem strains. Deletion of RD9 and other subsequent 
deletions occurred in a lineage now containing M. africanum, M. microti, and M. bovis that 
occurred before divergence from M. tuberculosis and before alterations in TbD1 occurred. 
This study contradicted the previous hypothesis that M. tuberculosis had evolved from M. 
bovis. The genomes of M. canettii and TbD1+ (ancestral) M. tuberculosis genomes were the 
most intact and had not undergone as much genetic reduction through loss of RD loci and 
appeared to be closest to a most recent common ancestor for the M. tuberculosis complex 
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(Brosch et al., 2002). Subsequent studies that combined RD9, TbD1 and PGG SNP data 
identified that RD9 was deleted in the ancestral PGG1 group but not in the modern PGG2/3 
group whereas TbD1 was present in ancestral strains but deleted in modern strains. The 
deletion of RD9 and presence of TbD1 in ancestral strains indicated that deletion of RD1 
occurred before deletion of TbD1 and the generation of modern lineages (Huard et al., 2006). 
 
 
 
Figure 1.15.  Scheme of the proposed evolutionary pathway of the tubercle bacilli 
illustrating successive loss of DNA in certain lineages. 
 
The scheme is based on the presence or absence of conserved deleted regions and on sequence 
polymorphisms in five selected genes. Note that the distances between certain branches may 
not correspond to actual phylogenetic differences calculated by other methods. Blue arrows 
indicate that strains are characterised by katG 463. CTG (Leu), gyrA 95 ACC (Thr), typical 
for group 1 organisms. Green arrows indicate that strains belong to group 2 characterised by 
katG 463 CGG (Arg), gyrA 95 ACC (Thr). The red arrow indicates that strains belong to 
group 3, characterised by katG 463 CGG (Arg), gyrA 95 AGC (Ser) (Brosch et al., 2002).  
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1.6.9. The origin and ancestry of M. tuberculosis 
M. canettii represents the most well-defined member of the smooth tubercle bacilli in the M. 
tuberculosis complex. After it was identified as an ancestral lineage to the rest of the M. 
tuberculosis complex by analysis of RDs, an analysis of the variation in six housekeeping 
genes (16S rRNA, katG, gyrA, gyrB, hsp65, rpoB, and sodA genes) of 37 smooth tubercle 
bacilli predominantly from Djibouti in East Africa compared to nine other members of the 
MTBC was undertaken (Gutierrez et al., 2005). It was found that the genetic diversity of the 
smooth bacilli was far greater than other members of the M. tuberculosis complex. Combined 
with the RD distribution, this placed the appearance of the smooth bacilli before the rest of the 
M. tuberculosis complex. This meant that at some point in time an evolutionary bottleneck 
had occurred where the diversity of the mycobacterial population was previously far greater 
than that of current modern M. tuberculosis strains which now represent a small proportion of 
the total diversity once exhibited by the ancestral strains of M. tuberculosis. M. 
prototuberculosis was proposed as the name for this new highly diverse species that is a 
progenitor of M. tuberculosis.  
 
The combined sequences of the six housekeeping genes were compared within the smooth 
bacilli and to the rest of the M. tuberculosis complex. The M. prototuberculosis housekeeping 
genes appear to be composed of a mosaic of gene sequences that originated from different 
eight subtypes of M. canettii whereas the other members of the M. tuberculosis complex had 
completely homologous gene sequences without any variation. This suggested that M. 
prototuberculosis had undergone multiple horizontal gene transfer events, a function that is 
absent in modern M. tuberculosis. (Gutierrez et al., 2005). Also, there is no convincing 
evidence to date for the presence of plasmids in M. tuberculosis. Extrachromosomal DNA 
Chapter 1 
 51 
which was presumed to be a plasmid was visualised by agarose gel electrophoresis but this 
has never been fully isolated or characterised (Crawford and Bates, 1979;Zainuddin and Dale, 
1990). The transfer of genomic DNA in M. tuberculosis under natural conditions has not yet 
been demonstrated (Balganesh et al., 2010). 
 
The increased nucleotide diversity in the ancestral strains also greatly increased the estimate 
of when a progenitor of M. tuberculosis originally appeared from 35,000 years to 2.6-2.8 
million years (Hughes et al., 2002). The new evolutionary age of 2.6-2.8 million years and the 
geographical restriction of smooth tubercle to East Africa where early human ancestors were 
present three million years ago has led to the hypothesis that both humans and tubercle bacilli 
emerged in Africa (Semaw et al., 2005). 
 
Further studies that examined 89 genes in 108 strains that originated from around the world 
found that the level of genetic diversity in M. tuberculosis was higher than previously thought 
(Hershberg et al., 2008). This diversity was linked to the emergence of ancient human 
populations in Africa about 40,000 years ago and subsequent migration. A second study 
identified that “modern” strains of M. tuberculosis emerged about 10-20,000 years later 
(Wirth et al., 2008). 
 
1.6.10. Clinical application of genome-informed assays 
Large sequence polymorphisms (LSP) are deletion events like RDs but they encompass all 
other deleted regions that are not part of the well-defined RD set (Mahairas et al., 1996). The 
analysis and identification of LSPs has been utilised to identify clinically important strains of 
M. tuberculosis. Analysis of five LSPs enabled the genome level-informed identification by 
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PCR of an outbreak strain in Leicester with a different set of LSPs bound to a nylon 
membrane in reverse-line hybridisation assay which could identify deletions in 43 genomic 
regions in up to 40 strains at one time (Rajakumar et al., 2004;Goguet de la Salmoniere YO et 
al., 2004; Cardoso Oelemann, 2011). More recently, a prevalent strain in Rio de Janeiro was 
identified through the detection of a solitary 26 kb deletion event (Lazzarini et al., 2007). 
 
1.6.11. High-throughput Whole Genome Sequencing 
New sequencing technologies have been developed using a variety of strategies that generate 
DNA sequence data using massively parallel reactions that generate millions of bases from a 
single experiment at a reduced cost (Pallen et al., 2010). High-throughput whole genome 
sequencing (WGS) is starting to be applied to M. tuberculosis strains to examine strain 
transmission, drug resistance, global phylogeny of the Beijing strain, and mutation rates in 
latent infection. WGS has been applied to the first and last isolates of one small cluster of five 
patients over a 12 year period and one large cluster in the Netherlands and one outbreak in 
British Columbia. In the small Dutch cluster, it was found that a total of six polymorphisms 
were present which consisted of four SNPs, a variation in a VNTR locus (not one that is 
internationally analysed), and a known transposition of IS6110. Surprisingly, 5/6 
polymorphisms arose first in a single patient who had been non-compliant. Within this cluster, 
M. tuberculosis had been relatively stable with a burst of mutation (Schurch et al., 2010b). 
Three isolates from a total of 104 in one of the largest clusters in the Netherlands (Harlingen) 
were selected for WGS which identified eight SNPs. Traditional contact tracing had identified 
two routes of transmission in this outbreak whereas application of WGS provided greater 
resolution with five SNP subclusters identified (Schurch et al., 2010a). In an earlier study, 
two apparently clonal Beijing strains from Uzbekistan were sequenced and considerable 
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diversity was identified with 130 SNPs present. However, these two strains did not share the 
exact same fingerprinting pattern as 23/24 MIRU-VNTR loci were indistinguishable 
(Niemann et al., 2009). It may be that this variation is indicative of the genetic distance 
between strains that are closely related. 
 
WGS was combined with social network analysis and applied to 32 isolates in an outbreak in 
British Columbia that had an indistinguishable MIRU-VNTR and RFLP genotype. WGS and 
social network analysis identified two lineages and clarified the potential routes of 
transmission (Gardy et al., 2011). In two independent studies in South Africa, WGS was used 
to examine the distribution of mutations in the KwaZulu-Natal (KZN) XDR and Beijing 
strains. WGS showed that MDR and XDR strains did not share the same mutations conferring 
resistance to rifampicin and pyrazinamide but XDR strains from various locations had 
identical drug resistance mutations. Therefore, MDR strains and XDR had acquired mutations 
independently which excluded gradual increment in drug resistance within each patient from 
MDR to XDR but rather that a single XDR clone had emerged and expanded (Ioerger et al., 
2009). Conversely, WGS of 14 XDR Beijing strains from two separate clusters identified that 
resistance mutations appeared multiple times independently within each of the two clusters. 
Therefore, drug resistance in these two clusters had been acquired within each patient and 
were not a result of increased rate of mutation and clonal expansion of a single drug-resistant 
strain (Ioerger et al., 2010). WGS of six Beijing strains from different countries combined 
with RFLP patterns identified that about 80% of Beijing strains were closely related and 
represented a monophyletic lineage that has recently appeared and undergone significant 
clonal expansion to become one of the most prevalent strains in the world today (Schurch et 
al., 2011). 
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The accumulation of mutations in active and latent disease was compared by sequencing 33 
M. tuberculosis isolates from nine experimentally infected macaques. It was found that there 
was a similar mutation rate during latency as during active disease or in a log phase culture. 
From the distribution of polymorphisms, it was deduced that the mutational changes were 
caused by oxidative damage in the absence of mycobacterial replication (Ford et al., 2011). 
This finding has several implications including the use of WGS in strain transmission studies 
as a strain infecting an individual, not presenting as primary disease initially, and eventually 
reactivating could possess a different SNP pattern to other strains within the same cluster. 
 
1.6.12. Clinical utility of DNA Fingerprinting 
DNA fingerprinting is an essential part of a TB control programme as it can estimate 
transmission in specific populations groups, focus interventions by identifying factors for 
transmission and can be used to evaluate the effectiveness of targeted interventions to prevent 
transmission. 
 
The Netherlands have undertaken universal prospective DNA fingerprinting of all M. 
tuberculosis isolates since 1993. This enabled the identification of transmission after 
migration in patients recently arrived in the Netherlands with 30-40% of cases in Turkish, 
Moroccan, and Somali patients attributed to recent transmission. (Borgdorff et al., 2001).  
 
Analysis of six years worth of data obtained from nationwide tuberculosis contact 
investigation and DNA fingerprinting surveillance in the Netherlands showed that in 2,206 
clustered cases, DNA fingerprinting increased the number of epidemiologic links from 462 
before DNA fingerprinting data to 1,002 epidemiologic established links after cluster 
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investigation which involved the combination of molecular and epidemiological data. DNA 
fingerprinting did not extend contact tracing investigations. Cluster monitoring did enable the 
identification of transmission events not detected by contact investigations, the development 
of focused interventions, and the evaluation of regional tuberculosis eradication programmes 
(Lambregts-van Weezenbeek et al., 2003). 
 
A third study in the Netherlands identified an association between rapidly expanding clusters 
that expanded from two patients to five or more patients within two years and patient 
epidemiological factors. If the first two patients in a cluster were identified within three 
months of each other, one or both were <35 years old, and both patients resided in an urban 
area and originated from Sub-Saharan Africa, there was a more than five times increased 
probability that a strain identified in an initial cluster of two paired patients would be 
identified in five or more patients within two years (Kik et al., 2008). 
 
A study in the US state of Maryland showed that cluster investigation which involved the 
combination of conventional and molecular epidemiological data increased the number of 
clusters with known links between patients by 61% from 70 using conventional 
epidemiological data alone to 113. This system also detected that 29% of case pairs defined 
by conventional epidemiological data were not actually the same strain (McNabb et al., 
2004).  
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1.7. BACKGROUND TO THE PROJECT 
The rates and case numbers of M. tuberculosis in the Midlands have been slowly and 
consistently increasing since the late 1980‟s. Conventional epidemiological data for TB cases 
in the Midlands are collected and analysed on an annual basis (Health Protection Agency, 
2010). However, the molecular epidemiology of M. tuberculosis in the Midlands has yet to be 
fully elucidated. Examining the molecular epidemiology will enable prevalent global lineages 
and specific strains to be identified within the Midlands as well as providing an insight into 
transmission routes. 
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1.8. AIMS OF THESIS 
The principal aim of this thesis was to understand the epidemiology and transmission of M. 
tuberculosis in the Midlands. 
 
The specific objectives were to: 
 Evaluate IS6110 RFLP data in comparison to MIRU-VNTR data to identify if MIRU-
VNTR typing could be a rapid alternative method to IS6110 RFLP. 
 Develop automated analysis of MIRU-VNTR loci using non-denaturing High 
Performance Liquid Chromatography (non-dHPLC) which would enable the analysis 
of all M. tuberculosis strains in the Midlands and enhance the knowledge and 
understanding of the epidemiology and transmission of M. tuberculosis. 
 Identify the prevalent global lineages present in the Midlands and the continental 
origin of infected patients using non-dHPLC, MIRU-VNTR, and a novel computer 
software programme called Origins. 
 Identify, confirm, and analyse the distribution of the single most prevalent MIRU-
VNTR profile in the Midlands. 
 Undertake a whole-genome analysis of prevalent strains in the Midlands using DNA-
DNA microarray hybridisation to identify properties unique to these strains and the 
genetic origin of these strains. 
 
  58 
2. MATERIALS AND METHODS 
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2.1. REAGENTS AND SUPPLIERS 
Reagents were purchased from Sigma-Aldrich (Gillingham, Dorset, UK) unless otherwise 
stated. Nucleotides for PCR were purchased from Eurofins MWG Operon (Ebersberg, 
Germany). For each DNA polymerase used, the provided PCR buffer and MgCl2 was also 
used. PCR amplifications were carried using MultiBlock System Thermal Cyclers from 
Thermo Fisher Scientific (Loughborough, Leicestershire, UK). A list of solutions frequently 
used in this thesis can be found in Appendix I. 
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2.2. STUDY POPULATION 
This PhD will focus on M. tuberculosis strains isolated from across the West and East 
Midlands. The Midlands region of the UK encompasses the West and East Midlands (Figure 
1.3) which had a total population of 5.4 and 4.4 million people respectively in 2009 (Office 
for National Statistics, 2010). There are 82 counties in England with six counties in the West 
Midlands region (Herefordshire, Shropshire, Staffordshire, Warwickshire, West Midlands 
county, Worcestershire) and five counties in the East Midlands (Derbyshire, Leicestershire, 
Lincolnshire, Northamptonshire, and Nottinghamshire) (Figure 2.1.). The West Midlands 
exists on two geographical levels as a region but also as a county. Community health care in 
England is currently organised and provided by 151 Primary Care Trusts (PCT) which work 
with local authorities (LA) to provide health and social care in local communities. There are 
17 PCTs in the West Midlands and nine PCTs in the East Midlands (Figure 2.2.A) with nine 
PCTs located in the county of the West Midlands (Figure 2.2.B). 
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Figure 2.1.  Counties in the West and East Midlands. 
This map was generated using the HPA Geographic Information System Intranet Application 
and under license by © Crown copyright and database right 2010. All rights reserved. 
Ordnance Survey Licence number 100016969 
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A. PCTs in West and East Midlands regions 
 
 
B. *PCTs in West Midlands county 
 
 
 
Figure 2.2. Primary care organisation boundaries in the West and East Midlands.  
This map was produced under license by ©Crown Copyright and database right 2010 using 
the HPA Geographic Information System Mapping System. Ordnance Survey License 
100016969/100022432. 
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2.3. INITIAL SPECIMEN COLLECTION, PROCESSING, AND RESULT 
REPORTING 
Specimens received at the MRCM were processed as described in the HPA National Standard 
Method BSOP40 (Evaluations and Standards Laboratory, 2006). 
 
2.3.1. Mycobacterial culture using solid media 
For each isolate, an approximate 20 ml universal containing a slope of LJ Medium (Media for 
Mycobacteriology, Penarth, South Glamorgan, UK) was inoculated. The formula for 600 ml 
was as follows: 2.5 g monopotassium phosphate; 0.24 g magnesium sulphate; 0.6 g sodium 
citrate; 3.6 g L-asparagine; 30 g potato flour; 0.4 g malachite green; 12 ml glycerol. The final 
step of preparation was the addition of 1,000 ml whole egg to the rest of the 600 ml. 
 
Egg-based media support the growth of a wide variety of mycobacteria. L-asparagine and 
potato flour provide nitrogen and vitamins, monopotassium phosphate and magnesium 
sulphate ac as buffers, glycerol and the egg suspension provide fatty acids and proteins 
required for mycobacterial metabolism, and sodium citrate and malachite green act as 
selective agents to prevent the growth of non-mycobacterial contaminants. 
 
2.3.2. Mycobacterial culture using liquid media 
Each MGIT (Becton-Dickinson, Oxford, UK) contained 7 ml of modified Middlebrook 7H9 
broth base. The complete medium included: 7H9; oleic acid, albumin, dextrose, catalase 
(OADC); and polymixin B, amphotericin B, nalidixic acid, trimethoprim, and azlocillin 
(PANTA). Each MGIT contained 110 μl of fluorescent indicator (Tris 4,7-diphenyl-1,10-
phenanthroline ruthenium chloride pentahydrate in a silicone rubber base) and 7 ml of 7H9 
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broth (5.9 g Modified Middlebrook 7H9 Broth base and 1.25 g Casein peptone per 1 l of 
purified H2O). For a batch of 18 MGITs, 15 ml of Middlebrook OADC enrichment was added 
to a lyophilised mixture of antimicrobial agents (PANTA) and 0.8 ml of the reconstituted 
OADC-PANTA supplement was then added to each individual MGIT. The OADC 
supplement contained: 0.1 g oleic acid; 50 g bovine albumin; 20 g dextrose; 0.03 g catalase; 
and 1.1 g polyoxyethylene stearate per l of purified H2O. The PANTA supplement contained: 
6,000 U polymyxin B; 600 µg amphotericin B; 2,400 µg nalidixic acid; 600 µg trimethoprim; 
and 600 µg azlocillin. 
 
For DNA microarray analysis, Dubos broth was used. For 900 ml of sterile distilled H2O, this 
contained approximately: 0.5 g pancreatic digest of casein; 2.0 g L-asparagine; 1.0 g 
monopotassium phosphate; 2.5 g disodium phosphate; 0.05 g ferric ammonium citrate; 0.01 g 
magnesium sulphate; 0.2 g polysorbate 80; 0.5 mg calcium chloride; 0.1 mg zinc sulphate; 0.1 
mg copper sulphate; and 100 ml bovine albumin. 
 
Enriched Dubos broth contains an enzymatic digest of casein and L-asparagine as nutrient 
sources. A variety of inorganic salts provide ions required for mycobacterial metabolism. 
Polysorbate 80, an oleic acid ester, supplies essential fatty acids for mycobacterial replication. 
Bovine albumin acts as a protective agent by binding free fatty acids that may be toxic to 
mycobacteria. The albumin is heat-treated to inactivate lipase, which may release fatty acids 
from the polysorbate 80. Phosphate buffers maintain the pH of the medium. The particular 
value of Dubos broth is that it provides enhanced dispersed growth, free of excessive clumps. 
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2.3.3. DNA extraction for PCR 
Either a 1 μl loopful of mycobacteria from solid culture was suspended in 0.5 ml sterile 
distilled H2O or 0.5 ml of liquid culture was pipetted into a 1.5 ml screw-capped micro 
centrifuge tube. The mycobacteria were centrifuged for 5 minutes at 8,000 g using an aerosol-
containment rotor. The supernatant was discarded and the pellet was resuspended in 300 μl 
sterile distilled H2O and vortexed for 5 seconds. The suspension was heated at 100 C for 30 
minutes and then sonicated for 15 minutes at room temperature. The samples were then 
centrifuged for 5 minutes at 13,000 g and the supernatant was transferred to a clean labelled 
1.5 ml microcentrifuge tube. DNA extracts were then stored at 
-
20ºC until analysis. 
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2.4. IDENTIFICATION OF MYCOBACTERIAL ISOLATES. 
All positive cultures in the HPA Midlands Region Centre for Mycobacteriology were 
identified as specific members of the M. tuberculosis complex with the GenoType® MTBC 
test (HAIN Lifescience, Nehren, Germany). This assay distinguishes between: M. 
tuberculosis; M. africanum; M. microti; M. bovis ssp. bovis; M. bovis ssp. BCG; and M. bovis 
ssp. caprae by PCR amplification and reverse line hybridisation of three target regions (23S 
rDNA, gyrB, and RD1 in BCG) (Richter et al., 2004).  
 
Hybridisation included the following steps: chemical denaturation of the amplification 
products; hybridisation of the single-stranded, biotin-labelled amplicons to membrane-bound 
probes; stringent washing; addition of a streptavidin/alkaline phosphatase (AP) conjugate; and 
an AP mediated staining reaction. Hybridisation can be automated using the GT-Blot 48 
System. 
 
2.4.1. HAIN GenoType MTBC: PCR amplification 
For each individual sample, the PCR amplification mix (45 μl) was prepared in a DNA-free 
room. The PCR mastermix contained: 35 μl PNM; 5 μl 10X polymerase incubation buffer; 4 
μl MgCl2 solution; 1.5 U HotStarTaq DNA Polymerase (Qiagen, Crawley, West Sussex, UK); 
and 0.7 μl H2O. In a separate laboratory, 5 μl of template DNA was added to make a final 
volume of 50 μl with one negative control containing 5 µl of sterile distilled H2O. An initial 
denaturation at 95°C for 5 minutes was followed by 10 cycles of denaturation at 95°C for 30 
seconds and annealing at 58°C for 2 minutes. This was then followed by 20 cycles of 95°C for 
25 seconds, annealing at 43 C for 40 seconds, and 70 C for 40 seconds. A final extension step 
at 70°C for 8 minutes concluded the reaction program. The amplified regions have a length of 
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215 bp (Universal Control), 152 bp and 203 bp (gyrB). BCG will have an additional amplicon 
of 117 bp. The amplicons were then hybridised using the provided reagents in the HAIN 
MTBC kit on a BeeBlot system (Bee Robotics, Caernarfon, Gwynedd, UK). 
 
2.4.2. HAIN GenoType MTBC: Evaluation and interpretation of results 
Hybridised strips were pasted onto a provided evaluation sheet, positive signals were noted, 
and species were determined using a provided interpretation chart. Each strip has a total of 13 
reaction zones including two control zones (conjugate and universal). The conjugate control 
identifies the efficiency of conjugate binding and the substrate reaction. A line should always 
be present in the conjugate control zone. The universal control detects all known 
mycobacteria and members of gram positive bacteria with a high GC content. The MTBC 
zone hybridises with amplicons generated from all members of the M. tuberculosis complex. 
There are 10 other zones with specific probes for each member of the M. tuberculosis 
complex. Only those bands whose intensities that are at least equivalent to the universal 
control zone were considered. 
 
2.4.3. Agarose gel electrophoresis  
For each agarose gel, the appropriate weight of Agarose-1000 (Invitrogen, Paisley, 
Renfrewshire, UK) was weighed, added to the appropriate volume of 0.5X tris borate EDTA 
(TBE), and left to hydrate for 15 minutes. The agarose-TBE mixture was then heated in a 
microwave until boiling, removed and mixed. If the agarose percentage was greater than 1%, 
the gel was heated again until boiling. If the agarose percentage was less than 1%, the gel was 
heated to boiling once again. The agarose was then left to cool for 5 minutes at room 
temperature. For all gels except those for IS6110 RFLP Southern Hybridisation, a 12 x 14 cm 
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gel casting tray was used. The agarose was poured into the gel tray, 1 mm width 20 lane gel 
combs inserted, left to set for 30 minutes at room temperature and then at least 30 minutes 
(preferably overnight) at 4ºC. For gels that analysed PCR amplicons, 10 µl 5X loading buffer 
was added to each PCR sample and mixed with a pipette. The gel was then inserted into the 
gel tank, TBE was added such that there was at least 0.5 cm TBE buffer above the gel, and gel 
combs were removed. Either 50 bp or 100 bp ladder was added to first, middle, and last wells 
and 12 µl of each amplicon was added to the corresponding well. The gel tank lid was placed 
and connected to a power supply unit. Voltage and time was set to the desired values. Gels for 
PCR amplicon detection were stained in ethidium bromide for 15 minutes and destained in 1X 
TBE for 15 minutes before an image was taken using an ImageMaster Gel Documentation 
System (GE Healthcare, Chalfont St Giles, Buckinghamshire, UK). 
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2.5. IS6110 RFLP 
2.5.1. Isolation of high molecular weight genomic DNA from mycobacteria  
All steps were performed in a Class I Biological Safety Cabinet within Containment Level III. 
One LJ slope was inoculated with the mycobacterial strain of interest and incubated at 37ºC 
for at least four weeks or until growth was clearly visible. At least two loops of mycobacteria 
were transferred into a 1.5 ml screw-capped microcentrifuge tube containing 400 µL 1X tris 
ethylenediaminetetraacetic acid (TE) buffer and the cells were then heated at 80ºC for 20 
minutes. To each strain, 50 µL lysozyme (10 mg/ml) was added; tubes were vortexed and 
incubated at 37°C overnight. The next day, 70 µL 10% sodium dodecyl sulphate (SDS) and 5 
µl proteinase K (10 mg/ml) was added, tubes were vortexed, and incubated at 65°C for 30 
minutes. After this, 100 µL 5 M NaCl and 100 µL cetyl trimethylammonium bromide 
(CTAB)/NaCl solution were added, tubes were vortexed, and incubated at 65°C for 10 
minutes. To separate DNA from the cell suspension, 750 µL chloroform/isoamyl alcohol 
(24:1) was added, tubes were inverted 10 times, and centrifuged at 12,000 g for 8 minutes. 
The aqueous supernatant was transferred to a fresh microcentrifuge tube and 450 µL 
isopropanol stored at -20ºC was added. Nucleic acids were precipitated by slowly inverting 
the tube a few times and the tube was incubated at -20°C for at least 30 minutes. DNA was 
pelleted by centrifugation at 12,000 g for 15 minutes. Most of the supernatant was removed 
and 1 ml 70% ethanol stored at -20ºC was added and centrifuged at 12,000 g for 5 minutes. 
Most of the supernatant was again removed and an additional centrifugation of at 12,000 g for 
1 minute was done. The rest of the supernatant was removed, dried for 15 minutes at room 
temperature, and resuspended in 1X TE buffer. If there was no precipitate of nucleic acids 
visible, the pellet was dissolved in 20 µL 1X TE buffer. If there was a small precipitate 
visible, then the pellet was dissolved in 35 µL. Medium and large precipitates required 50 µL 
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and 80 µL, respectively. The DNA extract was incubated at 4ºC overnight to redissolve and 
until needed. 
 
2.5.2. Estimation of the DNA concentration before digestion using a GeneQuant 
Spectrophotometer 
DNA samples were vortexed briefly and 2 µl of each DNA sample was added to 198 µL 1X 
TE. A GeneQuant™ Spectrophotometer (GE Healthcare, Little Chalfont, Buckinghamshire, 
UK) was used and the mode was selected for double stranded DNA quantification. A blank 
cuvette containing 100 µL 1X TE was pipetted into a clean cuvette and a reading was taken as 
the reference by using the “SET REF” function. For each sample, the absorbance of 100 µl of 
the diluted solution was analysed at 260 nm and noted. 
 
The concentration of DNA was calculated using the following formula: 
DNA concentration (mg/ml) = 50 mg/ml x Measured A260 x dilution factor 
 
The amount of DNA required for PvuII digestion (4.5 µg) was calculated with the formula: 
4500/DNA concentration (µg/ml) = µL DNA required for digestion. 
 
2.5.3. Analysis of the DNA quality 
A 0.8% agarose gel was prepared and 1 µl extracted DNA was added to 9 µL gel loading 
buffer. All (10 µL) of each sample was loaded into separate wells and 5 µl HyperLadder IV 
(Bioline, London, UK) was loaded into adjacent lanes. The samples were electrophoresed at 
110 V until the dye front had migrated to approximately 5 mm from the end of the gel and 
then visualised using a Gel Documentation System. The quality of the DNA samples was 
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assessed by the presence of unsheared whole genomic DNA or sheared DNA. If a DNA 
extract had a significant amount of sheared DNA then the extraction process would be 
repeated. 
 
2.5.4. Digestion of chromosomal DNA by PvuII 
For the digestion of each DNA extract, the following mastermix was used: 2 µl digestion 
buffer M; 1 µl PvuII restriction enzyme (10 U/µl) (Roche Applied Science, Burgess Hill, 
West Sussex, UK); volume of DNA for 4.5 µg; and sterile distilled H2O to make a total 
volume of 20 µl. The digestion reaction was vortexed briefly and centrifuged at 11,000 g for 5 
seconds. Sufficient control DNA (M. tuberculosis MT14323) for three reactions was also 
digested. The digestion reaction was vortexed briefly, centrifuged at 11,000 g for 5 seconds, 
and incubated at 37°C for 3 hours in a thermal cycler. The enzyme was inactivated by 
incubation at 65°C for 15 minutes. 
 
2.5.5. Estimation of the DNA concentration after digestion 
A small (14 x 20 cm) 0.8% agarose gel was prepared. For 2 µl digested DNA, 18 µl of gel 
loading buffer was added and 10 µl of each sample was then loaded into individual lanes on 
the gel. In the first and last lanes, 5 µl Molecular Weight Marker IV (Roche Applied Science, 
Burgess Hill, West Sussex, UK) was added. The samples were electrophoresed at 150V for 1 
hour and visualised using a Gel Documentation System. The intensity of digested DNA in 
each lane was analysed and the volume of DNA required to get an equal concentration in each 
lane on the Southern blot gel was estimated. 
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2.5.6. Agarose gel electrophoresis 
A large (28 x 20 cm) 0.8% agarose gel was prepared and 5 µL Molecular Weight Marker IV 
was loaded in the first and last lanes. In the remaining lanes, the volume of each DNA 
estimated previously was loaded including MT14323 in the first, middle, and last lanes. The 
gel was then subjected to electrophoresis at 100 V for 1 hour until the DNA samples had 
migrated out of the wells and into the gel. The voltage was then reduced to 60 V and 
electrophoresed for 20 hours. The migration of DNA in the gel was checked on a UV 
transilluminator and electrophoresed until the 2.0 kb fragment of the DNA standard had 
migrated at least 7 cm from the wells. The gel was then prepared for Southern blotting as 
follows. 
 
2.5.7. Gel pre-treatment before Southern blotting 
All pre-treatment steps were carried out with constant slow agitation. The gel was depurinated 
in 250 ml 0.25M hydrochloric acid twice for 15 minutes and then the gel was rinsed in sterile 
distilled H2O. The gel was then denatured in 250 ml 0.5M sodium hydroxide twice for 20 
minutes, and then 250 ml 1.5 M NaCl twice for 20 minutes and then rinsed in sterile distilled 
H2O. The gel was then neutralised in 250 ml 3M NaCl, 0.5M Tris (pH 7.0) twice for 20 
minutes each time. 
 
2.5.8. Transfer of DNA onto a membrane by vacuum blotting 
Once the gel pre-treatment was complete, a Hybaid Vacu-Aid (Thermo Fisher Scientific, 
Loughborough, Leicestershire, UK) was assembled to perform the vacuum blot. An aperture 
was cut in a rubber mask which was 5-10 mm smaller than the gel. This was used to form a 
seal around the gel when vacuum is applied. The wells in the gel were excluded by cutting 
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them off the gel which ensured that the wells would not rupture and 'short circuit' the DNA 
transfer. The Vacu-aid was assembled without locating the rubber mask or top manifold and a 
cross lattice support and porous screen was inserted. A piece of 3MM paper (Whatman, 
Maidstone, Kent, UK) 2-4 cm larger than the gel to be blotted was cut, wetted with 2X saline 
sodium citrate (SSC), and positioned onto the porous screen. The Hybond™-N+ (GE 
Healthcare, Chalfont St Giles, Buckinghamshire, UK) transfer membrane was cut slightly 
longer than the gel to be blotted and placed on top of the 3MM paper. The rubber mask was 
carefully placed over the membrane and 3MM paper so that the aperture was exactly over the 
membrane. The top manifold and clamp were inserted on top of the assembly. The aperture in 
the rubber mask was flooded with a small quantity of transfer buffer. Ensuring the rubber 
mask was lying flat; the agarose gel was positioned exactly over the aperture. All air bubbles 
were excluded from between the gel and the membrane using a gloved finger. Once a 
satisfactory seal was created, a vacuum was applied and transfer buffer was applied to the top 
of the gel so that all of the gel was immersed. Blotting was carried out for 90 minutes. When 
the transfer was completed, the vacuum was turned off and the transfer buffer and gel was 
removed. The membrane blot was removed and DNA was fixed by UV crosslinking. 
 
2.5.9. Preparation of IS6110 probe 
DNA from M. tuberculosis MT14323 was extracted by the CTAB method as described 
previously. Multiple PCR reactions were prepared using the following PCR mastermix for 
each reaction: 200 M each dNTP; 1 M each oligonucleotide (INS-1 5‟-CGT GAG GGC 
ATC GAG GTG GC-3‟ and INS-2 5‟-GCG TAG GCG TCG GTG ACA AA-3‟); 5 µl 10X 
PCR Buffer and 1.25 U Super Taq DNA polymerase (Sphaero Q, Gorinchem, Netherlands); 5 
µl template DNA; and H2O to a make a total reaction volume of 50 l. A negative control of 5 
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µl H2O instead of template DNA was added to one reaction. An initial denaturation at 96°C 
for 3 minutes was followed by 30 cycles of denaturation at 96°C for 1 minute, annealing at 
65°C for 1 min, and extension at 72 C for 2 minutes. A final extension step of 6 minutes at 
74°C concluded the reaction program. 
 
A 1% agarose gel was prepared using tris acetate EDTA (TAE) buffer. The PCR products 
were pooled, 2 L gel loading buffer was added to 10 L of the pooled PCR products and 
loaded onto the agarose gel. In the first and last lanes, 5 L 50 bp electrophoresis marker 
(Promega, Southampton, Hampshire, UK) was loaded and the gel was electrophoresed at 100 
V for 1 hour and visualised with the ImageMaster Gel Documentation system. A 245 bp PCR 
fragment was observed and excised using a clean, sterile scalpel in approximately 300 µl (300 
mg) agarose, transferred to a 1.5 ml microcentrifuge tube and incubated at 70°C until the 
agarose was completely melted. Each melted agarose slice was purified using the Wizard® 
PCR Preps DNA Purification Kit (Promega, Southampton, Hampshire, UK). The purified 245 
bp amplicon was then labelled with fluorescein using the Gene Images Random Prime 
Labelling Kit (GE Healthcare, Chalfont St Giles, Buckinghamshire, UK) and incorporation of 
fluorescein was confirmed by comparison with provided standards. 
 
2.5.10. Hybridisation and detection 
Hybridisation and detection was carried out using the Enhanced Chemiluminescence (ECL) 
Direct Nucleic Acid Labelling and Detection Kit (GE Healthcare, Chalfont St Giles, 
Buckinghamshire, UK). The required volume of hybridisation buffer (0.3 ml/cm
2
) was pre-
heated to 60°C and the blot was wetted in 5X SSC. The blot was placed in hybridisation 
buffer and pre-hybridised at 60°C for 30 minutes with constant, gentle rotation in a 
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hybridisation oven (Model 400 Hybridisation Incubator, SciGene, Sunnyvale, California, 
USA). The required amount of IS6110 probe (10 ng/ml of hybridisation buffer) was removed 
from -20ºC to a clean microcentrifuge tube, denatured by heating to 100°C, and snap cooled 
on ice. The denatured probe was centrifuged briefly and a small aliquot of the hybridisation 
buffer was removed from the blot, mixed with the probe, and returned to the bulk of the 
buffer. The blot was then hybridised at 60°C overnight with gentle rotation. Stringency wash 
solution 1 was prepared (5 ml per cm
2
 of membrane) and pre-heated to 60°C. The blot was 
transferred to this solution and washed at 60°C for 15 minutes with gentle rotation. The blot 
was then washed with pre-heated stringency wash solution 2 (5 ml per cm
2
 of membrane) and 
washed at 60°C for 15 minutes with gentle rotation 
 
2.5.11. Blocking, antibody incubation and washes 
The following steps were all performed at room temperature and all the incubations required 
constant agitation of the blot. All containers were rinsed with 70 % ethanol before use to 
remove any bacterial AP contamination. Following the stringency washes, the blot was 
incubated with gentle agitation for 1 hour in a 1:10 dilution of liquid blocking agent in 
hybridisation buffer (1.0 ml/cm
2
 membrane). The anti-fluorescein-AP conjugate was diluted 
1:5000 in freshly prepared 0.5 % (w/v) bovine serum albumin in hybridisation buffer and the 
blots were incubated in diluted conjugate (0.3 ml/cm
2
 of membrane) with gentle agitation for 
1 hour. Unbound conjugate was removed by washing three times for 10 minutes each time in 
0.3 % (w/v) Tween 20 in hybridisation buffer (5 ml/cm
2
 membrane) at room temperature with 
gentle agitation. 
 
Chapter 2 
 76 
2.5.12. Signal generation and detection 
After completion of the antibody incubation stage and subsequent stringency washes, any 
excess wash buffer was drained from the blots. The blot was placed sample side up on a sheet 
of SaranWrap on a flat surface. An aliquot of detection reagent (40 μl/cm2 membrane) was 
removed to a universal, pipetted on to the blots for 5 minutes and then drained off. The blot 
was then transferred to a supplied developing bag and the outside was wiped dry and then 
transferred to a darkroom. The blot was exposed for 5 minutes using one sheet of Hyperfilm-
MP (GE Healthcare, Chalfont St Giles, Buckinghamshire, UK) on top of the blot contained in 
a film cassette. After 5 minutes, the film was removed and placed in developer solution until 
all expected fragments in MT14323 were observed, rinsed in H2O, placed in fixer solution 
until the film was transparent, and then dried overnight. 
 
2.5.13. Cluster analysis 
Using a Gel Documentation System, an image of the developed blot was saved a Tagged 
Image File Format (TIFF) file. This file was imported into BioNumerics (Applied Maths, 
Sint-Martens-Latem, Belgium) as a 2D TIFF file with 8 bit optical density depth (256 grey 
scale). Each lane was identified and selected for analysis and a spectral analysis was carried 
out that removed background images and identified the fragments with lowest intensity that 
will be analysed. The gel was then normalised using the three external MT14323 reference 
standard lanes. Fragments containing IS6110 were then identified automatically with manual 
confirmation. A similarity dendrogram was constructed by using the Dice coefficient, and 
results were displayed via the unweighted pair group method using arithmetic averages 
(UPGMA). Band tolerance levels were set at 1%. 
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2.6. MIRU-VNTR TYPING USING AGAROSE GEL ELECTROPHORESIS 
2.6.1. MIRU-VNTR typing using the originally described oligonucleotides. 
VNTR analysis was performed by using the oligonucleotides for the five loci ETR-A to ETR-
E as originally described (Frothingham and Meeker-O'Connell, 1998) (Table 2.1). A total 
PCR volume of 25 µl was used for each reaction which contained: 400 nM each primer; 2.5 
µl of PCR Gold Buffer; 1.5 mM MgCl2; 200 µM each of the four dNTPs; 4% (vol/vol) 
dimethyl sulphoxide; 0.5 U of Amplitaq Gold (Applied Biosystems, Warrington, UK); and 2 
ng of DNA. An initial denaturation at 95°C for 7 minutes was followed by 35 cycles of 
denaturation at 95°C for 30 seconds, annealing at 60°C for 1 minute, and extension at 72°C 
for 1 minute. A final extension step at 72°C for 5 minutes concluded the reaction program. 
The amplicons were sized using a 2% (wt/vol) agarose-1000 gel for 2.5 h at 150 V with 50-bp 
and 100 bp ladder size standards (Table 2.2). 
 
MIRU analysis was performed using the primers for the 12 MIRU loci as originally described 
(Supply et al., 2001) (Table 2.1). Four different concentrations of MgCl2 were used. MgCl2 
was added to the reaction mixture at 1.5 mM for MIRU loci 20, 24, and 27. For MIRU loci 
10, 16, and 31, 2 mM MgCl2 was used. For MIRU loci 2, 23, and 39, 2.5 mM MgCl2 was 
used. For MIRU loci 4, 26, and 40, 3 mM MgCl2 was used. Each PCR mixture contained: 4% 
(vol/vol) dimethyl sulphoxide; 200 µM each of the four deoxynucleoside triphosphates; 2.5 µl 
PCR Gold buffer; 400 nM each primer; 0.25 U of AmpliTaq Gold; 2 ng of template DNA; 
and H2O to a final volume of 25 µl. An initial denaturation at 95°C for 7 minutes was 
followed by 40 cycles of denaturation at 95°C for 1 minute, annealing at 59°C for 1 minute, 
and 72°C for 90 seconds. A final extension step at 72°C for 10 minutes concluded the reaction 
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program. The amplicons were sized using a 2% (wt/vol) agarose-1000 gel for 2.5 h at 150 V 
with 50 bp and 100 bp ladder size standards (Table 2.2). 
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No. VNTR 
Locus 
Name 
Alias 
GenBank 
Accession No. 
Direction Oligonucleotide sequence (5’-3’) 
1 2165 ETR-A  BX842578 Forward AAATCGGTCCCATCACCTTCTTAT 
  Reverse CGAAGCCTGGGGTGCCCGCGATT 
2 2461 ETR-B   BX842579 Forward GCGAACACCAGGACAGCATCATG 
  Reverse GGCATGCCGGTGATCGAGTGG 
3 577 ETR-C   BX842573 Forward GTGAGTCGCTGCAGAACCTGCAG 
  Reverse GGCGTCTTGACCTCCACGAGT 
4 580 ETR-D   BX842573 Forward CAGGTCACAACGAGAGGAAGAGC 
  Reverse GCGGATCGGCCAGCGACTCCTC 
5 3192 ETR-E   BX842581 Forward CTTCGGCGTCGAAGAGAGCCTC 
  Reverse CGGAACGCTGGTCACCACCTAAG 
6 154 MIRU-02   BX842572 Forward TGGACTTGCAGCAATGGACCAACT  
  Reverse TACTCGGACGCCGGCTCAAAAT 
7 960 MIRU-10   BX842574 Forward GTTCTTGACCAACTGCAGTCGTCC  
  Reverse GCCACCTTGGTGATCAGCTACCT 
8 1644 MIRU-16   BX842576 Forward TCGGTGATCGGGTCCAGTCCAAGTA  
  Reverse CCCGTCGTGCAGCCCTGGTAC 
9 2059 MIRU-20   BX842577 Forward TCGGAGAGATGCCCTTCGAGTTAG 
  Reverse GGAGACCGCGACCAGGTACTTGTA  
10 2531 MIRU-23   BX842579 Forward CTGTCGATGGCCGCAACAAAACG 
  Reverse AGCTCAACGGGTTCGCCCTTTTGTC  
11 2687 MIRU-24   BX842579 Forward CGACCAAGATGTGCAGGAATACAT  
  Reverse GGGCGAGTTGAGCTCACAGAA 
12 2996 MIRU-26   BX842580 Forward TAGGTCTACCGTCGAAATCTGTGAC  
  Reverse CATAGGCGACCAGGCGAATAG 
13 3007 MIRU-27  QUB-5 BX842580 Forward TCGAAAGCCTCTGCGTGCCAGTAA  
  Reverse GCGATGTGAGCGTGCCACTCAA 
14 4348 MIRU-39   BX842584 Forward CGCATCGACAAACTGGAGCCAAAC  
  Reverse CGGAAACGTCTACGCCCCACACAT 
15 802 MIRU-40   BX842574 Forward GGGTTGCTGGATGACAACGTGT  
  Reverse GGGTGATCTCGGCGAAATCAGATA  
16 424 VNTR0424  Mtub04 BX842573 Forward CTTGGCCGGCATCAAGCGCATTATT 
  Reverse GGCAGCAGAGCCCGGGA 
17 1955 VNTR1955  Mtub21 BX842577 Forward AGATCCCAGTTGTCGTCGTC 
  Reverse CAACATCGCCTGGTTCTGTA 
18 2163b VNTR2163b  QUB-11b BX842578 Forward CGTAAGGGGGATGCGGGAAATAGG 
  Reverse CGAAGTGAATGGTGGCAT 
19 2347 VNTR2347  Mtub29 BX842578 Forward GCCAGCCGCCGTGCATAAACCT 
  Reverse AGCCACCCGGTGTGCCTTGTATGAC 
20 2401 VNTR2401  Mtub30 BX842578 Forward CTTGAAGCCCCGGTCTCATCTGT 
  Reverse ACTTGAACCCCCACGCCCATTAGTA 
21 3171 VNTR3171  Mtub34 BX842581 Forward GGTGCGCACCTGCTCCAGATAA 
  Reverse GGCTCTCATTGCTGGAGGGTTGTAC 
22 3690 VNTR3690  Mtub39 BX842582 Forward CGGTGGAGGCGATGAACGTCTTC 
  Reverse TAGAGCGGCACGGGGGAAAGCTTAG 
23 4052 VNTR4052   BX842583 Forward AACGCTCAGCTGTCGGAT 
  Reverse CGGCCGTGCCGGCCAGGTCCTTCCCGAT 
24 4156 VNTR4156   BX842583 Forward TGACCACGGATTGCTCTAGT 
  Reverse GCCGGCGTCCATGTT 
 
Table 2.1.  DNA sequences of original published oligonucleotides used in agarose gel 
electrophoresis. 
The oligonucleotides for the 5 ETR loci were first published by Frothingham in 1998, the 10 
MIRU loci by Supply in 2001, and the additional nine loci were first described together by 
Supply in 2006. 
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Locus 
Repeat 
Length 
(bp) 
H37Rv 
Allele 
Repeat number and expected size (bp) 
0 1 2 3 4 5 6 7 8 9 10 
A 75 3 195 270 345 420 495 570 645 720 795 870 945 
B 57 3 121 178 235 292 349 406 463 520 577 634 691 
C 58 4 44 102 160 218 276 334 392 450 508 566 624 
D 77 4‟ 56 133 210 287 364 441 518 595 672 749 826 
E 53 3 65 118 171 224 277 330 383 436 489 542 595 
M02 53 2 402 455 508 561 614 667 720 773 826 879 932 
M04 77 3‟ 133 210 287 364 441 518 595 672 749 826 903 
M10 53 3 482 535 588 641 694 747 800 853 906 959 1,012 
M16 53 2 565 618 671 724 777 830 883 936 989 1,042 1,095 
M20 77 2 437 514 591 668 745 822 899 976 1,053 1,130 1,207 
M23 53 6 558 611 664 717 770 823 876 929 982 1,035 1,088 
M24 54 1 395 449 503 557 611 665 719 773 827 881 935 
M26 51 3 461 512 563 614 665 716 767 818 869 920 971 
M27 53 3 498 551 604 657 710 763 816 869 922 975 1,028 
M31 53 3 65 118 171 224 277 330 383 436 489 542 595 
M39 53 2 540 593 646 699 752 805 858 911 964 1,017 1,070 
M40 54 1 354 408 462 516 570 624 678 732 786 840 894 
424 51 2 537 588 639 690 741 792 843 894 945 996 1,047 
1955 57 2 92 149 206 263 320 377 434 491 548 605 662 
2163b 69 5 67 136 205 274 343 412 481 550 619 688 757 
2347 57 4 335 392 449 506 563 620 677 734 791 848 905 
2401 58 2 247 305 363 421 479 537 595 653 711 769 827 
3171 54 3 326 380 434 488 542 596 650 704 758 812 866 
3690 58 5 272 330 388 446 504 562 620 678 736 794 852 
4052 111 5 163 274 385 496 607 718 829 940 1,051 1,162 1,273 
4156 59 2 563 622 681 740 799 858 917 976 1,035 1,094 1,153 
 
Table 2.2.  Sizing table for original published oligonucleotides using agarose gel 
electrophoresis.  
 
MIRU-04 contains an additional invariable 53 bp repeat at the 3‟ of the 77-bp VNTR units in 
nearly all clinical isolates. M. bovis BCG, H37Rv, H37Ra, and <1 % of all M. tuberculosis 
strains do not possess this 3‟-terminal bp MIRU unit and are designated with a prime symbol 
(i.e. 310 bp equates to 3‟ for H37Rv at MIRU-04. ETR-D and ETR-E are the same loci as 
MIRU-4 and MIRU-31 respectively. Assigning alleles using ETR-D counts all repeats present 
whereas MIRU-04 takes account of the 3‟ 53 bp repeat but does not count it in clinical strains. 
ETR-E and MIRU-04 count the same repeats. The alleles for H37Rv are from the published 
sequenced strain (GenBank Accession Number: AL123456.2). 
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2.6.2. Extra Nine Typing Loci using originally described oligonucleotides and agarose 
gel electrophoresis. 
To complete the optimal 24 loci set, an additional nine MIRU-VNTR loci were amplified.  
The universal PCR mastermix for these nine loci contained: 30.80 µl H2O; 2 µl DMSO 
(100%); 200 µM each dNTP; 5 µl 10X PCR Buffer; 0.5 µM each primer; 3.0 mM MgCl2; and 
1 U AmpliTaq Gold. 1 µl of template DNA was added to each 50 µl mastermix. An initial 
denaturation at 95°C for 10 minutes was followed by 40 cycles of denaturation at 95°C for 1 
minute, annealing at 63°C for 1 minute, and extension at 72°C for 2 minutes. A final 
extension step of 10 minutes at 72°C concluded the reaction program. 10 µl of each sample 
was electrophoresed for 2 hours 30 minutes at 150 V on a 2% agarose gel. 
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2.7. MIRU-VNTR TYPING USING NON-DHPLC 
2.7.1. MIRU-VNTR typing using non-dHPLC: Primer design 
New primers for all 24 loci were designed with shorter primer flanking regions so that 
amplicons could be reliably sized on a WAVE® System (Table 2.3). Primers were designed 
using the computer program Primer3 (Rozen and Skaletsky, 2000). To amplify all DNA 
templates using the same PCR mastermix reaction conditions, primer length and Tm were 
designed to be as similar as possible. A common magnesium concentration and annealing 
temperature was identified using serial titrations. 
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No. VNTR Locus Alias 
GenBank 
Accession No. 
Direction Oligonucleotide sequence (5’-3’) 
1 2165 ETR-A 
 
 BX842578 Forward TCGGTCCCATCACCTTCTTA 
Reverse GGATTGAGGGGATCGTGATT 
2 2461 ETR-B 
 
 BX842579 Forward CGAACACCAGGACAGCATC 
Reverse GGTGATCGAGTGGCTATACG 
3 577 ETR-C 
 
 BX842573 Forward CAGGCCTTCGCTCACTTAC 
Reverse CTTGACCTCCACGAGTGCTA 
4 580 ETR-D 
 
 BX842573 Forward GTTGATCGAGGCCTATCACG 
Reverse CTCGTCCTCCACAATCAACA 
5 3192 ETR-E 
 
 BX842581 Forward CCACAGCCTTCTCCATTTTC 
Reverse ACCACCTAAGGGGACTACGC 
6 154 MIRU-02 
 
 BX842572 Forward CAGGTGCCCTATCTGCTGAC 
Reverse GTGTCCGACCGAGTCATAGG 
7 960 MIRU-10 
 
 BX842574 Forward ACCGTCTTATCGGACTGCAC 
Reverse CCCACGACCGATAATGGAG 
8 1644 MIRU-16 
 
 BX842576 Forward CCCGTATCGCTTACATACCC 
Reverse ACGCCTACGCTGATTCCAC 
9 2059 MIRU-20 
 
 BX842577 Forward AGGTGCAAGTGCCGACAT 
Reverse ACTAACGGTGGCGGGTATG 
10 2531 MIRU-23 
 
 BX842579 Forward TCTTCGGTGGTCTCGAGTG 
Reverse CACCGTCTGACTCATGGTGT 
11 2687 MIRU-24 
 
 BX842579 Forward CTGGCCAAGACCGAATGC 
Reverse GGTGAGGACGAGCTGAGG 
12 2996 MIRU-26 
 
 BX842580 Forward CGGATAGGTCTACCGTCGAA 
Reverse CAACTGCCTCGCGGAATAG 
13 3007 MIRU-27 
 
QUB-5 BX842580 Forward GGTGACCAACGTCAGATTCA 
Reverse GGAGCGGATCAAGACGTTAC 
14 4348 MIRU-39 
 
 BX842584 Forward CCGGTCAACAGACCACTAGA 
Reverse GTCCGTACTTCCGGTTCAG 
15 802 MIRU-40 
 
 BX842574 Forward AAGCGCAAGAGCACCAAG 
Reverse TCTTTCTCTCACGCTCTCGTC 
16 424 VNTR0424 
 
Mtub04 BX842573 Forward CCTGGTCGTCTGGAAACC 
Reverse GGCATCCTCAACAACGGTAG 
17 1955 VNTR1955 
 
Mtub21 BX842577 Forward AGATCCCAGTTGTCGTCGTC 
Reverse GCCAATAGCACAGCACCAG 
18 2163b VNTR2163b 
 
QUB-11b BX842578 Forward GTTAATCGTAAGGGGGATGC 
Reverse AGCGTCGAAGTGAATGGTG 
19 2347 VNTR2347 
 
Mtub29 BX842578 Forward AACCCATGTCAGCCAGGTTA 
Reverse AGAACGAGCGGAACCACAT 
20 2401 VNTR2401 
 
Mtub30 BX842578 Forward GTCGCCGAGCTGGATTTG 
Reverse GCAGCTAAGGCTATCGGATT 
21 3171 VNTR3171 
 
Mtub34 BX842581 Forward TGCTCCAGATAAGCCGTCAG 
Reverse TCACCGATTGGGAGAGGATA 
22 3690 VNTR3690 
 
Mtub39 BX842582 Forward GATCACGATGCGGGTCAC 
Reverse CACGGGGGAAAGCTTAGAC 
23 4052 VNTR4052 
 
 BX842583 Forward CTGGAAAGTCCAGGTTACCG 
Reverse CTACCGGTCGTTGGTCTAGC 
24 4156 VNTR4156 
 
 BX842583 Forward ACATCACCTGGTCGCTACG 
Reverse GACCAGACCGCCGATCAT 
 
Table 2.3.  Oligonucleotide sequences designed for analysis by non-dHPLC on a 
Transgenomic WAVE® system. 
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2.7.2. MIRU-VNTR typing using non-dHPLC: Analysis gradient design 
The parameters for analysis of a PCR amplicon on a Transgenomic WAVE® System 
(Glasgow, UK) can be altered by the user to enable identification and sizing of specific sizes 
of PCR amplicons using a non-denaturing sizing programme type which analyses PCR 
amplicons at 50ºC. Variation in retention time is caused by differences in the sizes of PCR 
amplicon fragments and not in variation of the actual DNA sequence amplified as occurs at 
higher temperatures for mutation detection. The aim of designing a fragment sizing analysis 
gradient was to be able to size PCR amplicons as quickly as possible with a level of accuracy 
that was sufficient for differentiation between PCR fragments that differ in size by a 
minimum of 50 bp. After serial amendment of analysis parameters, the following WAVE® 
analysis parameters were selected: 0.5 minutes per 100 bp; 20 gradient segments; 20 base pair 
minimum; 900 base pair maximum; clean duration time of 0.1 minutes; equilibration duration 
time of 0.1 minutes; fast wash at the end of each injection; and a continuous buffer flow rate 
of 0.9 ml per minute. This resulted in an analysis time of 7.4 minutes for each single injection 
(Table 2.4). 
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Time 
(minutes) 
% Buffer A % Buffer B 
0.0 71.0 29.0 
0.5 66.0 34.0 
0.7 54.8 45.2 
1.0 48.9 51.1 
1.2 45.2 54.8 
1.4 42.7 57.3 
1.7 40.9 59.1 
1.9 39.5 60.5 
2.1 38.4 61.6 
2.3 37.5 62.5 
2.6 36.8 63.2 
2.8 36.2 63.8 
3.0 35.7 64.3 
3.3 35.2 64.8 
3.5 34.9 65.1 
3.7 34.5 65.5 
4.0 34.2 65.8 
4.2 34.0 66.0 
4.4 33.7 66.3 
4.6 33.5 66.5 
4.9 33.3 66.7 
5.0 0.0 100.0 
5.5 0.0 100.0 
5.6 71.0 29.0 
6.5 71.0 29.0 
 
Table 2.4.  non-dHPLC analysis conditions. 
 
Buffer A acts as the binding agent between the cartridge and DNA with Buffer B eluting 
DNA from the separation cartridge dependent on the length of the DNA sequence. 
  
Chapter 2 
 86 
2.7.3. MIRU-VNTR typing using non-dHPLC: Creation of customised standard 
To improve the accuracy of MIRU-VNTR fragment sizing when using a Transgenomic 
WAVE® System, an allele ladder was constructed using MIRU-23. M. tuberculosis strains 
that possessed 1-10 repeats at MIRU-23 were selected and amplified using the same PCR 
conditions as for MIRU-VNTR typing. The PCR amplicons from the 10 strains were then 
quantified by analysis of 5 µl on the WAVE® System. To obtain an allele ladder with 10 
fragments of equivalent intensity and height, the quantity of each amplicon was standardised 
by comparison with the other nine amplified alleles. Amplicons with higher intensity required 
less volume. The 10 PCR amplicons were then combined in a single tube and 5 µl was 
injected before and after each MIRU-VNTR locus. 
 
2.7.4. MIRU-VNTR Typing using non-dHPLC: MIRU-VNTR PCR set-up for nine and 
24 loci. 
In a PCR clean room separate from areas containing amplified DNA, PCR reactions for each 
of the MIRU-VNTR analysis loci was set up using the oligonucleotides for each of the 15 or 
24 loci listed in Table 2.3 in a single reaction well and not in a multiplex reaction. A total 
PCR volume of 50 µl was used for each reaction. Each PCR reaction contained: 400 nM each 
primer; 5 µl 10X PCR Gold Reaction Buffer; 1.5 mM MgCl2; 200 µM each dNTPs; 4% 
(vol/vol) dimethyl sulphoxide; 1 U Amplitaq Gold; and 2 µl template DNA. An initial 
denaturation 95°C for 5 minutes was followed by 40 cycles of denaturation at 95°C for 1 
minute, annealing at 63°C for 1 minute, and extension at 72°C for 2 minutes. A final 
extension step at 72°C for 5 minutes concluded the reaction program. One sample of M. 
tuberculosis H37Rv was included in each batch. For 15 or nine loci analysis, batch sizes were 
16 DNA extracts which included: 14 clinical DNA extracts; one H37Rv extract; and one 
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negative containing sterile distilled H20. For 24 loci analysis, batch sizes were eight DNA 
extracts which included: six clinical DNA extracts; one H37Rv extract; and one negative 
containing sterile distilled H20. Five microlitres of each amplified PCR product were injected 
onto the WAVE® System 
 
2.7.5. MIRU-VNTR typing using non-dHPLC: Calculation of a standard curve 
All single peaks on the WAVE® chromatogram between 2.5 and 6.2 minutes and more than 1 
mV in height were selected for repeat allele calculation using a Microsoft Excel file. 
Retention times for each of the standard peaks were entered into the Excel file which then 
calculates a standard curve. The retention times for each of the sample PCR amplicon peaks 
were then imported and compared against the standard curve to obtain a predicted size and 
nearest whole number of repeats based on the following equation (Table 2.5): 
 
Number of repeats = PCR amplicon size (bp) - VNTR primer flanking region (bp) 
__________________________________________________ 
Expected size of one VNTR repeat (bp) 
 
Any MIRU-VNTR alleles that were not amplified or were greater than +/- 0.25 repeats from 
the nearest whole repeat were repeated. Each MIRU-VNTR allele was concatenated together 
to obtain a five (ETR), 10 (MIRU), 17 (ETR+MIRU), or 24 digit profile and transferred to a 
Microsoft Access database for reporting and analysis via a linked BioNumerics database and 
the local Laboratory Information Management System. 
  
Chapter 2 
 88 
Locus 
Name 
Repeat 
Length 
(bp) 
H37Rv 
Allele 
Repeat number and expected size (bp) 
0 1 2 3 4 5 6 7 8 9 10 
A 75 3 117 192 267 342 417 492 567 642 717 792 867 
B 57 3 112 169 226 283 340 397 454 511 568 625 682 
C 58 4 39 97 155 213 271 329 387 445 503 561 619 
D 77 4‟ 102 179 256 333 410 487 564 641 718 795 872 
E 53 3 77 130 183 236 289 342 395 448 501 554 607 
M02 53 2 121 174 227 280 333 386 439 492 545 598 651 
M10 53 3 65 118 171 224 277 330 383 436 489 542 595 
M16 53 2 85 138 191 244 297 350 403 456 509 562 615 
M20 77 2 59 136 213 290 367 444 521 598 675 752 829 
M23 53 6 74 127 180 233 286 339 392 445 498 551 604 
M24 54 1 131 185 239 293 347 401 455 509 563 617 671 
M26 51 3 64 115 166 217 268 319 370 421 472 523 574 
M27 53 3 108 161 214 267 320 373 426 479 532 585 638 
M39 53 2 105 158 211 264 317 370 423 476 529 582 635 
M40 54 1 110 164 218 272 326 380 434 488 542 596 650 
424 51 2 80 131 182 233 284 335 386 437 488 539 590 
1955 57 2 48 105 162 219 276 333 390 447 504 561 618 
2163b 69 5 78 147 216 285 354 423 492 561 630 699 768 
2347 57 2 107 164 221 278 335 392 449 506 563 620 677 
2401 58 2 64 122 180 238 296 354 412 470 528 586 644 
3171 54 3 86 140 194 248 302 356 410 464 518 572 626 
3690 58 5 110 168 226 284 342 400 458 516 574 632 690 
4052 111 5 90 201 312 423 534 645 756 867 978 1,089 1,200 
4156 59 2 213 272 331 390 449 508 567 626 685 744 803 
 
Table 2.5.  Allele calling table for the 24 MIRU-VNTR loci using oligonucleotides 
designed for analysis using non-dHPLC. 
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2.8. SPOLIGOTYPING USING A SUSPENSION ARRAY SYSTEM 
2.8.1. Oligonucleotide-microsphere coupling protocol  
Spoligotyping was carried out using a BioPlex 200 Suspension Array System (Bio-Rad, 
Hemel Hempstead, Hertfordshire, UK) as previously described (Cowan et al., 2004), using 
oligonucleotides previously designed for use in membrane-based hybridisation (Table 2.6) 
(Kamerbeek et al., 1997). During the coupling procedure, exposure of the microspheres to 
light was minimised as much as possible. A fresh aliquot of EDC (1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride) powder (Thermo Fisher Scientific, 
Loughborough, Leicestershire, UK) was warmed to room temperature. Each of the 43 amino-
linked spacer oligonucleotides with a six carbon spacer were resuspended to a concentration 
of 0.1 mM in 0.1M morpholineethanesulfonic acid (MES) (pH 4.5). All of the 43 microsphere 
sets were pelleted by centrifugation at 8,000 g for 1 minute, sonicated for 15 seconds, and 
vortexed for 15 seconds. From each of the 43 stock solutions, 200 µl of microspheres were 
transferred to a 1.5 ml microtube and pelleted by centrifugation at 8,000 g for 1 minute. For 
each of the 43 bead sets, beads were then resuspended in 25 µl 0.1 M MES (pH 4.5) and 2 µl 
of the appropriate 0.1 mM amino linked oligonucleotide was added. To each of the bead sets, 
2.5 µl EDC (10 mg/ml) was added and sonicated for 15 seconds, vortexed gently for 15 
seconds, and then incubated for 30 minutes at room temperature protected from light. The 
addition of EDC was then repeated once. Each of the 43 bead sets were then washed twice. 
For the first wash, 0.9 ml 0.02% Tween-20 was added to the beads, vortexed for a few 
seconds, and then centrifuged at 8,000 g for 1 minute. The supernatant was then removed 
without disturbing the pellet. For the second wash, 0.9 ml 0.1% SDS was added to each bead 
set and vortexed for a few seconds. The beads were centrifuged at 8,000 g for 1 minute and 
the supernatant was removed. Each bead set was then resuspended in 50 µl 1X TE, pH 8.0 
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and pelleted by centrifugation at 8,000 g for 1 minute. The beads were then stored at 4ºC in 
the dark. 
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Name 
Bio-Rad 
Cat. No. 
Oligonucleotide sequence (5’-3’) 
sp01-011 171-506011 ATAGAGGGTCGCCGGTTCTGGATCA 
sp02-017 171-506017 CCTCATAATTGGGCGACAGCTTTTG 
sp03-018 171-506018 CCGTGCTTCCAGTGATCGCCTTCTA 
sp04-019 171-506019 ACGTCATACGCCGACCAATCATCAG 
sp05-020 171-506020 TTTTCTGACCACTTGTGCGGGATTA 
sp06-021 171-506021 CGTCGTCATTTCCGGCTTCAATTTC 
sp07-024 171-506024 GAGGAGAGCGAGTACTCGGGGCTGC 
sp08-025 171-506025 CGTGAAACCGCCCCCAGCCTCGCCG 
sp09-026 171-506026 ACTCGGAATCCCATGTGCTGACAGC 
sp10-027 171-506027 TCGACACCCGCTCTAGTTGACTTCC 
sp11-028 171-506028 GTGAGCAACGGCGGCGGCAACCTGG 
sp12-029 171-506029 ATATCTGCTGCCCGCCCGGGGAGAT 
sp13-032 171-506032 GACCATCATTGCCATTCCCTCTCCC 
sp14-033 171-506033 GGTGTGATGCGGATGGTCGGCTCGG 
sp15-034 171-506034 CTTGAATAACGCGCAGTGAATTTCG 
sp16-035 171-506035 CGAGTTCCCGTCAGCGTCGTAAATC 
sp17-036 171-506036 GCGCCGGCCCGCGCGGATGACTCCG 
sp18-037 171-506037 CATGGACCCGGGCGAGCTGCAGATG 
sp19-038 171-506038 TAACTGGCTTGGCGCTGATCCTGGT 
sp20-039 171-506039 TTGACCTCGCCAGGAGAGAAGATCA 
sp21-040 171-506040 TCGATGTCGATGTCCCAATCGTCGA 
sp22-041 171-506041 ACCGCAGACGGCACGATTGAGACAA 
sp23-042 171-506042 AGCATCGCTGATGCGGTCCAGCTCG 
sp24-046 171-506046 CCGCCTGCTGGGTGAGACGTGCTCG 
sp25-047 171-506047 GATCAGCGACCACCGCACCCTGTCA 
sp26-051 171-506051 CTTCAGCACCACCATCATCCGGCGC 
sp27-052 171-506052 GGATTCGTGATCTCTTCCCGCGGAT 
sp28-053 171-506053 TGCCCCGGCGTTTAGCGATCACAAC 
sp29-054 171-506054 AAATACAGGCTCCACGACACGACCA 
sp30-055 171-506055 GGTTGCCCCGCGCCCTTTTCCAGCC 
sp31-056 171-506056 TCAGACAGGTTCGCGTCGATCAAGT 
sp32-061 171-506061 GACCAAATAGGTATCGGCGTGTTCA 
sp33-062 171-506062 GACATGACGGCGGTGCCGCACTTGA 
sp34-063 171-506063 AAGTCACCTCGCCCACACCGTCGAA 
sp35-064 171-506064 TCCGTACGCTCGAAACGCTTCCAAC 
sp36-065 171-506065 CGAAATCCAGCACCACATCCGCAGC 
sp37-066 171-506066 CGCGAACTCGTCCACAGTCCCCCTT 
sp38-072 171-506072 CGTGGATGGCGGATGCGTTGTGCGC 
sp39-073 171-506073 GACGATGGCCAGTAAATCGGCGTGG 
sp40-074 171-506074 CGCCATCTGTGCCTCATACAGGTCC 
sp41-075 171-506075 GGAGCTTTCCGGCTTCTATCAGGTA 
sp42-076 171-506076 ATGGTGGGACATGGACGAGCGCGAC 
sp43-077 171-506077 CGCAGAATCGCACCGGGTGCGGGAG 
 
Table 2.6.  Sequences of the oligonucleotides used for spoligotyping. 
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2.8.2. PCR amplification of the DR locus 
For 28 isolates and 4 controls, the following PCR mastermix was prepared for a total volume 
of 25 µl per reaction: 75 µl 10X PCR Buffer; 15 µl dNTP mix; 60 µl Dra primer (5‟-
GGTTTTGGGTCTGACGAC-3‟, 5‟ biotinylated) (5 pmoles/µl); 60 µl DRb primer (5‟-
CCGAGAGGGGACGGAAAC-3‟) (5 pmoles/µl); 462 µl H2O; 3µl Super Tth DNA 
polymerase (Sphaero Q, Gorinchem, Netherlands); and 2.5 µl template DNA. M. tuberculosis 
H37Rv and M. bovis were used as controls with sterile distilled H2O added to the final two 
reactions. The PCR reactions were transferred to a thermal cycler and the following 
amplification programme was carried out: 3 minutes at 94°C; 20 cycles of 1 minute at 94°C, 1 
minute at 55°C, 30 seconds at 72°C; with a terminal extension step of 5 minutes at 72 °C. 
 
2.8.3. Hybridisation and detection 
The coupled spoligotyping microspheres solutions were resuspended by sonication for 10 
seconds and vortexing 10 times to ensure complete dispersion of the microsphere pellet. The 
working microsphere solution was prepared (990 µl 1.5X tetramethylammonium chloride 
(TMAC) hybridisation buffer and 128 µl bead mix) and gently vortexed for 15 second. In a 
96-well hybridisation plate, 33 µl of the working microsphere solution and 17 µl of each PCR 
reaction were added to 32 wells. The plate was sealed with plastic film. The beads and PCR 
amplicons were hybridised at 94ºC for 10 minutes followed by 52ºC for 30 minutes with 
continued heating at 52ºC until required. The hybridisation reaction plate was centrifuged at 
2,000 rpm for 3 minutes and the supernatant was then removed without disturbing the pellet. 
The detection reagent was then prepared (10 µl streptavidin-phycoerythrin conjugate 
(Invitrogen, Paisley, Renfrewshire, UK) and 2.5 ml 1X TMAC hybridisation buffer pre-
warmed at 52 C) and thoroughly vortexed. To each hybridisation reaction, 75 µl of detection 
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reagent was added and beads were resuspended by pipetting. The hybridisation reactions were 
then incubated for 5 minutes at 52°C. 
 
2.8.4. Microsphere Suspension Array analysis on the BioPlex and data analysis  
The hybridisation plate was loaded and the protocol settings were set so that 100 beads per 
region were analysed and the sample size was 50 µl. Data obtained was then exported to 
Microsoft Excel. Using an Excel file available from the CDC, the median rfu values for each 
bead set were analysed and used to construct the spoligotype for each strain. 
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2.9. DATA AND STATISTICAL ANALYSIS 
 
2.9.1. MIRU-VNTR M. tuberculosis Strain clustering analysis. 
MIRU-VNTR data were entered into a Microsoft Access database linked to BioNumerics. 
Individual Locus data was imported as character data and clusters were identified by using the 
Categorical Co-efficient and the UPGMA method for displaying the similarity dendrogram. 
Two or more strains with indistinguishable alleles at all loci were considered a cluster. 
 
2.9.2. Data Analysis: Assigning Cultural, Ethnic, and Linguistic groups.  
Experian Origins software v6.3.0.7 (Nottingham, UK) was used to assign (Cultural, Ethnic, 
and Linguistic) CEL groups (Webber, 2007). Data was imported as a Comma Separate 
Variable file, strings such as Jr, Mr, Mrs were removed and the “England, AAA” data 
processing type was selected. All specific CEL groups identified were accepted and used. 
 
 
2.9.3. n-1 clustering method 
Within a cluster, it can be assumed that the earliest case is the source case and subsequent 
patients were recently infected from contact with the source case and not reactivation of latent 
infection (Small et al., 1994;Godfrey-Faussett et al., 2000). A minimum estimate of the 
proportion of tuberculosis caused by transmission within each cluster can therefore be 
calculated as: 
 
Number of clustered patients - number of clusters 
________________________________________ 
 
Total number of patients 
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2.9.4. Hunter-Gaston Discrimination Index 
 
The discrimination and diversity of typing systems and mycobacterial populations was 
calculated using the Hunter-Gaston Discrimination Index (HGDI) (Hunter and Gaston, 1988): 
 
    1 s  
D = 1 –           Σ xj (xj - 1)  
    N(N – 1) j = 1  
 
Where D is the index of discriminatory power (0.000-1.000), N the number of unrelated 
strains tested, s the number of different types, and xj the number of strains belonging to the jth 
type. A D value of 1.000 indicates that a typing method was able to distinguish every member 
of a strain population from all other members of that population. Conversely, an index of 
0.000 would indicate that all members of a strain population were of an indistinguishable 
type. An index of 0.500 would mean that if one strain was chosen at random from a strain 
population, then there would be a 50% probability that the next strain chosen at random 
would be indistinguishable from the first (Bikandi et al., 2004). The HGDI value was 
calculated using the HPA VNTR Diversity and Confidence Extractor online tool (Platt, 2011). 
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2.9.5. Available online databases of M. tuberculosis Complex strains 
2.9.6. SpolDB4 
SpolDB4 is the fourth version of an international global spoligotyping database that contains 
at least 39,925 strains from 122 countries classified into 62 clades or lineages (Brudey et al., 
2006). A list of all known shared types is available as supplementary data with the publication 
by Brudey et al in 2006 or the dataset can be queried online at http://www.pasteur-
guadeloupe.fr:8081/SITVITDemo/index.jsp. 
 
2.9.7. MIRU-VNTRplus 
MIRU-VNTRplus is an online database that contains genotypic data from five distinct 
methods (MIRU-VNTR, Spoligotyping, LSPs, SNPs, and IS6110 RFLP) for 186 isolates that 
represent the major branches of the principal global M. tuberculosis complex lineages as 
defined by LSP and spoligotyping analysis. This database can be queried using data generated 
for any or all of the 5 genotyping methods and a strain lineage can be subsequently assigned. 
The MIRU-VNTRplus database (http://www.miru-vntrplus.org) was developed by D. 
Harmsen, S. Niemann, P. Supply and T. Weniger (Allix-Beguec et al., 2008b). 
 
2.9.8. Epidemiological data collection. 
Information from contact tracing and screening was collated by the Consultant in 
Communicable Disease Control (CCDC) responsible for the investigation of each described 
cluster. This information was then considered together with the results of molecular typing by 
the microbiologists in order to confirm or refute the clinical hypothesis of source and 
secondary cases, together with linkage. 
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2.9.9. Epidemiological data analysis 
Pearson‟s chi-squared test with Fisher's exact test was used where necessary. Univariate and 
multivariate logistic regression modelling was used to test the significance of odds ratios in 
Stata v10 (Stata, College Station, Texas, USA). The multivariable model was assembled by 
adding covariates individually in decreasing order of significance and the "goodness of fit" of 
each model was assessed using the likelihood ratio test. All cases with missing values for the 
variables examined were excluded from multivariate models. A univariate analysis of the 
epidemiological investigation of patients resident in Wolverhampton was undertaken using 
EpiData Analysis v2.2 (EpiData Association, Odense, Denmark). The extent of any 
association was expressed as an odds ratio (OR) with 95% confidence intervals. 
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2.10. DNA MICROARRAYS 
Whole genome DNA microarrays of M. tuberculosis were kindly provided by the BµG@S 
group at St. George‟s Hospital Medical School, London. They were constructed by spotting 
PCR amplicons from partial sequences of the 3,924 predicted ORFs of the sequenced strain 
M. tuberculosis H37Rv onto poly-L-lysine-coated glass microscope slides. Two 
hybridisations were done for each strain using a different dye (Cy3 or Cy5) each time.  
 
2.10.1. Preparation of genomic DNA from mycobacteria 
M. tuberculosis strains were grown in 100 ml Dubos medium for at least four weeks at 37ºC. 
The day before cell extraction was started; 10 ml 2 M glycine was added. Mycobacterial cells 
were harvested by centrifugation for 20 minutes at 7,000 g and washed in 30 ml SET solution 
(0.3 M sucrose, 50 mM Tris-Cl (pH 8.0), 10 mM EDTA). Cells were resuspended in 2 ml 
SET solution also containing 2 mg/ml lysozyme and 2 mg/ml lipase and incubated for 60 
minutes at 37ºC. To the resuspended cells, 8 ml GSE Solution (6 M guanidinium chloride, 1% 
sarkosyl, and 20 mM EDTA) was added and incubation was continued at 37ºC for a further 2 
hours. To separate DNA, 10 ml chloroform:isoamyl alcohol (24:1) was added, inverted, and 
centrifuged at 7,000 g for 20 min. The supernatant was removed, 2.5 vol ethanol was added 
and incubated overnight at -20 °C. The precipitate was centrifuged at 7,000 g for 20 minutes 
and the ethanol was removed. The pellet was resuspended in 2 ml TE (containing 0.5mg/ml of 
RNase, 0.5mg/ml of Proteinase K, and 0.5% SDS) and incubated at 37ºC overnight. The 
chloroform and ethanol steps were repeated using 2 ml and 2.5 vol respectively and the DNA 
was finally resuspended in 100 µl TE buffer (Davis et al., 1991). 
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2.10.2. DNA Microarray analysis: Preparation of Cy3/Cy5 labelled DNA 
One Cy3 and one Cy5 labelled DNA sample was prepared per microarray slide using the 
following mastermix (GE Healthcare, Chalfont St Giles, Buckinghamshire, UK): 2-5 µg 
DNA; 1 µl random primers (3 µg/µl); and H2O to a total volume of 41.5 µl. The mastermix 
was heated at 95ºC for 5 minutes, snap cooled on ice, and briefly centrifuged. To each 
mastermix was added: 5 µl 10X React2 Buffer; 1 µl dNTPs (5 mM dA/G/TTP, 2 mM dCTP); 
1.5 µl Cy3 or Cy5 dCTP; and 1 µl Klenow enzyme (3-9U/µl). This mastermix was then 
incubated in the dark for 90 min. 
 
2.10.3. Slide prehybridisation 
The prehybridisation solution for a maximum of four slides was prepared as follows: 8.75 ml 
20X SSC; 250 µl 20% SDS; 5 ml BSA (100 mg/ml); and H2O to a total volume of 50 ml. This 
solution was pre-warmed to 65ºC in a Coplin staining jar. Up to four slides in one Coplin jar 
were incubated at 65ºC for 20 minutes, rinsed in 400 ml sterile distilled H2O for 1 minute, 
rinsed in 400 ml isopropanol for 1 minute, and each slide was centrifuged at 1,500 rpm for 5 
minutes and then stored in a dark, dust-free box until hybridisation. 
 
2.10.4. Wash preparation 
Wash A was prepared as follows: 20 ml 20X SSC; 1 ml 20% SDS; and sterile distilled H2O to 
a total volume of 400 ml. The wash buffer was pre-warmed to 65ºC. 
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2.10.5. Slide hybridisation with Cy3/Cy5 labelled DNA 
Cy3 and Cy5 labelled DNA samples were purified using the MinElute Purification kit 
(Qiagen, Crawley, West Sussex, UK). The purified Cy3/Cy5 labelled DNA was mixed with 
hybridisation solution for one 22 x 22 mm LifterSlip slide (Thermo Fisher Scientific, 
Loughborough, Leicestershire, UK) as follows: 14.9 µl labelled DNA sample; 4.6 µl 20X 
SSC; and 3.5 µl 2% SDS. The prehybridised microarray slide was placed in the hybridisation 
cassette and two 15 µl aliquots H2O was added to the wells in the cassette. The labelled DNA 
and hybridisation solutions was heated at 95ºC for 2 minutes and allowed to cool slightly. A 
LifterSlip was placed carefully over the array area on the slide and the hybridisation solution 
was pipette under one corner of the LifterSlip allowing capillary action to draw the solution 
completely across the array. The hybridisation cassette was sealed and submerged in a 
waterbath at 65ºC in the dark for 16-20 hours. 
 
2.10.6. Slide washing 
Wash A buffer pre-heated to 65ºC was added to a pre-heated staining trough at 65ºC. The 
microarray slide was removed from the hybridisation cassette and washed in Buffer A to 
remove the LifterSlip. After this, the slide was then washed in Buffer A for 2 minutes. Wash 
B buffer (1.2 ml 20X SSC and 398.8 ml H2O) was prepared. The slide was then washed in 
Buffer B for 2 minutes and then transferred to fresh Buffer B for a second wash of 2 minutes. 
The slide was then centrifuged at 1,500 rpm for 5 minutes to dry. The slide was then scanned 
using a GenePix 4000A scanner (Molecular Devices, Wokingham, Berkshire, UK), analysed 
by GenePix v.3.0 software (Molecular Devices, Wokingham, Berkshire, UK) and normalized 
using GeneSpring v.6 (Silicon Genetics, Stockport, Cheshire, UK). The following 
normalizations were undertaken: after dye swap of the slides, the data were normalized per 
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spot dividing by control channel using a cut off 0.01 and per chip normalizing to the 50th 
percentile. Genes were only considered to be deleted when the p-value was <0.05. 
 
2.10.7. Confirmation of deleted regions by PCR and sequencing. 
PCR and DNA sequencing was used to confirm deletions which included: Rv1519; Rv3516-
17; Rv3738c-39c; Rv1917c; plcC-cut1; Rv3017c-Rv3022c; and Rv3135. Primers were 
designed using Primer 3 with an annealing temperature between 58 and 60ºC (Rozen and 
Skaletsky, 2000). AmpliTaq Gold polymerase or the Expand Long Template PCR System 
(Roche Applied Science, Burgess Hill, West Sussex, UK) was used depending on the 
genomic region and length of predicted amplicon. When AmpliTaq Gold was used, 1 mM of 
primers and 1.5 mM of MgCl2 was used. The following thermal cycler conditions were used: 
an initial denaturation of 95°C for 1 minute and then 35 cycles of 95ºC for 1 minute, 58ºC for 
1 minute, and 72ºC for 1 minute, followed by a terminal extension step at 72ºC for 10 
minutes. When the Expand Long Template PCR System was used, the PCR conditions were 
carried out using 1 mM of primers and 2 mM of MgCl2. The PCR cycling programme was as 
follows: 94ºC for 2 minutes; 10 cycles of 95ºC for 30 seconds, 58ºC for 30 seconds and 68ºC 
for 5-8 minutes (2 minutes for up to 3 kb, 4 minutes for 6 kb, 8 minutes for 10 kb) followed 
by 15 cycles of 95ºC for 30 seconds, 58ºC for 30 seconds and 68ºC for 5-8 minutes (2 minutes 
for up to 3 kb, 4 minutes for 6 kb, 8 minutes for 10 kb) plus 20 seconds cycle elongation for 
each successive cycle. A terminal extension step at 68ºC for 7 minutes completed the 
amplification. Sequencing reactions were performed with BigDye Terminator v 1.1 (Applied 
Biosystems, Warrington, UK) and purified with the DyeEx 2.0 Spin Kit (Qiagen, Crawley, 
West Sussex, UK). The reactions were purified and analysed by capillary sequencing using a 
MegaBACE DNA Analysis System (GE Healthcare, Chalfont St Giles, Buckinghamshire, 
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UK). The sequences obtained were compared to TubercuList 
(http://genolist.pasteur.fr/TubercuList/index.html) and NCBI (http://www.ncbi.nlm.nih.gov). 
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2.11. ETHICAL CONSIDERATIONS 
This thesis details the development of DNA fingerprinting and analysis of subsequent data 
generated which has been undertaken as part of normal public health practice by 
microbiologists, respiratory physicians, and public health teams in the West and East 
Midlands. Therefore, specific ethical approval was not required. The HPA has Patient 
Information Advisory Group permission under the Health and Social Care Act 2001 to collect 
and analyse such data for public health purposes. 
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3. A COMPARISON OF MIRU-VNTR AND IS6110 
RFLP MOLECULAR TYPING METHODS AND 
RELATIONSHIP TO CONVENTIONAL 
EPIDEMIOLOGICAL DATA. 
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3.1. INTRODUCTION 
3.1.1. IS6110 RFLP is the historical gold standard for DNA fingerprinting of M. 
tuberculosis 
Initial studies of the IS6110 element showed that isolates from epidemiologically linked 
patients generally possessed identical IS6110 RFLP patterns which equates to a transmission 
cluster. One of the initial studies that examined the association between epidemiological links 
and linkage of strains by IS6110 RFLP showed that two epidemiologically linked clusters of 
nine and 23 isolates were also clustered by IS6110 RFLP and that six epidemiologically 
distinct strains were distinct by RFLP (Hermans et al., 1990). A case-control study of 18 
AIDS patients with a drug resistant TB clone and fully sensitive control patients with different 
distinct strains in a New York Hospital showed that patients with drug-resistant TB had a 
significantly higher risk of hospitalisation and admittance to the same ward as an infectious 
patient with drug resistant TB than patients with drug sensitive TB (Edlin et al., 1992). One of 
the first reports of the use of RFLP in a public health investigation in the UK was in the 
Midlands. The isolates from one patient who had died of tuberculous meningitis and their 
neighbour were analysed by IS6110 RFLP to determine if transmission had occurred. Ten 
isolates from the same city isolated three months before the death of the patient were also 
typed. The patient with TB meningitis and neighbour had identical fingerprints whereas the 
10 control strains were all distinct. The authors concluded that this data was consistent with, 
but did not absolutely prove, transmission from the neighbour to the deceased patient 
(Godfrey-Faussett et al., 1992). 
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Since these early studies, IS6110 RFLP has been applied to many different epidemiological 
which have included regional epidemiological studies of drug-resistant strains, point source 
outbreaks, and laboratory cross-contamination. 
 
DNA fingerprinting of 253 strains in New York City showed transmission of a drug-resistant 
strain within New York but also spread of this clone to four other US cities (Bifani et al., 
1996). RFLP typing was used to investigate nosocomial transmission of MDR-TB in a HIV 
positive cohort. Isolates from 6/8 patients were identical by IS6110 RFLP. Patients who had 
been hospitalised for more than days within three rooms of an infectious MDR-TB patient had 
a significantly higher risk of acquiring the MDR-TB strain which highlighted the lack of 
adequate infection control procedures (Coronado et al., 1993). 
 
Two clusters highlighted the utility of DNA fingerprinting in identifying links that were not 
originally apparent when conventional epidemiological data was analysed. An 
epidemiological study of 48 individuals infected with the same strain in Houston showed that 
individuals who had visited multiple public bars in the same neighbourhood each night had 
few social links. Each individual was linked to no more than one or two other individuals 
infected with the same strain. This indicated that there was a complex transmission scenario 
where limited contact within a large cohort was enough to generate widespread transmission 
(Yaganehdoost et al., 1999). A retrospective epidemiological study in Berne, Switzerland 
identified an RFLP cluster that encompassed two apparently discrete social groups. The first 
group contained 22 patients who were all known to be drug addicts with the second 
apparently separate group centred on a restaurant. Further investigation revealed that a regular 
patron of the restaurant had a cough with bloody expectoration for six months before 
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diagnosis with active tuberculosis. This patient was in close contact with a second patient, 
who was living in a facility for drug addicts where six other people had tuberculosis 
(Genewein et al., 1993). 
 
As part of a regional epidemiological study in San Francisco, two clusters of six patients each 
were caused by laboratory cross-contamination. Only analysis of DNA fingerprinting and 
laboratory records identified these patients and the authors estimated that the cost of this 
series of false-positive cultures was approximately $15,000 (Small et al., 1993). 
 
3.1.2. Shortcomings of IS6110 RFLP Typing 
Although IS6110 RFLP had the best correlation with epidemiological data of any typing 
method developed before 2000, this method does have several shortcomings. Technically, 
IS6110 RFLP is labour-intensive and the data obtained requires intensive normalisation using 
software to overcome interpretability and inter-laboratory transfer issues (Collyns et al., 
2002;Kremer et al., 1999;van Soolingen, 2001). The timescale for obtaining IS6110 RFLP 
data is at least four weeks from first isolation of a positive culture which limits the 
opportunity for early and effective public health interventions to prevent further transmission. 
IS6110 RFLP cannot be used to assign a genotype to all M. tuberculosis strains as not all 
strains possess IS6110 elements and IS6110 RFLP exhibits an artificially increased level of 
clustering in strains which harbour less than five copies of IS6110 (van Soolingen et al., 
1993). There are specific regions around the world where strains that have low copy number 
strains are prevalent (Fomukong et al., 1994). In Southern India, it was found that 50/80 
(63%) of typed strains did not possess IS6110 or only had one copy which essentially meant 
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that the majority of strains in this region could not be adequately differentiated by IS6110 
RFLP (Radhakrishnan et al., 2001). 
 
3.1.3. Other alternative methods to IS6110 RFLP 
Molecular solutions for the problems of IS6110 RFLP have focused on PCR-based 
methodologies for characterizing IS6110 polymorphism, such as mixed linker typing or 
fluorescent amplified fragment length polymorphism (fAFLP) (Haas et al., 1993;Thorne et 
al., 2007a). Although these methods are attractive, the reproducibility of mixed-linker PCR is 
sometimes a problem, and the fundamental problems of zero and low copy number isolates 
are still evident in fAFLP. Multilocus sequence typing (MLST) has been used to produce a 
discriminatory, digital, PCR-based typing method in a range of bacteria, including 
methicillin-resistant S. aureus and Neisseria meningitidis (Maiden et al., 1998). Initial studies 
of a limited number of genes in M. tuberculosis identified few polymorphisms, which limited 
the utility of this method (Sreevatsan et al., 1997). Subsequent studies analysed an increasing 
number of target sequences, which in turn has substantially increased the range of diversity 
identified and improved our understanding of the global phylogeny of M. tuberculosis clades 
(Baker et al., 2004;dos Vultos et al., 2008). However, MLST has not replaced IS6110 RFLP 
as a DNA fingerprinting method for public health investigations. Spoligotyping is useful as a 
second-line alternative when required but does not generally provide sufficient discrimination 
as a single method for outbreak investigation (Kremer et al., 1999).   
 
3.1.4. MIRU-VNTR typing is a possible alternative to IS6110 RFLP 
MIRU-VNTR typing is being used in an increasing number of studies to overcome the 
problems of IS6110 RFLP typing. MIRU-VNTR typing is faster than IS6110 RFLP as it is a 
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PCR-based method and genotypes can be obtained from crude extracts after 1-2 weeks growth 
rather than four weeks growth required for IS6110 RFLP. MIRU-VNTR results are in a 
digital format which makes data exchange easier. Preliminary studies showed that MIRU-
VNTR typing is highly reproducible and discriminatory (Mazars et al., 2001;Savine et al., 
2002;Supply et al., 2001). A study of 93 isolates from Tanzania showed that VNTR typing 
can help to overcome the issues caused by strains with low copy numbers of IS6110. ETR 
typing reduced the number of isolates clustered by RFLP from 33/48 low copy number strains 
to 24/48 which increased the HGDI from 0.892 to 0.957. The addition of five locus ETR 
typing reduced the proportion of low-copy-number isolates that would have been clustered by 
IS6110 RFLP alone by 27% (Barlow et al., 2001). 
 
3.1.5. The discriminatory power of MIRU-VNTR typing has been increased by 
successive increments in the number of MIRU-VNTR loci analysed 
MIRU-VNTR typing achieves a high level of discrimination by combining genotyping data 
from multiple independent loci. There have been three widely used collections of MIRU-
VNTR loci published since 1998, each with an increased number of loci and associated 
increased discriminatory power and utility. The first collection was published in 1998 and 
used five ETR loci (Frothingham and Meeker-O'Connell, 1998). A second collection of 
MIRU-VNTR loci was published in 1998 and used 12 MIRU-VNTR loci (Supply et al., 
2001). The most recent “3rd generation” of MIRU-VNTR loci uses 24 loci that includes a 
subset of 15 highly discriminatory (HD) loci selected from multiple studies that examined 
other potentially useful loci (Table 3.1) (Supply et al., 2006). The highest level of 
performance exhibited by MIRU-VNTR typing was achieved when IS6110 RFLP clusters 
with no apparent epidemiological links were differentiated by the 24 MIRU-VNTR loci.  
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3.1.6. MIRU-VNTR loci set terminology 
Within this chapter, five sets of MIRU-VNTR loci that vary in locus composition and number 
will be analysed (Table 3.1): the five ETR loci that will be called “ETR typing”; the 12 MIRU 
loci will be called “MIRU typing”; the five ETR and 12 MIRU loci combined will be called 
“ETR+MIRU typing”; the recently internationally optimised set of 24 MIRU-VNTR loci 
(ETR, MIRU, and VNTR+ sets) will be called “24 loci typing” with a subset of these 24 loci 
that contains 15 highly discriminatory loci will be called “HD15 typing”. 
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Generation 
Loci 
Set 
name 
VNTR 
Locus 
name 
Alias ETR MIRU 
24 
loci 
HD 
15 
Reference 
1
st
 ETR 
2165 ETR-A      
Frothingham, 
1998 
2461 ETR-B      
577 ETR-C      
580 ETR-D*      
3192 ETR-E*      
2
nd
 MIRU 
154 MIRU-02      
Supply, 2001 
580 MIRU-04*      
960 MIRU-10      
1644 MIRU-16      
2059 MIRU-20      
2531 MIRU-23      
2687 MIRU-24      
2996 MIRU-26      
3007 MIRU-27 QUB-5     
3192 MIRU-31*      
4348 MIRU-39      
802 MIRU-40      
3
rd
 VNTR+ 
0424 VNTR0424 Mtub04     
Supply, 2006 
1955 VNTR1955 Mtub21     
2163b VNTR2163b QUB11b     
2347 VNTR2347 Mtub29     
2401 VNTR2401 Mtub30     
3171 VNTR3171 Mtub34     
3690 VNTR3690 Mtub39     
4052 VNTR4052      
4156 VNTR4156      
 
Table 3.1.  Composition of three published MIRU-VNTR loci sets.  
 
*There are two MIRU-VNTR loci that are present in both the ETR and MIRU loci sets but are 
the same locus. The two loci are ETR-D/MIRU-04 and ETR-E/MIRU-31. 
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3.2. AIMS 
This work presented in this chapter details two studies that evaluated the utility and precision 
of MIRU-VNTR typing. 
 
The aim of this chapter was to compare molecular genotyping data obtained from the various 
VNTR sets and IS6110 RFLP versus known conventional epidemiological data gathered from 
outbreak investigation records.  
 
We hypothesise that MIRU-VNTR typing can provide equivalent DNA fingerprinting results 
to that obtained by IS6110 RFLP across four criteria which can be used to assess the utility of 
a DNA fingerprinting method: typing ability, discriminatory power, reproducibility, and 
applicability (Hawkey and Kerr, 2003). The four criteria will be measured as follows: typing 
ability will be measured by the proportion of all isolates that have typing data; discriminatory 
power will be measured by calculation of the highest HGDI (See Methods Section 2.9.4) and 
lowest clustering rates (Methods Section 2.9.3); reproducibility will be assessed by variability 
between epidemiologically linked patients; and applicability will be assessed by the potential 
ability for universal prospective DNA fingerprinting on a regional scale. 
 
3.2.1. Collection 1: Comparison of IS6110 RFLP and 15 locus MIRU-VNTR data. 
The first study undertaken in 2003 assessed whether MIRU-VNTR typing could be used as a 
rapid alternative to IS6110 RFLP typing by comparing IS6110 RFLP data to 1st (ETR) and 
2nd (MIRU12) generation MIRU-VNTR loci data in four clusters (Collection 1) with defined 
epidemiological links. 
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3.2.2. Collection 2: Comparison of 15 and 24 locus MIRU-VNTR typing 
In 2009, to evaluate the increase in discrimination offered by the 3rd generation of 
internationally optimized 24 loci, we carried out an evaluation of 3rd generation MIRU-
VNTR data in seven clusters (Collection 2) defined by 1st and 2nd generation MIRU-VNTR 
loci with a spectrum of epidemiological links. The epidemiological evidence for the 
significance of the cluster ranged from complete linkage to no evidence of social linkage. 
Collection 2 compared 24 and 15 loci in clusters with varying degrees of epidemiological 
linkage. Collection 2 was used to assess the improvement in correlation between conventional 
epidemiological and molecular data provided by analysing 24 loci. 
 
The technical properties of MIRU-VNTR typing could enable a large-scale prospective 
population based study where every isolate of M. tuberculosis is typed which in turn would 
improve our understanding of the epidemiology and transmission of M. tuberculosis in the 
Midlands. 
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3.3. METHODS 
Primary specimens were processed as described in Methods Section 2.3 and cultures were 
grown on LJ slopes for at least four weeks (Section 2.3.1). For collection 1, DNA was 
extracted using the CTAB method (Section 2.5.1) and DNA was extracted using a heating and 
sonication method for strains in Collection 2 (Section 2.3.3). IS6110 RFLP was carried out 
using the recommended international method (Section 2.5). For MIRU-VNTR typing of 
strains in Collection 1, the five ETR and 12 MIRU loci were analysed using the primers and 
PCR conditions described by Frothingham and Supply. PCR amplicons were analysed by 
agarose gel electrophoresis (Section 2.6.1). For Collection 2, the classical 15 MIRU-VNTR 
loci were analysed using non-dHPLC (Section 2.7) with the additional nine loci amplified as 
described by Supply using agarose gel electrophoresis (Section 2.6.2). Epidemiological data 
for each cluster was collected (Section 2.9.8) and compared to molecular data to assess the 
degree of concordance. 
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3.4. RESULTS 
3.4.1. Collection 1: Discriminatory power of MIRU-VNTR and IS6110 RFLP typing in 
clusters with defined epidemiological links. 
The proportion of clustering and discriminatory power exhibited by each of the three sets of 
VNTR loci and the gold standard for DNA fingerprinting (IS6110 RFLP) was assessed (Table 
3.2). 1
st
 generation ETR typing using five loci exhibited the highest rate of clustering (75%) 
and the lowest HGDI value (0.75, 95% CI 0.682-0.818). Results obtained with the 2nd 
generation 12 MIRU loci and combining the five ETR loci and 12 MIRU loci 
(ETR+MIRU12) were equivalent as the less discriminatory ETR loci did not split any 12 
locus MIRU profiles in this study. ETR+MIRU12 typing did produce a slightly lower rate of 
clustering (32%) than IS6110 RFLP (40%) with one more cluster and three fewer clustered 
isolates across the four clusters with similar levels of diversity as determined by the HGDI. 
There were three instances of indistinguishable strains identified in two or more 
investigations. MIRU-VNTR profiles 94265 254326223513 (isolate 78) and 71466 
254326153622 (isolate 295) were present as single strains in Investigations A and C were 
clustered by IS6110 RFLP as both strains possessed a single copy of IS6110 in a similar 
genomic location. MIRU-VNTR profile 32433 224325153324 was the major strain in 
Investigation B and possessed only two copies of IS6110. A single strain in Investigation C 
also possessed two copies of IS6110 and had a similar but different MIRU-VNTR profile 
(32433 224326153324). No specific epidemiological links were identified between any of the 
investigations. 
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Typing method 
ETR 
(5 loci) 
MIRU 
(12 loci) 
ETR+MIRU 
(17 loci) 
IS6110 
RFLP 
No. of clusters 9 21 21 20 
No. of clustered isolates 49 38 38 41 
No. of unique isolates 4 15 15 12 
Total isolates 53 53 53 53 
Clustering (%) 75 32 32 40 
HGDI (95% CI) 
0.750 
(0.682-0.818) 
0.881 
(0.830-0.932) 
0.881 
(0.830-0.932) 
0.89 
(0.845--0.936) 
Concordance with 
RFLP in isolates 
part of main clusters 
30/32 (94%) 31/32 (97%) 31/32 (97%) - 
Concordance with 
RFLP in isolates 
outside main clusters 
12/21 (57%) 20/21 (95%) 20/21 (95%) - 
 
Table 3.2.  Discriminatory power of ETR, MIRU12, ETR+MIRU, and IS6110 RFLP 
in Collection 1. 
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3.4.2. Collection 1: Correlation between MIRU-VNTR and IS6110 data in clusters with 
defined epidemiological links. 
The clustering of isolates by IS6110 RFLP is shown in Figure 3.1.
 
The ETR and MIRU 
profiles are shown adjacent to each isolate number.
 
Inspection of the data set reveals a very 
strong correlation
 
between IS6110 RFLP type and both the ETR and the MIRU type. The 
three different sets of MIRU-VNTR loci were compared to RFLP fingerprints within each 
investigation based on concordance in isolates that were assigned to the major 
epidemiological cluster by RFLP typing and those that were excluded from the major 
epidemiological cluster. ETR, MIRU, and ETR+MIRU concorded with RFLP data in at least 
94% isolates within and outwith major epidemiological clusters. The only exception was five 
locus ETR typing in strains that had been excluded from epidemiological clusters by RFLP as 
ETR typing clustered more strains than RFLP in this group (57% vs 14% respectively) (Table 
3.2). The ETR profiles identified the major clusters in investigations B and
 
C and identified 
15/20 (75%) of the unrelated (by IS6110 RFLP analysis)
 
isolates as unrelated by ETR typing. 
In investigation A, the predominant group of indistinguishable
 
isolates (by IS6110 RFLP 
analysis) belonged to ETR type 42235, and
 
another six unrelated isolates showed the same 
ETR code. Isolates
 
09 and 92 were less than 100% related by IS6110 RFLP (each
 
had an 
additional band) but had identical MIRU profiles. These
 
patients were considered to be 
epidemiologically part of the
 
main cluster. The same was true to a lesser extent of 
investigation
 
D, in which isolates 17, 130, and 221, from family members,
 
were all ETR type 
42235 but one (isolate 221) had a different
 
subtype by IS6110 RFLP. The other two patient 
isolates had indistinguishable
 
IS6110 RFLP patterns but differing MIRU codes (two different 
alleles).
 
MIRU typing split ETR type 42235 into subtypes which
 
correlated strongly with 
IS6110 RFLP and epidemiological
 
findings. 
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Figure 3.1.  IS6110 RFLP similarity dendrograms 
 
Dendrograms were created using the Dice co-efficient and displayed via UPGMA. Isolates 
were from four distinct geographical locations in the Midlands region of the United Kingdom 
(investigations A to D). VNTR and MIRU typing results are shown for each isolate. Dots 
represent alleles with the same numbers of repeat units, indicating isolates with 
indistinguishable types. 
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3.4.3. Collection 1: Epidemiology of clusters 
Investigation A concerned a complex, large-scale outbreak centred on a single index case in a 
school. However, the high background level of tuberculosis in the community and in pupils in 
the school not directly related to the index case required the use of molecular typing in order 
to fully understand routes of transmission. It was originally thought that isolates 78 and 263 
were the index cases who were part of the general community and not school pupils. 
However, application of five locus ETR typing excluded these two patients from the cluster 
and focussed public health efforts onto the school. Other pairs of cases (e.g., 67-68, 08-51) 
which were not caused by the outbreak strain but were subsequently linked epidemiologically 
with each other were identified. Two isolates, 09 and 92, showed single additional bands in 
the IS6110 pattern compared to the outbreak strain but had identical MIRU codes. 
Epidemiologically, these isolates were indisputably part of the main outbreak, a case where 
the greater stability of MIRU enhanced the clarity of typing. A number of subsequent cases 
that may have represented failure of implemented control measures were quickly excluded 
from the outbreak cluster. 
 
In investigation B, molecular typing was used to examine isolates from a community with a 
previously low incidence of tuberculosis where a sharp increase in the number of cases over 
the preceding 12 to 18 months had been noted. In investigation B, MIRU typing linked four 
family members (isolates 134, 03, 32, and 79), as was expected, but also linked these with 
other cases within the same city which were indistinguishable by typing and led to the 
discovery of an unsuspected social link. Two other isolates, 121 and 239, which might have 
been linked, were shown to be clearly unrelated. Typing was unable to distinguish between 
strains from two apparently distinct epidemiological clusters, prompting further investigation, 
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which revealed unsuspected social links between the two clusters. The information was used 
to plan the extent of contact examination. 
 
Investigation C was triggered by the recognition of an increase in the number of isoniazid-
resistant strains over a five year period and the concern that transmission of a resistant clone 
was occurring. MIRU typing confirmed a common profile for 11/17 (65%) isolates which also 
had indistinguishable IS6110 RFLP patterns. In this cluster of 11 patients, nine patients were 
UK-born and two patients originated from the Indian subcontinent (ISC). This was in contrast 
to the other six non-clustered isolates, all of which were from patients who originated from 
the ISC. Preliminary epidemiological investigation demonstrated geographical clustering of 
some cases with indistinguishable strains. 
 
Investigation D concerned a small group of strains primarily from a family of three patients 
that were thought to be clustered, but IS6110 RFLP typing showed them to be all unrelated 
with the exception of isolates 17 and 130, which were from a husband and wife. A close 
family contact (isolate 221) had a different RFLP and MIRU type, as did all the other 
contacts. MIRU typing showed differences at two loci, although the isolates were separated 
by three years. 
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3.4.4. Collection 2: The discriminatory power of 24 MIRU-VNTR loci compared to 15 
locus ETR+MIRU typing. 
The proportion of clustering and discriminatory power exhibited by ETR+MIRU typing, the 
recently published optimal set of 24 loci, and highly discriminatory set of 15 loci was 
assessed in seven clusters defined by ETR-MIRU typing (Table 3.3). Application of the 3
rd
 
generation of 24 MIRU-VNTR loci increased the number of clustered profiles from seven to 
eight and resulted in 19 strains differentiated as unique or orphan profiles. All 19 of these 
strains split further by 24 loci typing were considered to concord with the available 
epidemiological data. The 3
rd
 generation loci reduced clustering from 92% to 59% and 
increased the HGDI from 0.793 (95% CI 0.730-0.856) to 0.890 (95% CI 0.835-0.944). Within 
this study, there were no differences in clustering or levels of differentiation obtained when 
the 24 loci (8 clusters, 47 clustered isolates, 59% clustering and HGDI = 0.890) or the subset 
of highly discriminatory 15 loci (8 clusters, 47 clustered isolates, 59% clustering and HGDI = 
0.890) were applied. 
 
Typing method 
ETR+MIRU 
(17 loci) 
VNTR+ 
(24 loci) 
HD15 
(15 loci) 
No. of  clusters 7 8 8 
No. of clustered isolates 68 47 47 
No. of unique isolates 0 19 19 
Total isolates 66 66 66 
Clustering (%) 92 59 59 
HGDI (95% CI) 
0.793 
(0.730 - 0.856) 
0.890 
(0.835 - 0.944) 
0.890 
(0.835 - 0.944) 
 
 
Table 3.3.  Discriminatory power of three sets of MIRU-VNTR loci in Collection 2. 
 
Collection 2 contained 66 isolates from seven clusters defined by ETR-MIRU typing. 
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3.4.5. Collection 2: Concordance between epidemiological and genotyping data. 
The concordance between available epidemiological data and DNA fingerprinting data was 
evaluated (Table 3.4). The seven investigated clusters ranged in the degree of certainty of 
epidemiological links between patients in a cluster. In cluster 2, epidemiological links had 
been investigated by reviewing patient case notes but no common links were identified. 
Epidemiological links between patients were investigated with identification of common 
social links for most or all patients in clusters 5 and 6. In clusters 3, 4, and 7 some but not all 
of the patients within each cluster were linked by conventional epidemiological data. Cluster 
1 was a single locus variant (SLV) of the ETR+MIRU profile present in cluster 5. The four 
patients in this cluster lived within the same county as Cluster 5 but in different towns. The 
hypothesis for investigating this cluster was to examine the potential further differentiation 
afforded by 24 loci in strains which only differ at one locus in the 15 loci.  
 
Cluster 1 and 2 were separated by the 24 loci set into two smaller clusters with two and seven 
orphan profiles in cluster 1 and 2 respectively. Cluster 3 was split in half whereas cluster 4 
had only one isolate split by the 24 loci with a cluster of 10 isolates remaining intact. The 
largest cluster (cluster 5) had 5/24 isolates split by the 24 loci with a central cluster of 19 
isolates still indistinguishable. Cluster 6 still remained as a cluster of four isolates even after 
application of the 24 loci and cluster 7 was reduced from a cluster of six to four isolates.  
 
In all seven clusters containing 66 isolates, there was an increase in the concordance between 
conventional epidemiological data from 38/66 (58%) isolates for 17 locus ETR+MIRU typing 
to 59/66 (89%) isolates for 24 locus MIRU-VNTR typing. 
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3.4.6. Collection 2: Conventional epidemiology of investigated clusters 
The clusters investigated in Collection 2 were mainly from 2004. Due to the intensive nature 
of reviewing patient case notes, the epidemiological links between every isolate and 
associated patient were not investigated. Several of the clusters represented large, complex 
clusters where the social networks extended beyond the investigated patients. Definite 
epidemiological links were identified when a patient was named as a contact of another 
patient that was known to have been infected with the same MIRU-VNTR profile or when a 
common specific link was identified. Isolates from identified contacts were not always typed 
further. Review of case notes without positive identification of any possible links was 
accepted as proof of no epidemiological linkage between patients. 
 
Cluster 2 was the second most prevalent ETR+MIRU profile in the Midlands in 2004. Within 
2004, there were a total of 19 isolates with this profile in seven locations across the Midlands. 
Strains were selected such that at least one representative strain from each location was 
analysed. Epidemiological links were investigated but none were found in any of the nine 
patients. The 24 loci split this cluster into seven orphan profiles and a pair of isolates which 
increased the number of isolates with concordant epidemiological and genotyping data from 
none to seven (Table 3.4). 
 
Cluster 3 was a cluster of eight patients identified by 17 locus ETR+MIRU typing where five 
patients were linked socially through common contact with a family and public houses were 
also a common factor. All eight isolates identified by ETR+MIRU typing in 2004 across the 
Midlands were selected for further analysis. The four patients who were linked with family 1 
remained clustered after 24 loci typing. Two of the four other patients had possible 
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connections through public bars but the two isolates were split into unique isolates by 24 loci 
typing. The other two patients had no epidemiological links at all and were also split into 
unique isolates. 
 
Cluster 4 included 11 strains that are part of the most prevalent ETR+MIRU profile in the 
Midlands. In 2004, there was a total of 37 isolates across six cities in the West and East 
Midlands with this profile. At least one representative isolate from each location was chosen 
for further molecular and epidemiological analysis. Six patients had known contact with other 
patients infected with this strain. Only one isolate was split from this ETR+MIRU cluster by 
24 loci. Four clustered isolates did not have any specific epidemiological links identified. 
 
Cluster 5 was a long-standing outbreak first identified in the 1990‟s with multiple links 
between families, various public houses and homeless hostels. All 24 isolates genotyped 
between 2000 and 2007 were selected for further analysis. From the prospective phase of 
DNA fingerprinting presented later in chapter 5 of this thesis, 32433 2432515324 was the 
most prevalent strain (11/389, 3%) in the local area with the SLV only identified in one 
patient between 2004 and 2009 within the same town. The degree of relatedness between 
these two ETR+MIRU profiles was queried as the patients in cluster 1 were not 
epidemiologically linked to any patients in cluster 5. Two of the isolates in cluster 1 were still 
clustered by 24 loci with two orphan strains. All of the four patients in cluster 1 were 
differentiated further from all patients in cluster 5 by 24 loci. The further differentiation 
exhibited by the 24 loci was accepted as achieving concordance with conventional 
epidemiological data since the epidemiological hypothesis was that these strains are not 
related. The pair of clustered isolates (Cluster 1, 2 and 3) were actually resident in the same 
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town. Application of the 24 loci revealed a central clone present in all of the mentioned 
overlapping links with 5/24 isolates separated from the main ETR+MIRU profile. The pair of 
patients (Cluster 5, 21 and 23) worked together and none of the orphan strains had any 
specific social links.   
 
Cluster 6 was a cohort of four patients who all worked in two warehouses of the same 
company in 2004. Across the Midlands, there were only four isolates with the 42433 
2331513321 profile. There was strong epidemiological linkage between patients which was 
confirmed as the four isolates were still indistinguishable after analysis by 24 loci. Cluster 7 
contained six patients with various social links which included known contact with members 
of the same family that were culture positive or public bars or prison. This cluster was 
separated into a cluster of four isolates and two orphan profiles by the 24 loci. The patients 
with the two orphan profiles did not have any linking epidemiology to the family, public bars, 
or prison. Review of case notes hinted at possible links between patients 2, 3, 5, and 6 in this 
cluster but the linkage was probably the weakest of all the clusters. The presence or absence 
of epidemiological data in this cluster correlated with the 24 loci clustering. So, the further 
differentiation of the two patients without known social links and clustering of four patients 
with some form of epidemiological links was accepted as full concordance between 
conventional and molecular epidemiological data in this cluster. 
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Cluster 
ETR+MIRU profile 
 
Cluster Description 
Extra nine 
loci profiles 
No. isolates where 
epidemiology concords 
with VNTR data (%) Total 
ETR+MIRU VNTR+ 
1 
32433 224325153323 (2002-07) 
Four culture positive patients resident 
within same county as Cluster 5 
but in three different towns. 
 
2 x 344423692 
2 x orphan 
0 (0) 4 (100) 4 
2 
42235 225425173533 (2004) 
2
nd
 most prevalent profile in 2004. 
Nine isolates from seven locations. 
Links investigated but none found. 
 
2 x 442423384 
7 x orphan 
0 (0) 7 (78) 9 
3 
42435 223325153533 (2004) 
Members and contacts of family 1. 
Possible extended social links to public bars. 
 
4 x 456443362 
4 x orphan 
4 (50) 8 (100) 8 
4 
32333 224325153314 (2004) 
Most prevalent profile. 
No specific social links.  
Nine isolates from six locations. 
Six patients had contact with 
individuals who were culture 
positive with an indistinguishable 
ETR+MIRU profile. 
 
10 x 434443183 
1 x orphan 
6 (55) 7 (64) 11 
5 
32433 224325153324 (2000-07) 
Multiple well-defined overlapping links: 
family, hostel, bars. 
 
19 x 443443153 
2 x 442443151 
3 x orphan 
20 (83) 23 (96) 24 
6 
42433 223315133321 (2004) 
All four patients worked 
in the same warehouse. 
 
4 x 236423252 4 (100) 4 (100) 4 
7 
42235 226425163533 (2004) 
Various social links including 
public bar, prison, and a family. 
 
4 x 442423382 
2 x orphan 
4 (67) 6 (100) 6 
  Total isolates 38 (58) 59 (89) 66 
 
Table 3.4.  Collection 2: Concordance between molecular and epidemiological data in 
clusters identified by ETR+MIRU typing. 
 
Please see Appendix II for more detailed descriptions of the epidemiological associations. 
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3.5. DISCUSSION 
This study has demonstrated that 17 locus ETR+MIRU typing provides comparable 
genotyping data to IS6110 RFLP, the historical gold standard method for M. tuberculosis 
DNA fingerprinting, in a collection of clusters (Collection 1) where conventional 
epidemiological data was known. 
 
In a follow-on evaluation of the 3
rd
 generation set of 24 MIRU-VNTR loci applied to a 
collection of genotypically defined clusters with varying degree of concordance between 
conventional and molecular data (Collection 2), it was shown that the 24 loci set improved the 
degree of concordance between conventional epidemiological and molecular data. The 
optimal 24 loci set separates isolates with weak or non-existent epidemiological links but does 
not separate isolates with strong epidemiological links. 
 
By comparing the results obtained from MIRU-VNTR and IS6110 RFLP typing within this 
chapter to the criteria described in the Aims Section (Section 3.2) we can assess the utility of 
each DNA fingerprinting method in terms of typing ability, discriminatory power, 
reproducibility, and applicability.  
 
The ability of IS6110 RFLP to type all isolates in this chapter was not 100% as 17/53 (32%) 
strains had low copy numbers of IS6110 and therefore cannot be accurately typed by RFLP. A 
typing result was obtained for all strains in all versions of MIRU-VNTR typing in both strain 
collections. Within collection 1, 12 MIRU loci and ETR+MIRU typing had equivalent HGDI 
values (0.881, 95% CI 0.830 - 0.932) to RFLP (0.890, (95% CI 0.845 - 0.936) when 
overlapping confidence intervals were taken into account and slightly lower clustering rates 
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(32% vs 40% respectively). The slight variation in diversity and clustering identified when 
using RFLP (higher HGDI and higher clustering) was caused by clustering of low copy 
number isolates by MIRU-VNTR typing (strains 78 and 263 in Investigation A) which were 
split by RFLP. Reproducibility within Collection 1 can be assessed by the serial detection of 
conserved clones within each cluster, 31/32 clustered isolates that were part of the major 
epidemiologically linked clusters were also clustered by ETR+MIRU typing.  The only 
discrepancy was strain 221 in Investigation D. RFLP had a similar level of agreement but 
with the appearance of additional bands in strains 92 and 163 in the major cluster in 
Investigation A. However, clusters based on RFLP data are commonly analysed using a +/- 
one band difference (Savine et al., 2002). Reproducibility could not be assessed within 
Collection 2 as some of these clusters have quite complex epidemiology which has not been 
fully elucidated from initial epidemiological investigations. MIRU-VNTR typing is a 
discriminatory, reproducible method that can type all strains of M. tuberculosis. The 
combination of these criteria makes MIRU-VNTR typing a highly applicable DNA 
fingerprinting method. 
 
3.5.1. ETR+MIRU typing can be used as a rapid 1st-line alternative to IS6110 RFLP 
From the results of Collection 1, it was concluded that ETR+MIRU typing could be used as a 
rapid 1
st
-line alternative to IS6110 RFLP typing. To enable full implementation as a 1
st
-line 
typing method, transfer from agarose gel electrophoresis to automated analysis is required to 
enable regional universal prospective typing of all M. tuberculosis strains. From Collection 2, 
it was concluded that the 17 loci should be extended to the optimal 24 loci set as the 1
st
-line 
method for DNA fingerprinting of M. tuberculosis strains in the Midlands. From 2003-2009, 
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all isolates received at the HPA MRCM were typed using the ETR+MIRU loci with 24 loci 
analysis implemented in January 2010. 
 
3.5.2. Collection 1: IS6110 RFLP compared to 15 locus MIRU-VNTR data 
In our study, ETR+MIRU typing accurately identified the clusters in investigations A,
 
B, and 
C and confirmed the lack of a suspected cluster in the
 
case of investigation D. Our experience 
of the MIRU-VNTR loci is in accord with
 
the report of Supply and colleagues (Supply et al., 
2001), who applied MIRU typing
 
to a blinded set of 90 strains from 38 countries, and 
demonstrated that it was 100% reproducible, sensitive, and specific for M. tuberculosis. 
Mazars and colleagues also applied MIRU typing
 
to 12 clusters which contained 28 
epidemiologically related isolates and found that all 28 were also clustered by 12 locus MIRU 
typing (Mazars et al., 2001). 
 
The ability to rapidly and conclusively exclude strains (and therefore cases) from large-scale 
outbreaks is very useful for public health teams. We found, as others have, that relying on 
absolute identity of IS6110 RFLP patterns leads to erroneous exclusion of a significant 
proportion of isolates. In 49 patients with two isolates first cultured more than 90 days apart, 
12/49 (25%) patients showed changes in their IS6110 genotypes (Yeh et al., 1998). MIRU 
typing in our hands resulted in the potential exclusion of only 2/56 isolates, a finding similar 
to a recent report (Savine et al., 2002). In investigation B, the outbreak strain carried only two 
copies of IS6110, which can easily result in the false identification of clusters when IS6110 
RFLP is used as a single method (Gillespie et al., 2000). However, distinct and unique MIRU 
codes were found.  
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In Collection 1, two of these
 
isolates in one cluster (Investigation A) had IS6110 RFLP 
patterns differing
 
by one band; otherwise, the concordance was 100%. The pair of strains 
identified
 
by IS6110 RFLP but with differences in the MIRU-VNTR profile in Investigation 
D were isolated
 
from a husband and wife three years apart, suggesting
 
a higher rate of 
evolution at loci 16 and 26 compared to that
 
of IS6110 RFLP patterns. Both of these loci have 
been reported
 
to exhibit a high degree of diversity in strains (Mazars et al., 2001).
 
The 
stability of MIRU has recently been investigated with pairs
 
of isolates from patients separated 
by as many as six years (Savine et al., 2002).
 
Only in a single case were isolates found with 
identical IS6110
 
patterns and a single change in a MIRU locus. Our finding for
 
a single strain 
with a high copy number of IS6110 is in contrast to
 
the observation that the "molecular clock" 
for MIRU runs at
 
a lower rate than that for IS6110 RFLP (Supply et al., 2001). In 
investigation A, IS6110
 
RFLP failed to identify a pair of epidemiologically related
 
strains 
identified by MIRU; these strains also had a rare VNTR
 
type, confirming their close 
relationship. 
 
This study demonstrated that ETR+MIRU typing provided equivalent data when compared to 
IS6110 RFLP in the investigation of
 
epidemiologically linked outbreaks of M. tuberculosis. 
The use of a two typing method strategy has been evaluated by others
 
for population-
screening studies (Wilson et al., 1998). The greater technical
 
reliability, ease of automation 
and data storage, and analysis of
 
typing data make MIRU-VNTR typing, in my opinion, 
superior to IS6110
 
RFLP. ETR+MIRU typing system could be automated and the digital 
results produced facilitate easier data storage and analysis than IS6110 RFLP which makes 
MIRU-VNTR attractive for outbreak
 
investigation, and as a method
 
for compiling a 
comprehensive national database.
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3.5.3. Successive refinements in the MIRU-VNTR loci used in typing schemes have 
improved the epidemiological relevance of MIRU-VNTR data. 
The initial description of MIRU loci in 31 M. tuberculosis complex strains from around the 
world identified 12 loci that contained variable numbers of tandem repeats (VNTRs) in strains 
that originated from different geographical locations (Supply et al., 2000). A second study 
compared IS6110 RFLP and MIRU-VNTR data obtained from isolates involved in laboratory 
cross contamination, identified transmission events, relapses or different anatomical sites in 
Paris. This study showed that in 12 distinct clusters, 28/28 epidemiologically related isolates 
were also clustered by MIRU-VNTR typing which included strains that had few IS6110 
copies. This study in Paris indicated that MIRU-VNTR loci are stable enough to accurately 
track outbreaks (Mazars et al., 2001). A third study of a blinded reference set of 90 strains 
from 38 countries then showed that high-throughput MIRU-VNTR typing using a DNA 
sequencer was 100% reproducible, sensitive, and specific for M. tuberculosis complex 
isolates, a performance that had not been achieved by any other typing method tested in the 
same conditions (Supply et al., 2001). 
 
Two studies from North America evaluated the potential for the implementation of MIRU-
VNTR typing as a 1
st
 line alternative method to IS6110 RFLP. A study of 259 isolates from 
Wisconsin between 2000 and 2003 concluded that spoligotyping and MIRU-VNTR typing 
combined together provided adequate discrimination in most cases. If required, IS6110 RFLP 
could be used as a secondary typing method (Cowan et al., 2005). This study formed the basis 
for the US national strategy for genotyping M. tuberculosis strains from 2005 onwards. A 
study in Manitoba, Canada compared MIRU-VNTR to IS6110 RFLP for 126 isolates 
identified in 2003 and found that both methods had similar levels of discrimination and the 
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clustering of isolates using MIRU-VNTR data correlated with IS6110 RFLP-derived 
clustering (Blackwood et al., 2004). 
 
In a comparison of nine recently described DNA typing methods that had been suggested as 
alternatives for IS6110 RFLP analysis, MIRU-VNTR using the 12 MIRU loci was found to 
be the most reproducible method and second most discriminatory method (Kremer et al., 
2005a). 
 
3.5.4. Two studies that demonstrated sub-optimal performance of 12 locus MIRU-
VNTR typing  
Two studies reported results that countered the equivalent performance of 12 locus MIRU-
VNTR typing when compared to IS6110 RFLP. The first study from Montreal showed that in 
high IS6110 copy number isolates, the sensitivity of spoligotyping (83%) and MIRU-VNTR 
typing (52%) in identifying isolates clustered by IS6110 RFLP and specificity in the 
identification of unique IS6110 RFLP patterns was low (56% for MIRU-VNTR typing and 
40% for spoligotyping). The authors warned that these techniques had unsuitable operating 
parameters for population-based molecular epidemiology studies (Scott et al., 2005). A later 
study from Spain of 134 isolates analysed by IS6110 RFLP, MIRU-VNTR using the 12 
MIRU loci, and spoligotyping showed that the HGDI index was slightly higher for IS6110 
RFLP (0.989) than for MIRU-VNTR (0.978). IS6110 RFLP clustered 42% of isolates 
whereas MIRU-VNTR clustered 58% of isolates. MIRU-VNTR data in IS6110 RFLP-defined 
clusters showed full concordance in 7/17 (41%) of clusters. The addition of spoligotyping 
data to MIRU-VNTR data reduced the proportion of clustered isolates to 43% and increased 
the number of concordant clusters to 11/17 (65%) (Garcia de Viedma et al., 2006).  
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Conclusions from these two studies required cautious interpretation as both accepted IS6110 
RFLP data as the gold standard without any comparison to conventional epidemiological data. 
However, no molecular genotyping method for M. tuberculosis, including IS6110 RFLP is 
100% sensitive and specific. Therefore, to confirm the validity of clustering, each new 
molecular genotyping method should be evaluated by comparison to data obtained from 
conventional epidemiological investigation (Koksalan, 2005). 
 
3.5.5. Identification and evaluation of VNTR loci not part of the ETR or 12 MIRU-
VNTR schemes for M. tuberculosis 
The five ETR loci were identified using the preliminary H37Rv whole genome sequence 
(Frothingham and Meeker-O'Connell, 1998). The 12 MIRU loci were identified using the 
complete genome of H37Rv and preliminary genome sequences for M. tuberculosis 
CDC1551 and M. bovis AF2122/97 (Supply et al., 2000) whereas additional genome searches 
utilised the subsequent availability of the complete genome sequences of CDC1551 
(Fleischmann et al., 2002), and M. bovis AF2122/97 (Garnier et al., 2003) to identify more 
VNTR loci (Le Fleche et al., 2002). Other groups used slightly different search strategies and 
parameters to identify additional VNTR loci (Smittipat and Palittapongarnpim, 2000). 
 
From these evaluations of five and 12 locus MIRU-VNTR typing, various subsequent studies 
published evaluations of MIRU-VNTR loci that were not originally part of the five ETR or 12 
MIRU and potentially offered even further strain differentiation (Kremer et al., 2005b;Le 
Fleche et al., 2002;Smittipat et al., 2005).  
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3.5.6. The definition and evaluation of an internationally agreed set of 24 MIRU-VNTR 
loci 
These various evaluations of multiple different sets of MIRU-VNTR loci led to an evaluation 
in a single study of the technical robustness, stability, and reproducibility of 29 putative loci 
which were applied to a collection of 824 isolates of M. tuberculosis that represented all of the 
main global lineages. Five loci were excluded for technical reasons which included: instability 
in serial isolates or isolates from epidemiologically linked patients; apparent multiple alleles 
within a single locus; uninterpretable long amplicons; or problematic amplification by PCR. 
The 24 remaining loci were found to increase the number of sub-types in the collection by 
40% and reduced the clustering rate fourfold when compared to the original set of 12 MIRU 
loci. A subset of 15 loci with the highest evolutionary rates was identified that generated 96% 
of the total resolution shown with the full 24 locus set (Supply et al., 2006). The predictive 
value for assessing transmission was shown to be equal to that of IS6110 RFLP in a 
companion population-based study in Hamburg, Germany (Oelemann et al., 2007). The 
authors of this study proposed the 15 and 24 locus systems as the new standard for routine 
epidemiological typing and phylogenetic analysis. Interestingly, all five of the original five 
ETR loci are included in the 24 loci and 4/5 are included in the high-definition 15 locus set 
(Frothingham and Meeker-O'Connell, 1998). 
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3.5.7. The internationally optimised set of 24 loci improves the correlation between 
conventional epidemiological and molecular data 
Data obtained from seven clusters in the Midlands presented in this chapter showed that the 
24 loci increased the level of discrimination (HGDI of 0.793 for ETR+MIRU and 0.890 for 
24 loci) but not significantly and increased the concordance between molecular and 
conventional epidemiological data (58% to 89% in seven clusters containing 66 isolates) 
which correlated with recent subsequent evaluations of the “3rd generation” of 15 and 24 
MIRU-VNTR loci by other groups. Other studies in Madrid, the Netherlands, Bulgaria, and 
Canada showed that 24 loci typing offered a higher discriminatory power than 12 MIRU-
VNTR loci and better correlation with IS6110 RFLP data (Alonso-Rodriguez et al., 
2008;Maes et al., 2008;Valcheva et al., 2008;Christianson et al., 2010). However, it must be 
noted that genotyping data provided by the “3rd generation” 24 locus MIRU-VNTR set is not 
absolute as a 39-month universal population-based study undertaken in Madrid found that 24 
loci typing and IS6110 RFLP data was concordant in 85% of typed M. tuberculosis isolates. 
Epidemiological links were identified in 84% of cases clustered by both 24 loci typing and 
IS6110 RFLP. Less than 40% of isolates with discordant typing data had identified 
epidemiological links (Alonso-Rodriguez et al., 2009).  
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3.6. CONCLUSIONS 
There are four criteria which can be used to assess the utility of a typing method: typing 
ability, discriminatory power, reproducibility, and applicability (Hawkey and Kerr, 2003). For 
IS6110 RFLP, technical expertise is required to achieve good reproducibility and the lengthy 
culture, DNA preparation and analysis procedure limits applicability to newly positive 
cultures or rapidly expanding clusters. MIRU-VNTR typing can type all isolates, is highly 
discriminatory and reproducible and can be readily applied to newly positive cultures using 
simple, rapid extraction methods such as thermolysis by heating to 100 C. Therefore, MIRU-
VNTR can be used as a 1
st
 line method for genotyping of M. tuberculosis. Transfer of VNTR 
allele analysis from agarose gel electrophoresis to an automated analysis system would enable 
a regional assessment of the epidemiology and transmission of M. tuberculosis across the 
Midlands. 
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4. AUTOMATED HIGH-THROUGHPUT 
MYCOBACTERIAL INTERSPERSED REPETITIVE 
UNIT TYPING OF M. TUBERCULOSIS. 
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4.1. INTRODUCTION 
4.1.1. Background 
Data in chapter 3 demonstrated that MIRU-VNTR typing provided similar clustering data to 
IS6110 RFLP typing in clusters with known epidemiological links. Transfer of MIRU-VNTR 
analysis from agarose gel electrophoresis to an automated analysis system would increase the 
sample through-put and enhance the utility of MIRU-VNTR typing by enabling application 
on a regional, prospective and universal basis. The evaluation of an option for an automated 
system is described in this chapter. 
 
4.1.2. A novel variation of HPLC that has been used in SNP genotyping 
dHPLC is a technique that uses reversed-phase HPLC to identify Single Nucleotide 
Polymorphisms (SNPs) (Oefner and Underhill, 1995). dHPLC offers an automated alternative 
to agarose-gel based SNP genotyping techniques such as single strand conformation 
polymorphism analysis or denaturing gradient gel electrophoresis (Fischer and Lerman, 
1979;Orita et al., 1989). dHPLC detects SNPs by using a solid phase that has a differential 
affinity for DNA dependent on whether the two strands are entirely complementary or if there 
is a mismatch when a SNP is present. dHPLC was utilized in the initial studies that 
deciphered human evolutionary history through the analysis of human Y chromosome 
haplotypes (Underhill et al., 1997) and has been applied to a wide range of studies that have 
identified mutations involved in human genetic disorders including: BRCA1 and BRCA2  in 
breast and ovarian cancer (Gross et al., 1999); tuberous sclerosis (Choy et al., 1999); and the 
cystic fibrosis transmembrane conductance regulator gene (Liu et al., 1998).  
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4.1.3. Mutation detection in bacteria 
dHPLC was first used in bacteria to characterise mutations conferring quinolone resistance in 
S. aureus (Hannachi-M'Zali et al., 2002), Salmonella
 
enterica (Eaves et al., 2002), and beta-
lactam resistance in gram-negative organisms (Perez-Perez and Hanson, 2002). This method 
has also been used for a modified version of MLST in meningococci (Shlush et al., 2002) and 
in the detection
 
of mutations conferring antibiotic resistance in M. tuberculosis
 
(Cooksey et 
al., 2002). All bacterial studies prior to the data presented in this chapter had used the 
denaturing mode of dHPLC to detect mutations. The data in this chapter describes the 
validation of MIRU-VNTR typing using the non-denaturing mode (non-dHPLC) that can size 
PCR amplicons.  
 
4.1.4. Principles of dHPLC analysis 
dHPLC utilises a form of HPLC called reverse-phase ion-pair high performance liquid 
chromatography (RP-IP-HPLC) to perform analytical separations. A commercially available 
system specifically designed for dHPLC from Transgenomic called a WAVE® System was 
used for analysis (Figure 4.1). The central component of the WAVE® System is the 
separation cartridge which DNA binds to and elutes depending on the presence of a SNP or 
the length of the DNA fragment. 
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Figure 4.1.  Transgenomic WAVE® dHPLC system.  
 
The four sub-units are: UV detector (A); Oven containing analysis cartridge (B); 96-well three 
plate autosampler (C); and pump unit (D). 
 
  
A 
C 
D 
B 
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The WAVE® System DNASep separation cartridge is packed with a non-porous matrix 
consisting of polystyrene-divinylbenzene (PS-DVB) copolymer beads. The beads are 
alkylated with C-18 chains that form single C-C bonds. By nature, the beads within the 
cartridge are electrostatically neutral and hydrophobic, and do not readily react with nucleic 
acids. Triethylammonium acetate (TEAA) is an ion pairing reagent that acts as a „bridging 
molecule‟ to aid in the adsorption of nucleic acids to the beads. The ion-pairing reagent is 
both hydrophobic and positively charged, and interacts with the negative charge of the anionic 
phosphate backbone of the nucleic acid, while the hydrophobic groups of the TEAA interact 
with the hydrophobic C-18 chains on the PS-DVB beads. This ion-pairing reagent serves as a 
bridge between the nucleic acid and the cartridge matrix as shown in Figure 4.2. 
 
The cartridge matrix described above is referred to as the stationary phase. The mobile phase 
consists of the combination of buffers that elute the DNA off from the cartridge. A 0.1M 
solution of TEAA mixed with 25% acetonitrile is used to elute the DNA. As increasing 
concentrations of acetonitrile flow across the cartridge matrix, the hydrophobic interaction 
between the cartridge and the DNA/TEAA is broken which causes elution of the DNA. 
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Figure 4.2.  dHPLC Separation Cartridge Surface Chemistry. 
 
In the separation cartridge, TEAA forms a positively charged triethylammonium ion (TEA+) 
that has both hydrophobic and hydrophilic ends. The DNASep cartridge contains beads that 
are hydrophobic. The positively charged portion of the TEA+ forms an association with the 
negatively charged phosphate backbone of the DNA creating a hydrophobic "fur" on the 
fragment. This entire hydrophobic entity then behaves as would a typical hydrophobic 
molecule and is attracted to the hydrophobic beads. 
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4.1.5. Denaturing conditions: Separation based on presence or absence of a SNP 
The majority of studies have used dHPLC for SNP genotyping. PCR fragments containing the 
region of interest in the wild-type control containing no mutations and the sample of interest 
are amplified in separate reactions (Figure 4.3). After completion of the PCR, the amplicons 
can be quantified and then mixed together and denatured into single-strand forms by heating 
to 95 C and then annealed by cooling to 4 C. Once denatured, each strand can either re-
anneal with its own entirely complementary strand of DNA (homoduplex), or it can anneal 
with the other type of DNA molecular present which will result in a DNA binding mismatch 
if there is a SNP present (heteroduplex). Each PCR fragment requires a specific analysis 
temperature and buffer proportions which are designed using WAVE® System software. The 
annealed amplicons are applied to the dHPLC cartridge and an increasing gradient of 
acetonitrile is applied which reduces the bridging affinity of TEAA and the amplicons are 
eluted from the cartridge. Heteroduplexes, containing mismatched SNPs, elute off before 
homoduplexes. The eluted amplicons then pass through a UV absorbance detector which 
measures absorbance over the time of each injection and the WAVE® System software 
constructs a chromatogram. If no SNP is present, there is one species of DNA (wild-type and 
sample which both have the same base pairing at the SNP site). These possess 
indistinguishable cartridge affinities so they elute at the same retention time which results in a 
single chromatogram peak. If a SNP is present, there are four species of DNA present (i.e. AC 
and GT heteroduplexes and AT and GC homoduplexes), which can potentially elute as four 
separate chromatogram peaks. The first two peaks contain the two heteroduplexes and the 
latter two peaks contain the two homoduplexes. 
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Figure 4.3.  Mutation Detection by dHPLC.  
 
Wild and test or mutant type alleles are amplified separately, mixed, heated and then cooled to 
form homoduplexes or heteroduplexes if a mutation is present. As the acetonitrile 
concentration increases the bridging capabilities of the TEA+ ions decrease and the DNA 
fragments are released from the cartridge. Heteroduplexes elute off of the cartridge first 
followed by the homoduplexes and pass through a UV detector which detects the absorbance 
over time and is recorded as a chromatogram. If no mutation is present, all of the homoduplex 
DNA fragments elute off of the cartridge at the same time producing a single peak on the 
chromatogram. If a mutation is present then two to four peaks will be visible.  
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4.1.6. Non-denaturing conditions: Separation based on size 
dHPLC can be used in a non-denaturing form (non-dHPLC) by analysing double-stranded 
PCR amplicons at 50 C. This essentially changes the method of separation analysis from 
dHPLC analysis based on individual base composition at SNP sites to non-dHPLC analysis 
based on the relationship between amplicon length and the number of bonds between each 
amplicon and the cartridge matrix. Each phosphate group in the backbone of each DNA 
molecule binds to an available TEAA molecule which in turn binds to the cartridge matrix. 
Shorter amplicons have fewer phosphates to bind to the cartridge matrix and longer amplicons 
possess more phosphates that can bind to the cartridge matrix. For separation based on size, 
each amplicon of interest is generated by PCR and injected onto the WAVE® System. Within 
each run, a known molecular standard can also be analysed which can be used to generate a 
standard curve against which samples can be compared. Specific analysis conditions are also 
designed using the WAVE® System software which are not specific to each individually 
designed amplicon sequence but based on the size range of DNA fragments analysed. An 
increasing buffer gradient is used similar to SNP detection but as the concentration of 
acetonitrile across the cartridge rises  the fragments elute, smallest to largest (Figure 4.4) 
(Devaney et al., 2000). 
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Figure 4.4.  PCR amplicon sizing by non-denaturing HPLC.  
 
PCR amplicons are amplified and then injected onto the sizing cartridge. Shorter fragments 
bind with less affinity and are eluted quicker than larger fragments. Two amplicons from 
MIRU-10 are shown with sizes of 171 bp and 224 bp which equate to two and three repeats 
respectively. 
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4.2. AIMS 
MIRU-VNTR typing has been previously automated using capillary electrophoresis (Supply 
et al., 2000). In this study we evaluated the utility of non-dHPLC in MIRU-VNTR typing 
because it has proved to be one of the most cost-effective
 
methods for DNA mutation analysis 
in prokaryotic biology. 
 
This study describes the initial
 
validation of a WAVE® System for MIRU-VNTR
 
typing of 
M. tuberculosis strains with use of 12 separate injections. 
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4.3. METHODS 
Primary specimens were processed as described in Section 2.3, cultured using liquid media 
(Section 2.3.2), DNA was extracted (Section 2.3.3) and isolates were identified as M. 
tuberculosis using the HAIN GenoType MTBC assay (Section 2.4). 
 
4.3.1. Strain collection 
Seventy M. tuberculosis strains were selected from the MRCM culture collection. These 
strains had
 
been previously characterized by MIRU-VNTR typing with the primers described 
by Philip Supply on agarose
 
gels (Section 2.6.1). A dendrogram of the obtained results was 
constructed using the categorical coefficient algorithm and produced via UPGMA in 
BioNumerics. Twenty isolates were selected
 
to represent the entire range of repeats observed 
at each locus from previous typing. The remaining 50 isolates were randomly
 
selected from 
the clinical isolates typed at the Birmingham
 
Regional Centre for Mycobacteriology. This 
collection represented
 
the entire spectrum of MIRU locus alleles identified from clinical strain 
typing in the Midlands in 2003. 
 
4.3.2. Allelic range of the Birmingham strain collection 
The allele range of the Birmingham strain collection was compared to a global collection 
analysed in a previous study on MIRU-VNTR typing of 31 strains from seven countries 
(Supply et al., 2000) in terms of the range of alleles identified at each of the 12 MIRU loci. 
 
4.3.3. MIRU-VNTR typing using non-dHPLC 
Oligonucleotides were designed for non-dHPLC analysis so that the length of flanking 
regions upstream and downstream of the actual VNTRs was as short as possible to enable 
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analysis on a WAVE® system (Section 2.7.1). The PCR mastermix and thermal cycling 
conditions are described in Section 2.7.4. 
 
4.3.4. MIRU-VNTR typing using non-dHPLC: Analysis gradient design 
Each sample injected onto a WAVE® system undergoes an increasing gradient of acetonitrile 
which elutes bound DNA at a specific timepoint or “retention time”. The exact increase in 
buffer percentage can be designed using Transgenomic WAVE® system software which 
enables the optimal separation of DNA molecules. For this study, a “DNA multiple 
fragments” gradient was chosen as the basis for development with parameters altered included 
the rate of analysis (minutes per 100 bp) and size range (bp) evaluated (Section 2.7.2).  
 
4.3.5. MIRU-VNTR typing using non-dHPLC: Calculation of a standard curve 
Data generated by a WAVE® system contains two data fields that were used for this study: 
retention time and peak height. Chromatogram peaks with a height ≥1 mV and within the 
range of the molecular standard were exported as a Comma Separate Variable file and 
imported for analysis into a laboratory-designed Microsoft Office Excel calculation file. The 
retention time of the samples was compared to the molecular standard and the size (bp) and 
number of repeats was calculated (Section 2.7.5). 
 
4.3.6. Concordance between MIRU-VNTR data obtained from agarose gel 
electrophoresis and WAVE® System analysis. 
MIRU-VNTR profiles obtained from the two methods were analysed in a blinded manner by 
a single operator and were then directly compared to calculate concordance. 
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4.3.7. Analysis of the performance of the WAVE® System 
Within the Birmingham strain collection, the lowest and highest VNTR allele observed was 
identified along with the median allele for each MIRU locus. Replicate injections were carried 
out to ensure that each identified allele had at least 10 replicate data points for analysis. 
Statistical criteria analysed were the observed calculated size with a 95% confidence interval 
and the mean variance when compared to the expected size. 
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4.4. RESULTS 
4.4.1. Allelic range of the Birmingham strain collection. 
Table 4.1 is a comparison of the allelic range of the Birmingham strain collection with those 
obtained in a global strain collection (Supply et al., 2000). For nine of the MIRU loci, isolates 
from a global collection
 
displayed a greater range of alleles than in our collection. The highest 
allele observed in five loci in the global collection was only one repeat higher than the 
Birmingham strain collection with four loci containing two or more repeats in the global 
collection. 
 
For two MIRU loci (MIRU-02 and MIRU-20) the allele range was the same for 
the two
 
strain collections. For one locus (MIRU 26) the collection from
 
Birmingham Regional 
Centre for Mycobacteriology exhibited a
 
greater range of alleles than the global collection. 
 
Locus 
 
Allele Range 
 
West Midlands 
 
Global 
 
2 
 
1-3 
 
1-3 
4 1-5 1-9 
10 2-7 2-8 
16 1-6 2-8 
20 1-2 1-2 
23 1-7 1-11 
24 1-2 1-6 
26 1-9 1-6 
27 2-4 2-5 
31 2-5 1-6 
39 1-3 1-4  
40 
 
1-7 
 
1-8 
 
 
Table 4.1.  Allelic range of typed strains from West Midlands compared to that of 
global strains in 2003. 
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4.4.2. MIRU-VNTR typing by agarose gel electrophoresis 
In the Birmingham strain collection of 70 M. tuberculosis complex isolates, there were
 
56 
distinct MIRU-VNTR profiles with a total of 26 isolates indistinguishable
 
by MIRU-VNTR in 
12 clusters. Forty-four isolates possessed a
 
unique MIRU-VNTR profile compared to other 
strains in the collection.
 
The largest cluster of four isolates (223325173533) represented
 
a 
group of four epidemiologically linked patients from one sending
 
location. Of the other 11 
clusters each containing a pair of
 
isolates, only two clusters contained isolates received from
 
the same sending laboratory (Figure 4.5). 
 
4.4.3. MIRU-VNTR typing using non-dHPLC 
An example chromatogram of PCR fragments amplified from different strains is shown in 
Figure 4.6.   
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Figure 4.5.  MIRU typing results obtained for each of the 70 M. tuberculosis strains 
analysed. 
 
The dendrogram was constructed with use of the categorical coefficient algorithm and 
produced via the Unweighted Pair Group Method using Arithmetic Average. 
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Figure 4.6 MIRU-23 alleles analysed by non-dHPLC. 
The MIRU-23 locus in ten different M. tuberculosis strains was amplified by PCR and 
separated by non-dHPLC. Each strain had a different allele value which ranged from one 
(furthest left) to nine (furthest right) repeats.  
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4.4.4. MIRU-VNTR typing using non-dHPLC: Primer design 
Primer flanking regions either upstream and downstream for the original primers used were an 
average 420 bp in length (range 44-565 bp) whereas for the oligonucleotides designed for 
sizing by non-dHPLC the average length of the primer flanking regions was 98 bp (range 39-
213 bp). This meant that the highest allele and largest PCR amplicon in this study (7 repeats 
at MIRU-23) was reduced in size from 863 bp to 445 bp. 
 
4.4.5. MIRU-VNTR typing using non-dHPLC: Analysis gradient design 
From initial experiments, it was identified that for MIRU-VNTR typing using non-dHPLC to 
be a realistic proposition in terms of high-throughput genotyping, the gradient parameters 
would have to be set to provide the most rapid injection analysis gradient possible. Therefore, 
the evaluated rate of analysis was set to 0.5 minutes per 100 bp and the size range from 20-
900 bp. This size range would cover all of the alleles in the Birmingham and global 
collection. 
 
4.4.6. MIRU-VNTR typing using non-dHPLC: Calculation of a standard curve 
From an initial evaluation, it was found that a MIRU allele ladder constructed from 10 PCR 
products (1-10 repeats) from MIRU-23 in 10 different strains provided more accurate VNTR 
allele assignation than a commercially available 50 bp standard. With use of this DNA 
standard,
 
the effects of different sequence composition between the molecular standard and 
analysed amplicons were reduced. 
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4.4.7. Concordance between MIRU-VNTR Data obtained from agarose gel 
electrophoresis and WAVE® System analysis 
Figure 4.5 displays the 70 strains analyzed by agarose gel electrophoresis
 
and the WAVE® 
System as single
 
amplifications. A concordance level of 100% between MIRU-VNTR
 
profiles 
generated by agarose gel electrophoresis and by the
 
non-dHPLC method was obtained when 
results from the two methods
 
were compared. 
 
 
4.4.8. Performance of MIRU-VNTR typing carried out using non-dHPLC. 
Table 4.2 displays the statistical analysis of peaks obtained
 
over multiple runs when the 
collection of 70 strains was typed using the WAVE® System. The
 
minimum, median, and 
maximum numbers of repeats observed in
 
clinical strains previously typed in the West 
Midlands were
 
statistically analysed. 
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Locus 
Value for product containing expected no. of repeats 
Expected 
no. of 
repeats 
No. of results 
Expected 
(bp) 
Observed (bp) 
95% CI (bp) 
Mean variance 
(bp) Min. Mean Max. 
Minimum         
2 1 10 168 155 160 164 158-162 -8 
4 1 11 196 182 195 211 189-201 -1 
10 2 14 195 183 190 198 187-193 -5 
16 1 39 107 95 103 108 102-104 -4 
20 1 12 156 144 150 156 148-152 -6 
23 1 10 134 121 133 138 132-138 -1 
24 1 59 179 166 173 178 172-174 -6 
26 1 17 113 100 108 115 106-110 -5 
27 2 10 210 193 201 208 198-204 -9 
31 2 13 183 175 177 183 175-179 -6 
39 1 17 187 178 182 187 181-183 -5 
40 1 16 206 197 200 203 199-201 -6 
Median         
2 2 67 221 209 216 222 215-217 -5 
4 2 59 273 261 270 275 269-271 -3 
10 4 29 301 287 293 301 292-294 -8 
16 3 39 213 201 209 214 208-210 -4 
20 2 63 233 221 228 235 227-229 -5 
23 5 45 346 338 347 359 345-349 1 
24 1 59 179 166 173 178 172-174 -6 
26 5 30 317 305 316 323 315-317 -1 
27 3 64 263 247 255 261 254-256 -8 
31 3 37 236 225 231 235 230-232 -5 
39 2 38 240 228 233 237 232-234 -7 
40 3 31 314 301 308 314 307-309 -6 
Maximum         
2 2 67 221 209 216 222 215-217 -5 
4 5 10 504 481 490 503 485-495 -14 
10 7 10 460 439 450 460 446-454 -10 
16 6 14 372 365 368 374 367-369 -4 
20 2 63 233 221 228 235 227-229 -5 
23 7 18 452 441 451 465 448-454 -1 
24 2 11 233 226 228 231 227-229 -5 
26 9 14 521 512 517 522 515-519 -4 
27 4 10 316 303 306 308 305-307 -10 
31 5 28 342 332 340 347 338-342 -2 
39 3 27 293 281 286 290 285-287 -7 
40 7 10 530 505 515 524 512-518 -15 
 
Table 4.2.  Analysis of product sizes calculated from WAVE® system DNA fragment 
analysis chromatograms. 
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4.4.9. Performance of dHPLC in typing alleles with low numbers of repeats 
For the products containing the lowest number of repeats observed
 
at each locus (all 12 loci 
concatenated together: 112111112211), the 95% confidence interval (CI) ranged from 2-12 bp 
(0.04
 
to 0.16 repeats) with a mean interval of 5 bp (0.07 repeats).
 
The variance of the mean 
calculated sizes from the expected
 
product sizes ranged from 1 to 9 bp (0.01 to 0.16 repeats) 
less
 
than the expected product size, with an average of -5
 
bp (-0.09 repeats) across the 12 
MIRU loci.
 
 
4.4.10. Performance of dHPLC in typing alleles with median numbers of repeats 
The concatenated median number of repeats for each locus was 224325153323.
 
For these 
PCR products, the 95% CI varied from 2-4
 
bp (0.02 to 0.06 repeats) with an average interval 
of 2 bp (0.04
 
repeats). The mean of the calculated product sizes varied from
 
the expected size 
by -1 to -8 bp (-0.01 to
 
-0.13 repeats) with an average of -5 bp (-0.09
 
repeats) for all 12 MIRU 
loci.
 
 
4.4.11. Performance of dHPLC in typing alleles with high numbers of repeats 
For PCR products analysed from isolates
 
that possessed the maximum number of repeats 
observed at each
 
locus in clinical strains (257627294537), the 95% CI ranged from
 
2-10 bp 
(0.02 to 0.14 repeats), with a mean interval of 4
 
bp (0.07 repeats). The variance of the mean 
calculated size
 
from the expected product size ranged from -1 to -14
 
bp (-0.02 to -0.27 
repeats) with an average variance
 
from the expected size of -7 bp (-0.12 repeats).
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4.4.12. Performance of non-dHPLC for all 840 PCR amplicons in this study. 
Of 840 PCR fragments analyzed, 828 (99%) were sized accurately
 
within a repeat integer 
range of ±0.25 repeats. For all
 
840 PCR fragments analyzed within this study, the WAVE® 
System exhibited a mean accuracy of +4.8 bp or +0.09
 
repeats. The 12 PCR products that 
were not within this range
 
had an average variance of -0.29 repeats from the expected
 
repeat 
number. Upon repeat analysis, all of the 12 PCR products
 
that did not initially group within 
this interval were sized
 
accurately to within ±0.25 repeats. 
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4.5. DISCUSSION 
 
4.5.1. Allelic range of the Birmingham strain collection 
The allele range of the Birmingham collection of 70 strains used in this study equates to 
approximately 80% of the total allelic range observed in a global collection of strains from 
seven countries analysed by MIRU-VNTR typing (Supply et al., 2000). Therefore, the range 
of alleles tested is notable for a study based in one geographical location. 
 
4.5.2. Non-dHPLC can be used for automated MIRU-VNTR typing 
The results of this study showed that non-dHPLC using a
 
WAVE® System produced accurate 
and reproducible
 
sizing of MIRU-VNTR amplicons when utilized for single PCR MIRU-
VNTR
 
typing of M. tuberculosis strains. The highest number of repeats
 
analyzed in this study 
was nine repeats (521 bp) for MIRU-VNTR
 
locus 26. For nine repeats at this locus, the total 
range of calculated amplicon
 
sizes was 512 to 522 bp, the 95% CI
 
was 515 to 519 bp, and the 
mean variance of calculated product
 
sizes from expected product size was -4 bp. The
 
largest 
product size analyzed was 530 bp for MIRU 40 (seven
 
repeats). For this locus the calculated 
amplicon size ranged
 
from 505 to 524 bp, with a 95% CI of
 
512 to 518 bp, and a mean 
variance from calculated to expected
 
amplicon size of -15 bp. The relatively narrow 95% CI 
values indicate that the majority of PCR products were grouped together. When sizing 
amplicons for tandem repeat typing,
 
very high levels of accuracy of sizing are not necessary 
as
 
the analysed MIRU-VNTR repeats are all longer than 50 bp. Therefore, it is
 
necessary only 
to have sufficient accuracy to unambiguously
 
determine the number of repeat sequences at 
each locus. Combining
 
the 281 amplicons analyzed for the maximum number of repeats
 
category, the mean variance for all samples compared to the
 
expected amplicon size was -6 
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bp. For quality control
 
purposes, certain ranges of allowable repeat numbers must be
 
implemented. For single amplicon analysis, a "buffer zone" of 50% of the repeat size between 
predicted PCR fragment sizes was used. This meant that any PCR product calculated as 
within ±0.25
 
repeats when compared to a repeat integer was accepted. On a WAVE® System 
828 of 840 (99%) of single PCR fragments analysed
 
were within this interval. The 12 PCR 
products that were not
 
within this range had an average variance of -0.29 repeats
 
(i.e. only -
0.04 repeats outside the limit) from the
 
expected repeat number. This variation probably 
occurred as
 
a result of systematic calculation because retention times were recorded to two 
decimal places. Repeat values were then calculated and rounded to two decimal places before 
rounding up or
 
down to a repeat integer value.
 
 
Within this study, it was found that an allelic standard using 10 alleles in MIRU-23 provided 
more accurate allele calling than a 50 bp standard. This is most likely due to differences in 
GC content between M. tuberculosis amplicons and the 50 bp standard. For evaluation of any 
automated system, the effect of GC content should be taken into account when assessing 
performance. A different strategy to improve accuracy is the application of an offset to each 
calculated fragment size and allele value (Allix et al., 2004).  
 
4.5.3. Comparison of non-dHPLC to Capillary Electrophoresis 
In a previous study (Supply et al., 2001), sizing of MIRU-VNTR PCR amplicons using a 
DNA sequencer was found to be reproducible, with
 
within-run and between-run average 
precisions of ±0.5
 
and ±0.6 bp, respectively. Mean errors for the sizing
 
accuracy were 1.1 bp 
for fragments below 500 bp and 0.8 bp for
 
fragments from 500 to up to 971 bp. The WAVE® 
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microbial analysis
 
system exhibits a mean error of 4.8 bp for all PCR fragments
 
analyzed 
within this study.
 
 
4.5.4. Other microfluidic technologies 
At least two other equivalent microfluidic methods for automating MIRU-VNTR analysis in 
M. tuberculosis and one method for automated VNTR analysis in methicillin-resistant S. 
aureus have been subsequently evaluated and suggested as potential methods for high-
throughput prospective clinical diagnostic purposes (Cooksey et al., 2003;Mallard et al., 
2009;McMurray et al., 2010).  
 
4.5.5. Cost and logistics of MIRU-VNTR typing using the WAVE® System 
To perform MIRU-VNTR typing with 12
 
single reactions, post-amplification analysis by non-
dHPLC on a WAVE® System would cost $7 per isolate. After PCR amplification for non-
dHPLC MIRU-VNTR typing, the next step is straightforward uncapping and loading of tubes
 
into the autosampler unit of the WAVE® System.
 
No intermediary manipulation of the PCR 
product such as addition
 
of loading buffer, denaturation, and prerunning, which is required
 
on 
a 96-well ABI 377 Capillary Electrophoresis System (Bio-Whittaker Molecular
 
Applications, 
Rockland, Maine), is required (Supply et al., 2000). Non-dHPLC involves single injection and 
single analysis of each MIRU-VNTR amplicon without multiplex analysis. We have 
estimated the annual capacity of a single WAVE® system to be >2,000 strains for MIRU-
VNTR typing. Multiplex analysis using capillary electrophoresis can increase capacity and 
through-put but signal noise within and between capillaries caused by fluorescence “cross-
talk” can be problematic when assigning alleles (Orita et al., 1989;Thorne et al., 2007b). 
 
Chapter 4 
 164 
4.5.6. Primer design was optimised for non-dHPLC analysis 
The total size range of amplicons amplified by our novel set
 
of primers was 107 to 521 bp (1-
9 repeats). This optimized
 
range further reduced the analysis time to 7.4 minutes per injection,
 
as the primer-binding flanking regions are relatively small
 
(the largest is MIRU-40 at 152 bp).
 
 
This study is the first to report the successful use of non-dHPLC
 
for screening for variations in 
the number of MIRU-VNTRs in
 
mycobacterial DNA. The fragments of various retention 
times
 
detected by agarose gel analysis could be rapidly and reproducibly
 
identified in single 
PCR products by non-dHPLC, and produced specific
 
DNA WAVE® patterns that correlated 
with MIRU-VNTR genotypes.  
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4.6. CONCLUSIONS 
Non-dHPLC analysis was demonstrated to be a rapid, low-labour
 
input method for the 
detection and analysis of PCR fragments
 
containing various numbers of tandem repeats in M. 
tuberculosis.
 
The development of automated MIRU-VNTR typing using non-dHPLC will 
enable the future implementation of prospective universal DNA fingerprinting of all M. 
tuberculosis strains within the Midlands which will greatly increase our knowledge and 
understanding of the epidemiology and transmission of M. tuberculosis. Non-dHPLC using a 
WAVE® System has been applied to genotype >8,000 M. tuberculosis strains between 2003 
and 2010. 
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5. GLOBAL ORIGIN OF M. TUBERCULOSIS            
IN THE MIDLANDS, UK. 
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5.1. INTRODUCTION 
Knowledge and understanding of the transmission dynamics of M. tuberculosis have been 
improved by the development of rapid molecular techniques that are being more extensively 
applied such as MIRU-VNTR typing (Evans et al., 2004;Mazars et al., 2001). On a global 
scale, the distribution of major M. tuberculosis phylogenetic lineages has been elucidated as a 
result of the application of various molecular typing tools with varying rates of evolution such 
as: the DR locus (Brudey et al., 2006); SNPs (Sreevatsan et al., 1997); MIRU-VNTRs 
(Mazars et al., 2001); LSPs (Fleischmann et al., 2002); and IS6110-RFLP (Kremer et al., 
2004). 
 
It has been hypothesized that M. tuberculosis emerged in East Africa (Gutierrez et al., 
2005;Hershberg et al., 2008;Wirth et al., 2008), with dispersal and regional evolution in 
different continents that has generated distinct global populations of M. tuberculosis (Baker et 
al., 2004). A study in San Francisco also found that these global lineages can exhibit specific 
associations between the global origin of a TB patient and the lineage of the associated strain 
(Figure 5.1) (Gagneux et al., 2006). A similar replicate study in Montreal analyzed the 
robustness and reproducibility of the LSP methodology for global phylogenetic analysis in M. 
tuberculosis (Reed et al., 2009). Comparison between the San Francisco and Montreal 
populations revealed that the initial associations detected between bacterial genotype and 
patient ethnic origins were conserved, even though the two patient populations differed in the 
distribution of their geographic origins. 
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Figure 5.1  Global population structure and geographical distribution of M. 
tuberculosis.  
 
LSPs define a global phylogeny for M. tuberculosis. The names of the lineage-defining LSPs 
or regions of difference are shown in rectangles. The geographic regions associated with 
specific lineages are indicated. (b) The six main lineages of M. tuberculosis are 
geographically structured. Each dot corresponds to one of 80 countries represented in the 
global strain collection analysed. The colours of the dots relate to the six main lineages 
defined and indicate the dominant lineage(s) in the respective countries (Gagneux et al., 
2006). 
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The Midlands region of the UK contains a population of ~9.8 million people, and in 2009 had 
a rate of 15.8 TB cases per 100,000 population with 1,564 clinical cases. In 1,429 individuals 
where the place of birth was known, most individuals diagnosed with TB in the Midlands 
were born outside of the UK (966/1,429, 68%). Southern Asia was the most common region 
(609/1,429, 43%), and India was the most frequent country of birth (352/1,429, 25%) (Health 
Protection Agency, 2010).  The HPA MRCM has typed all received M. tuberculosis isolates 
in the Midlands since January 2004 by MIRU-VNTR typing with the aim of prospectively 
detecting unsuspected transmission events and informing public health control efforts to 
reduce the incidence of M. tuberculosis (Evans et al., 2007). 
 
This chapter combines molecular epidemiological data with data obtained from a novel 
software programme (Origins) that assigns a CEL group based on the combination of given 
and family names. The Origins software program was developed by analyzing reference 
records from multiple countries (Australia, France, India, Ireland, Italy, Netherlands, Norway, 
Romania, Spain, Sweden, the USA, and the UK) to formulate algorithms based on the 
cultural, ethnic, and linguistic factors found to be associated with the given and family name. 
This has resulted in a reference database now containing 1,600,000 family names and 600,000 
given names. From this database,>200 different CEL groups have been constructed which are 
applicable across the world.  
 
In the UK, the non-UK population CEL groups were validated by comparison to the UK 
Consumer Dynamics Database (Experian, Nottingham) which essentially contains the UK 
electoral register and population groups used in the UK census. This comparison showed that 
the proportion of names in each main group generated by Origins was broadly similar to the 
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proportions of the UK census population in each group. The proportion of individuals that 
Origins defined as originating from Southern Asia was broadly similar to that present in the 
UK census with 2-11% differences in proportions within subgroups between the two data 
sources. Population groups who originated from Eastern Asia were slightly underrepresented 
in Origins when compared to the UK census. Population groups from Africa had very similar 
representation in both datasets (Webber, 2007). 
 
Origins software gives much greater accuracy and coverage of origin assignment than 
previous programs such as Nam Pehchan, Sangram and the Dictionary of American Family 
Names (Webber, 2007). The first use of the Origins software program in healthcare was the 
successful identification of the Polish population group sought clinical advice and treatment 
from the NHS in the UK (Leaman et al., 2006).  
 
Chapter 5 
 171 
5.2. AIMS AND HYPOTHESIS 
The aim of this study was to combine mycobacterial fingerprinting data and patient origin as 
assigned by Origins software to relate the occurrence of major global M. tuberculosis lineages 
in populations that originate from around the world. Combining data obtained from universal 
typing and associated cultural and social links identified by Origins provides the potential for 
a deeper understanding of the causes for distribution of prevalent strains in specific population 
groups. We hypothesise that since patients originating from Southern Asia form the largest 
immigrant group in the Midlands that strains that are present in Southern Asia will also be 
present in the Midlands. 
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5.3. METHODS 
5.3.1. Study population 
Nonduplicate initial M. tuberculosis complex isolates (n = 5,731) were referred from the 
Midlands region (Figure 2.1) of the United Kingdom (population 9.5 million) to our 
laboratory between 1
st
 January 2004 and 31
st
 December 2009. 
 
5.3.2. Mycobacterial culture, identification, and MIRU-VNTR genotyping 
Primary specimens were processed as described in Section 2.3, cultured using liquid media 
(Section 2.3.2), DNA was extracted (Section (2.3.3) and isolates were identified as M. 
tuberculosis using the HAIN GenoType MTBC assay (Section 2.4). MIRU-VNTR typing of 
the five ETR (ETR-A to -E) and 10 MIRU loci (MIRU-02, -10, -16, -20, -23, -24, -26, -27, -
39, and -40) was carried out using a Transgenomic WAVE® System (Section 2.7). MIRU-04 
and MIRU-31 were removed from the 12 MIRU loci and analysed as ETR-D and ETR-E in 
the five ETR loci. 
 
5.3.3. Assignation of CEL groups 
Origins software (Experian, Nottingham, UK) was used to analyze given and family names 
and assign a CEL group to each patient (Section 2.9.2). The given and family name of each of 
the 5,731 patients were entered into Origins to obtain a CEL group, which was then assigned 
a continent based on the United Nations Standard Country and Area Codes Classification 
Scheme (United Nations Statistics Division., 2009). This classification places the British Isles 
in Northern Europe and India, Pakistan and Bangladesh in Southern Asia. 
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5.3.4. Available online databases of M. tuberculosis complex strains 
MIRU-VNTR data was compared to MIRU-VNTRplus (See Methods Section 2.9.7) to assign 
M. tuberculosis strains to one of six lineages: East African-Indian, East Asian, Euro-
American, Indo-Oceanic, West African-1, or West African-2. 
 
There is also the fourth international global spoligotyping database (SpolDB4) that contains at 
least 39,925 strains from 122 countries classified into 62 clades or lineages (Brudey et al., 
2006). The spoligotype lineages used in MIRU-VNTRplus and SpolDB4 are mostly 
equivalent but there are some differences (Table 5.2). MIRU-VNTRplus was chosen for the 
ability to directly compare MIRU-VNTR data online. 
 
Strains were compared to MIRU-VNTRplus using the categorical co-efficient which 
generated a match distance for each strain in the Midlands to the closest relative strain in 
MIRU-VNTRplus. A value of 0.000 equated to an absolute match at all of the 15 MIRU-
VNTR loci and a value of 1.000 equated to a complete non-match at all 15 loci. 
 
5.3.5. Global and regional geographical associations within the Midlands 
For the analysis of the distribution of strain lineage and patient location of residence, three 
levels of geography were analysed within the Midlands: globally, regionally by counties 
(Figure 2.1), and within the county of the West Midlands (Figure 2.2A). Further examination 
of strain distribution was carried out by analysis of lineage distribution across the nine PCTs 
located in the county of the West Midlands (Figure 2.2B). 
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5.4. RESULTS 
5.4.1. Prominent CEL Groups in the Midlands 
To estimate the coverage of typing within the six year study period, the total proportion of M. 
tuberculosis isolates typed in 2006 and 2007 was compared to the national HPA MycobNet 
database that contains all drug sensitivity testing data in the UK and therefore all positive 
cultures. It was found that 1,686/1,765 (96%) isolates in MycobNet from the Birmingham 
laboratory had a MIRU-VNTR result. Of the 5,731 isolates typed between 2004 and 2009, a 
CEL group was identified in 5,625/5,731 (98%) of all patients (Table 5.1). The single most 
predominant CEL group overall was the Indian CEL group (1,202/5,731, 35%) with CEL 
groups who originated from Asia accounting for the highest number of patients from one 
continent with 1,587/5,731 (47%) of all patients. The European CEL group was the second 
most prevalent continental group (1,323/5,731, 39%), with the England CEL group the second 
most prevalent individual CEL group overall (1,190/5,731, 35%). Patients that originated 
from Africa (341/5,731, 10%), the Americas (47/5,731, 1%), and Oceania (5/5,731, <1%) 
accounted for 12% of all strains. The largest CEL group in Africa originated from Somalia 
(126/5,731, 4%). Within the Midlands patient population, there were a total of 134 individual 
CEL groups identified. The most diverse region was Southern Asia with 23 individual CEL 
groups which included: Pakistan (700/5,731, 12%); Bangladesh (193/5,731, 3%); and more 
specific geographical areas such as Kashmir (93/5,731, 2%) and 13 Indian States (172/5,731, 
3%). Within the British Isles, patients that originated from each of the four nations were 
identified with: 1,190/5,731 (35%) from England; 130/5,731 (2%) from Ireland; 127/5,731 
(2%) from Scotland; and 122/5,731 (2%) from Wales. The single largest non-specific CEL 
group was Western Asia (345/5,731, 6%). In the rest of Western Asia, there were two large 
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specific CEL groups that originated from Lebanon (130/5,731, 2%) and Turkey (54/5,731, 
1%). 
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Continental 
Origin 
of 
patient 
Region 
Most prevalent 
CEL Group 
n (%) 
No. of other 
CEL Groups 
In region 
n (%) 
Total 
Isolates 
(%) 
Africa 
Africa Africa 18 (1) 1 3 (0) 21 (0) 
Eastern Somalia 126 (4) 8 59 (3) 185 (3) 
Middle Congo 12 (0) 1 1 (0) 13 (0) 
Northern Morocco 69 (2) 2 17 (1) 86 (2) 
Southern 
Black Southern 
Africa 
74 (2) 7 49 (2) 123 (2) 
Western Nigeria 42 (1) 5 61 (3) 103 (2) 
 Region total 341 (10) 24 190 (8) 531 (9) 
Americas 
Caribbean Black Caribbean 14 (0) 2 2 (0) 16 (0) 
Central Central 2 (0) 0 0 (0) 2 (0) 
Northern USA Black 11 (0) 3 11 (0) 22 (0) 
South Brazil 20 (1) 2 4 (0) 24 (0) 
 Region total 47 (1) 7 17 (1) 64 (1) 
Asia 
Central Central 1 (0) 0 0 (0) 1 (0) 
Eastern China Cantonese 24 (1) 5 36 (2) 60 (1) 
South-Eastern Vietnam 15 (0) 6 21 (1) 36 (1) 
Southern India 1,202 (35) 22 1,288 (55) 2,490 (43) 
Western Western Asia 345 (10) 8 193 (8) 538 (9) 
 Region total 1,587 (47) 41 1,538 (66) 3,125 (55) 
Europe 
Eastern Poland 36 (1) 9 30 (1) 66 (1) 
British Isles England 1,190 (35) 5 388 (17) 1,578 (28) 
Northern Norway 10 (0) 6 24 (1) 34 (1) 
Southern Italy 49 (1) 11 92 (4) 141 (2) 
Western Germany 38 (1) 5 42 (2) 80 (1) 
 Region total 1,323 (39) 36 576 (25) 1,899 (33) 
Oceania  Region total 6 (0) 0 0 (0) 6 (0) 
Not assigned Not assigned Not assigned 106 (3) 0 0 (0) 106 (2) 
  Total 3,410 (100) 109 2,321 (100) 5,731 (100) 
 
Table 5.1.  Major Cultural, Ethnic, and Linguistic (CEL) Groups present in patients 
with typed M. tuberculosis isolates in the Midlands between 2004 and 
2009.  
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5.4.2. Assignation of global strain lineage via MIRU-VNTRplus 
MIRU-VNTRplus enables users to match against 186 reference strains using MIRU-VNTR, 
spoligotyping, LSP, or SNP data. Within the MIRU-VNTRplus database, there are 154 M. 
tuberculosis complex strains that are members of one of the six major LSP lineages and one 
of 17 spoligotype clades (Table 5.2). When the 5,731 strains from the Midlands were matched 
to MIRU-VNTRplus, 4,951/5,731 (86%) strains were matched to one of 19 specific 
spoligotypes including “non-human” clades and 5,636/5,731 (98%) strains were matched to 
one of the six LSP lineages. There were 780/5,731 (14%) and 95/5,731 (2%) strains with 
mixed lineages respectively. A strain was assigned as a mixed lineage if two or more MIRU-
VNTRplus strains of different lineages matched with the closest distance to a strain from the 
Midlands. Therefore, to maintain the highest proportion of matched strains, the assignations to 
LSP lineages were used for further analysis. 
 
Using the 15 MIRU-VNTR loci, 5,550/5,731 (97%) strains were matched to one of the six 
major human global lineages and 86/5,731 (2%) strains were matched to other recognised 
lineages with an average match distance of 0.16 (95 % CI: 0.15-0.16) for all 5,731 strains 
(Table 5.3). The West African-1 lineage showed the closest average match distance (0.05, 
95% CI 0.01-0.08) with the Indo-Oceanic lineage exhibiting the highest average match 
distance (0.19, 95% CI 0.19-0.20) for a specific lineage. There were 3,475/5,731 (61%) typed 
strains from the Midlands that matched to strains in the MIRU-VNTRplus database with less 
than 0.17 match distance and 5,517/5,731 (96%) strains from the Midlands matched with less 
than 0.30 match distance. For this chapter, all unambiguous strain assignations were accepted 
as a global lineage assignation. 
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LSP Lineage n (%) 
MIRU-VNTRplus 
Spoligotype Lineage 
n (%) 
SpolDB4 
Equivalent 
East African Indian 10 (5) Delhi/CAS 10 (5) CAS 
East Asian 10 (5) Beijing 10 (5) Beijing 
Euro-American 91 (49) 
Cameroon 10 (5) LAM_CAM 
Ghana 10 (5) T 
H37Rv 1 (1) H37Rv  
Haarlem 13 (7) Haarlem 
LAM 11 (6) LAM 
NEW-1 3 (2) Haarlem 
S 12 (6) S 
TUR 4 (2) LAM_TUR 
UgandaI 10 (5) T 
UgandaII 10 (5) T 
URAL 4 (2) Haarlem 
X 3 (2) X 
Indo-Oceanic 12 (6) EAI 12 (6) EAI 
M. bovis 11 (6) Bovis 11 (6) Bovis 
M. canettii 2 (1) Canetti 2 (1) Canettii 
M. caprae 11 (6) Caprae 11 (6) CAP 
M. microti  6 (3)  
llama 4 (2) MICROTI 
vole 2 (1) MICROTI 
M. pinnipedii 2 (1) Seal 2 (1) PIN 
West African-1 20 (11) West African 1 20 (11) AFRI 
West African-2 11 (6) West African 2 11 (6) AFRI 
 186 (100)  186 (100)  
 
Table 5.2.  Distribution of lineages in the MIRU-VNTRplus database.  
 
Equivalent LSP, MIRU-VNTRplus spoligotype clade and SpolDB4 spoligotype clades are 
shown. Global spoligotype lineages in MIRU-VNTRplus and SpolDB4 are equivalent but 
exact assignations differ for some lineages. 
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Strain lineage n 
Avg. Match Distance 
(95% CI) 
No. strains with a 
MIRU-VNTRplus match distance of: 
<0.17 (%) <0.30 (%) >0.30 (%) 
East African Indian 1,888 0.15 (0.15-0.15) 1,287 (68) 1,868 (99) 20 (1) 
East Asian 356 0.11 (0.10-0.11) 292 (82) 346 (97) 10 (3) 
Euro-American 2,495 0.15 (0.14-0.15) 1,514 (61) 2,439 (98) 56 (2) 
Indo-Oceanic 778 0.19 (0.19-0.20) 342 (44) 680 (87) 98 (13) 
West African-1 16 0.05 (0.01-0.08) 15 (94) 16 (100) 0 (0) 
West African-2 17 0.18 (0.13-0.22) 8 (47) 15 (88) 2 (12) 
Mixed lineage 95 0.26 (0.25-0.27) 4 (4) 80 (84) 15 (16) 
Other lineage 86 0.25 (0.23-0.27) 13 (15) 73 (85) 13 (15) 
Total 5,731 0.16 (0.15-0.16) 3,475 (61) 5,517 (96) 214 (4) 
 
Table 5.3.  Similarity of 5,731 M. tuberculosis strains in the Midlands genotyped 
between 2004 and 2009 when compared to MIRU-VNTRplus.  
 
5.4.3. Global distribution of M. tuberculosis Lineages in CEL groups resident in the 
Midlands 
The Euro-American lineage was the single most prevalent lineage in our study with 
2,495/5,731 (44%) strains and was present in each continental human population group (Table 
5.4 and Figure 5.2). The Euro-American strain was the most prevalent lineage in patients that 
originated from Africa (296/531, 56%), the Americas (44/64, 69%), and Europe (1,342/1,899, 
71%) and was the second most prevalent lineage in patients originating from Asia (752/3,125, 
24%). The most prevalent M. tuberculosis lineage in patients that originated from Asia was 
the East African Indian lineage (1,499/3,125, 48%). Asia had the highest number of East 
Asian strains (218) with the two West African lineages most prevalent in Europe (16 and 17 
isolates). 
 
The East African Indian lineage was most closely associated with Asia (1,499/1,888, 79%), 
and in particular Southern Asia (1,258/1,888, 63%). Europe was the second closely associated 
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continent with 270/1,888 (14%) and more specifically the British Isles CEL group (217/1,914, 
11%). 
 
Combining geographic data assigned by Origins and DNA fingerprinting data could influence 
public health efforts to control tuberculosis as this approach can identify strains in CEL 
groups where specific global M. tuberculosis lineages are not expected. The MIRU-VNTR 
profile 42235 2542517333 was the single East African Indian strain that infected the highest 
number of patients (n=152). This strain showed wide geographic distribution across the West 
and Midlands but was restricted in the distribution of patient origin as 142/152 (93%) patients 
originated from Asia whereas only 8/152 (5%) from Europe and one individual each from the 
Americas and Africa. The MIRU-VNTR profile 42435 2332515333 was assigned as a 
member of the East Asian lineage and was identified in 31 patients. Even though this strain 
originates from Eastern Asia, 19/31 (62%) of patients infected with this strain originated from 
the British Isles and only 12/31 (38%) patients in the Asian CEL group. 
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Continental 
origin of 
patient 
Region 
No. isolates in each M. tuberculosis global lineage 
Total 
Isolates 
(%) 
East 
African 
Indian (%) 
East 
Asian 
(%) 
Euro 
American 
(%) 
Indo 
Oceanic 
(%) 
West 
African-1 
(%) 
West 
African-2 
(%) 
Mixed 
Lineage 
(%) 
Other 
Lineage 
(%) 
Africa 
Africa 1 (1) 1 (0) 17 (1) 2 (0) 0 (0) 0 (0) 0 (0) 0 (0) 21 (0) 
Eastern 45 (2) 10 (3) 74 (3) 42 (5) 0 (0) 2 (12) 11 (12) 1 (1) 185 (3) 
Middle 1 (0) 0 (0) 10 (0) 2 (0) 0 (0) 0 (0) 0 (0) 0 (0) 13 (0) 
Northern 36 (2) 2 (1) 26 (1) 17 (2) 0 (0) 2 (12) 3 (3) 0 (0) 86 (2) 
Southern 3 (0) 9 (3) 97 (4) 13 (2) 0 (0) 0 (0) 0 (0) 1 (1) 123 (2) 
Western 6 (0) 4 (1) 72 (3) 5 (1) 6 (38) 2 (12) 4 (4) 4 (5) 103 (2) 
Region Total* 92 (5) 26 (7) 296 (12) 81 (10) 6 (38) 6 (35) 18 (19) 6 (7) 531 (9) 
Americas 
Caribbean 3 (0) 2 (1) 11 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 16 (0) 
Central 0 (0) 0 (0) 2 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (0) 
Northern 3 (0) 0 (0) 18 (1) 0 (0) 0 (0) 0 (0) 1 (1) 0 (0) 22 (0) 
South 4 (0) 2 (1) 13 (1) 5 (1) 0 (0) 0 (0) 0 (0) 0 (0) 24 (0) 
Region Total* 10 (1) 4 (1) 44 (2) 5 (1) 0 (0) 0 (0) 1 (1) 0 (0) 64 (1) 
Asia 
Central 0 (0) 0 (0) 1 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (0) 
Eastern 1 (0) 36 (10) 15 (1) 7 (1) 0 (0) 0 (0) 1 (1) 0 (0) 60 (1) 
South-Eastern 5 (0) 12 (3) 8 (0) 11 (1) 0 (0) 0 (0) 0 (0) 0 (0) 36 (1) 
Southern 1,258 (67) 136 (38) 560 (22) 450 (58) 1 (6) 4 (24) 45 (47) 36 (42) 2,490 (43) 
Western 235 (12) 34 (10) 168 (7) 77 (10) 1 (6) 1 (6) 15 (16) 7 (8) 538 (9) 
Region Total* 1,499 (79) 218 (61) 752 (30) 545 (70) 2 (13) 5 (29) 61 (64) 43 (50) 3,125 (55) 
Europe 
Eastern 6 (0) 7 (2) 49 (2) 2 (0) 1 (6) 0 (0) 1 (1) 0 (0) 66 (1) 
British Isles 217 (11) 80 (22) 1,156 (46) 73 (9) 4 (25) 4 (24) 11 (12) 33 (38) 1,578 (28) 
Northern 6 (0) 2 (1) 13 (1) 11 (1) 0 (0) 1 (6) 1 (1) 0 (0) 34 (1) 
Southern 24 (1) 5 (1) 78 (3) 32 (4) 0 (0) 0 (0) 1 (1) 1 (1) 141 (2) 
Western 17 (1) 1 (0) 46 (2) 12 (2) 2 (13) 1 (6) 0 (0) 1 (1) 80 (1) 
Region Total* 270 (14) 95 (27) 1,342 (54) 130 (17) 7 (44) 6 (35) 14 (15) 35 (41) 1,899 (33) 
Oceania Region Total* 0 (0) 1 (0) 5 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 6 (0) 
Not assigned Not assigned 17 (1) 12 (3) 56 (2) 17 (2) 1 (6) 0 (0) 1 (1) 2 (2) 106 (2) 
 Total 1,888 (100) 356 (100) 2,495 (100) 778 (100) 16 (100) 17 (100) 95 (100) 86 (100) 5,731 (100) 
 
Table 5.4.  Distribution of M. tuberculosis isolates in the Midlands between 2004 and 2009 according to lineage and continent of 
patient origin based on CEL group.  
Percentages indicate the proportion of the total number of isolates in that particular lineage. *Region total, total number of isolates in that 
region and percentage of all isolates in that region that are members of that particular lineage. 
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Figure 5.2.  Global distribution of CEL groups and the six M. tuberculosis global LSP 
lineages present in the Midlands between 2004 and 2009. 
 
A total of 5,550 strains were assigned to one of the six global lineages. Each circle is located 
in the continental region that each CEL group originates from. The proportions in each circle 
represent the proportion of each of the six M. tuberculosis lineages within that specific CEL 
group with the scale of the circles indicating the number of strains and patients within each 
region. Map adapted from http://commons.wikimedia.org/wiki/File:BlankMap-World-
2009.PNG. The same colour scheme for lineages as used in Gagneux, 2006 was also used in 
this chapter to allow easy comparison. 
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5.4.4. Distribution of M. tuberculosis lineages in 11 counties across the Midlands 
In eleven counties across the Midlands region, the county of the West Midlands had the 
highest number of typed isolates with 2,646/5,731 (46%) (Figure 5.3). In the East Midlands, 
Leicestershire had the highest number of typed isolates with 752/5,731 (13%). There were 
3,193/5,731 (56%) typed isolates from the West Midlands, 1,672/5,731 (29%) isolates from 
the East Midlands, 143/5,731 (2%) patients resident outside of the Midlands, and 723/5,731 
(13%) patients with no recorded place of residence. The number of isolates typed in each 
county ranged from 17 in Herefordshire to 2,646 in the West Midlands County. Three 
counties had less than 100 isolates typed (Lincolnshire, Herefordshire, and Shropshire) and 
six counties had between 100 and 499 isolates typed (Derbyshire, Northamptonshire, 
Nottinghamshire, Staffordshire, Warwickshire, and Worcestershire). 
 
The Euro-American lineage was the most prevalent lineage in 10/11 (91%) counties with the 
highest proportion in Shropshire where it accounted for 40/61 (66%) isolates. Leicestershire 
was the only county where the most prevalent lineage was not the Euro-American lineage. In 
Leicestershire, the most prevalent lineage was the East African Indian lineage (272/752, 
36%). Leicestershire was also the county with the highest proportion of the East Asian 
(65/752, 9%) and Indo-Oceanic (140/752, 19%) lineages. The two West African lineages did 
not account for more than 1% of typed strains in any of the eleven counties. The Euro-
American and East African Indian lineages combined accounted for 4,383/5,731 (76%) of all 
strains typed in the Midlands. 
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Figure 5.3.  Distribution of the six M. tuberculosis global LSP lineages in the Midlands 
between 2004 and 2009.  
 
A total of 4,782 strains had associated patient postcode of residence and were mapped. The 
scale of the circles indicates the number of strains within each county. Map was adapted from 
http://en.wikipedia.org/wiki/File:Map_of_the_administrative_geography_of_the_United_Kin
gdom.png. 
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5.4.5. Distribution of CEL groups in 11 counties across the Midlands 
The Asian continental CEL group was the most prevalent CEL group across the Midlands 
with 3,125/5,731 (55%) patients and it was the most prevalent CEL group in 6/11 (55%0 
counties with the highest proportion in Leicestershire where 531/752 (71%) patients 
originated from Asia (Figure 5.4). The Asian CEL group was also the most prevalent CEL 
group in Derbyshire (118/240, 49%), Staffordshire (114/238, 48%), and West Midlands 
county (1,610/2,646, 61%). The European continental CEL group was the most prevalent 
CEL group in Lincolnshire (54/75, 72%), Northamptonshire (119/252, 47%), Herefordshire 
(12/17, 71%), Shropshire (37/61, 61%), Warwickshire (69/124, 56%), and Worcestershire 
(74/107, 69%). In Nottinghamshire, there were almost equal proportions of the Asian 
(152/353, 43%) and European (151/353, 43%) CEL groups. The highest number of patients 
that originated from Africa (531/5,731, 9%) was in the West Midlands county (264/2,646, 
10%) with the highest proportion in any county in Northamptonshire (35/252, 14%). The 
Asian and European CEL groups combined accounted for 5,024/5,731 (88%) of all strains 
typed in the Midlands. 
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Figure 5.4.  Distribution of CEL groups present in the Midlands (2004-2009).  
 
A total of 4,782 strains had associated patient postcode of residence and were mapped. The 
scale of the circles indicates the number of strains within each county. Map adapted from 
http://en.wikipedia.org/wiki/File:Map_of_the_administrative_geography_of_the_United_Kin
gdom.png. 
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5.4.6. Distribution of M. tuberculosis lineages across nine PCTs within the West 
Midlands county 
In nine Primary Care Trusts (PCTs) within the West Midlands county, the highest number of 
typed strains was in the Heart of Birmingham PCT with 811/2,646 (31%) typed strains 
(Figure 5.5). Two PCTs counties had less than 100 isolates typed (Dudley and Solihull) and 
six PCTs had between 100 and 499 isolates typed between 2004 and 2009 (Birmingham East 
and North, Coventry, Sandwell, South Birmingham, Walsall, and Wolverhampton City). 
 
Within the nine PCTs in the West Midlands county, the Euro-American (1,075/2,646, 41%) 
and the East African Indian (972/2,646, 37%) lineages were the two most prevalent lineages 
accounting for 2,047/2,646 (77%) of all typed strains. The Euro-American lineage was the 
most prevalent lineage in 5/9 (56%) PCTs in the West Midlands county: Coventry (171/325, 
53%); Dudley (43/97, 44%); Solihull (19/41, 46%); South Birmingham (110/217, 51%); and 
Wolverhampton City (167/283, 59%). The East African Indian lineage was the most prevalent 
lineage in 4/9 (44%) PCTs in the West Midlands county: Birmingham East and North 
(164/386, 42%); Heart of Birmingham (311/811, 38%), Sandwell (145/306, 47%); and 
Walsall (82/180, 46%). The highest number of Euro-American strains was in the Heart of 
Birmingham (283/811, 35%) with the highest proportion of Euro-American in a single PCT in 
Wolverhampton City where 167/283 (59%) were members of the Euro-American lineage 
whereas only 87/306 (28%) strains in Sandwell were Euro-American. The highest numbers of 
the East Asian (52/811, 6%) and Indo Oceanic lineages were both in Heart of Birmingham 
(127/811, 16%). The PCTs with the highest proportion of the East Asian and Indo Oceanic 
lineages were Dudley (10/97, 10%) and Solihull (7/41, 17%) respectively. 
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Figure 5.5.  Distribution of the six M. tuberculosis global LSP lineages in the West 
Midlands county present between 2004 and 2009.  
 
A total of 2,603 strains had associated patient postcode of residence and were mapped. The 
scale of the circles indicates the number of strains within each county. Map adapted from 
http://en.wikipedia.org/wiki/File:West_Midlands_County.png. 
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5.4.7. Distribution of CEL groups across nine PCTs within the West Midlands County 
The Asian continental CEL group was the most prevalent CEL group in the West Midlands 
county with 1,610/2,646 (61%) patients and it was the most prevalent CEL group in all nine 
PCTs with the highest proportion in Sandwell where 210/306 (69%) patients originated from 
Asia (Figure 5.6). The lowest proportion in any PCT was in Dudley (45/97, 46%) and Solihull 
(19/41, 46%). Heart of Birmingham PCT had the highest numbers of patients originating from 
Africa (101/811, 12%), Asia (541/811, 67%), and Europe (156/811, 19%). Coventry had the 
highest proportion of patients originating from Africa (48/325, 15%) and Dudley and Solihull 
had the highest proportion of patients originating from Europe (43/97, 44% and 18/41, 44% 
respectively). The Asian and European CEL groups combined accounted for 2,322/2,646 
(88%) of all strains typed in the West Midlands county. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 
 190 
 
 
Figure 5.6.  Distribution of continental CEL groups in the West Midlands County 
present between 2004 and 2009. 
 
A total of 2,603 strains had associated patient postcode of residence and were mapped. The 
scale of the circles indicates the number of strains within each county. Map adapted from 
http://en.wikipedia.org/wiki/File:West_Midlands_County.png . 
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5.5. DISCUSSION 
In this chapter, the analysis of 5,731 M. tuberculosis isolates typed in the United Kingdom 
demonstrated that the combination of molecular and population group data provided by novel 
software can provide information about the molecular epidemiology of M. tuberculosis. 
 
The proportion of strains typed by MIRU-VNTR in this study was very high with 96% of all 
strains typed in 2006 and 2007 when compared to a national database. Most of the apparently 
untyped strains (4%) are probably data entries where an exact match between regional and 
national data was not obtained and so the data has remained unlinked. 
 
The Midlands region of the UK encompasses a population of 9.8 million people with the 
single largest immigrant CEL group originating from India with 1,202/5,731 (21%) patients. 
However, the most predominant strain was the Euro-American lineage with 2,495/5,731 
(44%) isolates. The data from this study support previous findings from studies in San 
Francisco and Montreal but also importantly extends the data set to Europe and includes a 
large number of strains from the ISC which were under represented in other studies (Gagneux 
et al., 2006;Reed et al., 2009). All of the six global lineages present in the Midlands exhibited 
previously identified associations with respective human population groups but crossover of 
all lineages between distinct human population groups was also identified which indicated 
that importation and transmission of strains between different human population groups may 
have occurred in the Midlands. 
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5.5.1. Distribution of global lineages in the Midlands: East African Indian 
The association of lineages with distinct human population groups within the Midlands is 
similar when compared with previous studies (Gagneux et al., 2006;Reed et al., 2009), and 
also expands the global range of patients to the ISC, which were underrepresented in other 
studies. Only 17/875 (2%) strains (Gagneux et al., 2006) and 91/730 (12%) strains (Reed et 
al., 2009) in the San Francisco and Montreal studies originated from Southern Asia. In the 
Midlands, the East African Indian strain is tightly associated with patients who originate from 
Asia as 1,499/1,888 (79%) patients originating from Asia were infected with this lineage. 
However, East African Indian is not the sole lineage present in Asia as just under half of all 
patients that originated from Asia were infected with this lineage (1,512/3,125, 48%). The 
Euro-American (752/3,125, 24%) and Indo-Oceanic lineages (545/3,125, 17%) were also 
present in patients who originated from Asia. In a previous study based in San Francisco, 
there were only 11 isolates from Asia that were part of the East African Indian lineage 
(Gagneux et al., 2006). 
 
 
5.5.2. Distribution of global lineages in the Midlands: East Asian 
In the Midlands, the East Asian lineage was not restricted only to the Eastern Asian CEL 
group as most patients infected with the East Asian lineage originated from Southern Asia 
(136/356, 38%), with only 36/356 (10%) patients from Eastern Asia. In two previous studies 
(Gagneux et al., 2006;Reed et al., 2009), most patients infected with the East Asian lineage 
did originate from Eastern Asia (190/277, 69% and 32/63, 51% respectively) and this lineage 
was also identified in patients who originated from Southeast Asia (73/277, 26% and 19/63, 
30% respectively). However, in San Francisco and Montreal the East Asian lineage was rarely 
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found in the autochthonous populations (7/277, 3% and 6/63, 10% respectively). In the 
Midlands, a higher proportion (80/356, 22%) of the autochthonous population was infected 
with the East Asian lineage. 
 
The combination of DNA fingerprinting and origins data can provide deeper insights into the 
epidemiological backgrounds of specific MIRU-VNTR profiles. The two example MIRU-
VNTR profiles shown (42235 2542517333 and 42435 2332515333) both originate from Asia 
but exhibit very different distribution in individuals within the Midlands. The 42235 strain is 
the most prevalent East African Indian strain and is highly restricted to patients who originate 
from Asia whereas the 42435 strain is a prevalent East Asian strain but has been identified 
predominantly in patients who originate from Europe. This indicates that transmission of the 
East Asian lineage may have occurred between two distinct CEL groups (Eastern Asia to 
British). However, it cannot be excluded that the original source may not have been resident 
in the Midlands and so transmission between CEL groups may have originally occurred 
outside the Midlands from a different CEL group altogether. 
 
5.5.3. Distribution of global lineages in the Midlands: Euro-American 
The Euro-American lineage was the only lineage to be identified in every one of the global 
regions represented in the Midlands and this lineage has been shown to be present throughout 
the world in studies on patients in San Francisco and Montreal (Gagneux et al., 2006;Reed et 
al., 2009). 
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5.5.4. Distribution of global lineages in the Midlands: Indo-Oceanic and West-African 
Within the Midlands, the Indo-Oceanic lineage was identified predominantly in patients who 
originated from Southern Asia (450/2,490, 18%) whereas in the San Francisco and Montreal 
cohorts the Indo-Oceanic lineage was predominantly associated with South-Eastern Asia. This 
difference in associated regions may be caused by the paucity of patients who originate from 
South-Eastern Asia in the Midlands (36/5,731, <1%). In the previous studies in San Francisco 
and Montreal, West African strains were only identified in Africa whereas in the Midlands, 
21/33 (64%) of the West African lineage were identified in patients that did not originate from 
Africa with 7/33 (21%) patients from Asia, 13/33 (39%) from Europe and 1/33 (3%) from 
Oceania. 
 
5.5.5. Distribution of global lineages in the Midlands: Comparison of the Two 
Dominant Lineages 
The two most prevalent lineages in the Midlands (East African Indian and Euro-American) 
have two contrasting patterns of distribution. The East African Indian lineage is highly 
restricted to patients originating from Asia as 79% (1,499/1,888) of patients infected with the 
East African Indian lineage originate from Asia. The Euro-American lineage exhibits a much 
more diverse distribution with Europe (1,342/2,495, 54%), Asia (752/2,495, 30%), and Africa 
(296/2,526, 12%) being the predominant continents associated with the Euro-American 
lineage. The dispersal of the Euro-American lineage throughout the world has been observed 
in two previous studies (Gagneux et al., 2006;Reed et al., 2009) but this is the first study to 
detail the restricted geographical association of the East African Indian lineage with Asia even 
in a dispersed population outside Asia. 
Chapter 5 
 195 
5.5.6. Distribution of the East African Indian Lineage in Europe 
The East African Indian LSP lineage or CAS spoligotype clade has been reported at low 
levels in mainland Europe in Hamburg. Germany (7.8%) (Oelemann et al., 2007), 2007); 7% 
in Brussels, Belgium (Allix-Beguec et al., 2008a); and in Spain (Alonso et al., 2008); 9.4% in 
Greece (Rovina et al., 2011). Within Southwest Ireland, only 4/171 (2%) patients were 
infected with a CAS strain (Ojo et al., 2010). The highest reported proportion of CAS strains 
was also in England. In London, the most prevalent spoligotype was CAS (552/2,262, 24%) 
and patients who originated from the ISC were the largest patient population group 
(463/2,262, 20%) (Brown et al., 2010). 
 
5.5.7. Utility of Origins software in identification of CEL groups within countries 
Origins software identified CEL groups within a country (e.g., Kashmir in Pakistan or various 
states in India) and divided the British Isles into four CEL groups. This enhanced 
differentiation could be useful in future population-based studies as migration patterns may be 
localized to specific areas within countries and common social networks could be identified. 
CEL groups can be assigned to any dataset in which the patient‟s name is known. Traditional 
epidemiologic identification of ethnic groups requires a questionnaire, but if patient names are 
not in a dataset, then CEL groups cannot be assigned (Webber, 2007). 
 
The use of Origins software can enable a deeper understanding of epidemiological 
relationships between diverse CEL groups as a total of 134 individual CEL groups out of a 
potential total of >200 were identified whereas conventional epidemiological analysis such as 
the HPA Annual Report on the Epidemiology of Tuberculosis in the UK uses only nine ethnic 
groups (Bangladeshi, Black - other, Black-African, Black-Caribbean, Chinese, Indian, 
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Mixed/other, Pakistani, and White) (Health Protection Agency, 2010). The completeness of 
ethnic group data in the HPA annual report is high as information was available on both 
ethnic group and place of birth for 8,064/9,040 (89%) TB cases in 2009 (Health Protection 
Agency, 2010). However, some studies do not have complete patient origin data as 39% 
(880/2,261) patients in a study based in London did not have any patient origin data (Brown et 
al., 2010). 
 
5.5.8. Identification of patient origin: Conventional versus Origins data 
Comparing the data generated by the use of Origins software within the West and East 
Midlands to national data, the proportions for patients originating from Asia were very similar 
with 1,587/5,731 (47%) in the Midlands and 3,423/7,980 (43%) nationally in the UK. 
Proportions were also very similar for the few Black Caribbean patients diagnosed with TB 
each year with 14/5,731 (<1%) in the Midlands and 157/7,980 (2%) in the UK. The two most 
dissimilar groups were Africa/Black African with 341/5,731 (10%) in the Midlands versus 
1,779/7,980 (22%) nationally and White/British with 1190/5,731 (35%) in the Midlands and 
1648/7,980 (21%) nationally.  
 
Origins was developed using electoral register data in the UK and in other countries around 
the world (Webber, 2007). It is known that Origins software has reduced sensitivity when 
applied to Black Caribbean populations as many individuals have apparently Anglo-Saxon 
names. Between the Midlands and UK data there are differences in the proportion of Black 
Caribbean patients. However, the total number of individuals originating from the Caribbean 
with TB in 2008 was only 2% of the total number of TB cases in the UK. CEL group data 
provided by Origins software cannot assign the country of birth of a patient whereas self-
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declared epidemiological data can analyse country of birth data. The distinction between 
country of birth is important as in all population groups in the UK, the incidence rates are 
higher in non-UK-born patients than in UK-born patients within the same ethnic groups 
(Health Protection Agency, 2010). 
 
5.5.9. The impact of immigration on TB rates in the UK 
In a study of the impact of migration within 21 European countries between 1996 and 2005, 
the UK was one of only three countries where an increase in rates between 1996 and 2005 
was recorded (Gilbert et al., 2009). Rates in the UK increased by 31% from 10.8 to 14.2 per 
100,000 population. The two other countries that also had an increase in rates were Norway 
and Sweden. In Norway the incidence rate increased from 4.3 to 6.3 (31% increase) cases per 
100,000 in nine years, and in Sweden the rate increased from 5.6 to 6.3 (13% increase) 
(Gilbert et al., 2009). Portugal had the highest overall rate of TB in 2005 (34 cases per 
100,000) but only 12% of cases occurred in the foreign-born population. Within the 21 
countries analysed, Poland had the highest number of cases in 2005 with 9,269 (24.3 per 
100,000) (European Centre for Disease Prevention and Control/WHO Regional Office for 
Europe., 2011). However, data from high incidence countries in Europe such as Russia were 
not included in the 21 countries studied. 
 
The UK has the third largest foreign national population in Europe (3,035,000, 5% of total 
population) behind Germany (6,755,821, 9%) and France (3,263,200, 6%). In Europe, only 
the UK and Ireland have foreign national population groups that originate from countries with 
TB incidence rates of >500 cases per 100,000 with 168,000 individuals in the UK and 4,113 
in Ireland (Gilbert et al., 2009). Of the 21 countries included, the UK had the highest number 
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and proportion of immigrants (3,575/5,994, 59.6%) with TB who originated from Asia in 
2009 (European Centre for Disease Prevention and Control/WHO Regional Office for 
Europe., 2011;Gilbert et al., 2009). 
 
Between 1999 and 2003, the number of TB patients in England increased by 19% from 5,539 
to 6,608. A study of this time period identified that TB in non-UK-born individuals who had 
presented less than five years after arrival in the UK was one of three groups significantly 
associated with the increase in TB across England. Patients co-infected with HIV and small 
increases in the number of cases living in deprived areas also contributed to the observed 
increase (Crofts et al., 2008). Between 1999 and 2006, the proportion of patients with extra-
pulmonary disease also significantly increased from 2,717 (48%) to 4,205 (53%). Analysis of 
this increase showed that it was significantly associated with an increase in the proportion of 
non-UK born cases (OR 2.7, 95% CI 2.6-2.8) (Kruijshaar and Abubakar, 2009). 
 
5.5.10. Use of MIRU-VNTRplus and clade assignation 
Within this chapter, patient origin was identified using Origins software. Mycobacterial 
lineages were assigned by using 15 locus MIRU-VNTR data with comparison to an online 
database (MIRU-VNTRplus). This database contains 186 reference M. tuberculosis complex 
strains with associated MIRU-VNTR, spoligotype, LSP, and SNP data for each strain. The 
186 strains represent all of the major phylogenetic lineages known in the M. tuberculosis 
complex (Allix-Beguec et al., 2008b). 
 
The distribution of strains within MIRU-VNTRplus is heavily focused on the Euro-American 
lineage (91/186, 49%), “animal” strains (32/186, 17%) and the ancestral West African lineage 
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(31/186. 17%) whereas there are only 10 (5%) East African and 10 (5%) East Asian strains 
present. In the Midlands, an equivalent proportion of strains are members of the Euro-
American lineage (2,526/5,731, 44%) but the East African Indian lineage is represented in a 
far greater proportion in the Midlands (1914/5731, 33%) than in MIRU-VNTRplus. 
 
An internal evaluation of the MIRU-VNTRplus database by the database creators examined 
the effect of two different similarity distance cut-off values (0.17 and 0.30) on lineage 
assignation. These two values equate to 83% and 70% similarity respectively. Using MIRU-
VNTR data only, a value of 0.17 corresponds to a maximum tolerance level of differences at 
four loci. A value of 0.17 matched 170/186 strains which resulted in a sensitivity value of 
79% and specificity of 100%. The sensitivity of strain lineage assignation was increased to 
95.1% when the distance cutoff was increased to 0.30 (up to seven variant MIRU-VNTR 
loci). However, specificity was reduced from 100% to 98.4% with two mismatches in the 186 
strain database (Allix-Beguec et al., 2008b). 
 
Within the Midlands dataset, most strains (3,475/5,731, 61%) matched to a MIRU-VNTRplus 
strain with <0.17 match distance and almost all strains in the Midlands matched to a MIRU-
VNTRplus strain with <0.30 match distance (5,517/5,731, 96%). Overall, all 5,731 strains in 
the Midlands matched to MIRU-VNTRplus exhibited an average match distance of 0.16 (95% 
CI: 0.15-0.16). This means that 61% of strains in the Midlands matched to MIRU-VNTRplus 
with differences in 4/15 analysed MIRU-VNTR loci and 96% strains matched with 
differences at seven loci. 
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5.5.11. The rationale for the use of LSP Lineages instead of spoligotype lineages 
LSP lineages were used in this chapter as a greater proportion of strains from the Midlands 
were matched to a single LSP lineage in MIRU-VNTRplus (5,636/5,731, 98%) compared to 
single spoligotypes (4,951/5,731, 86%). There are also known discrepancies in MIRU-
VNTRplus with the assignation of spoligotype clades that are members of the Euro-American 
lineage such as New-1, Clade X, and Haarlem (Allix-Beguec et al., 2008b).  
 
5.5.12. Improvement of matching to MIRU-VNTRplus 
Between the human global spoligotype and LSP lineages, there are equivalent lineages 
present in each scheme as all but one of the LSP lineages corresponds to one spoligotype 
clade apart from the Euro-American lineage. The Euro-American lineage encompasses at 
least five separate spoligotype clades (Haarlem, LAM, S, T, X). This chapter used the 12 
“classical” MIRU loci and three ETR loci. MIRU-VNTRplus allows a user to use various sets 
of loci including the 24 loci which make up the current internationally optimised set of 
MIRU-VNTR loci (Supply et al., 2006). A study in Canada that examined the properties of 24 
loci typing compared to the “classical” 12 MIRU loci typing when strain data was matched to 
MIRU-VNTRplus. This study showed that the number of strains that could not be assigned to 
a single spoligotype lineage were reduced from 282/650 (43%) using 12 loci to just one 
isolate using 24 loci. However, the increase in the number of loci increased the overall 
matching distance of all isolates as the number of strains that did not match any strains 
(“unknown lineage”) in MIRU-VNTRplus increased from 23/650 (4%) using 12 loci to 
429/650 (66%) using 24 loci (Christianson et al., 2010). The MIRU-VNTRplus database does 
have a limited number of strains compared to other global databases such as SpolDB4 but 
MIRU-VNTRplus does provide a tool for direct assignation of lineages based on MIRU-
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VNTR data that is obtained on a prospective basis in the Midlands. Spoligotyping data is not 
obtained prospectively in the Midlands. It is anticipated that MIRU-VNTRplus will 
eventually expand and include a wider collection of strains for comparison of M. tuberculosis 
strains from around the world. 
 
5.5.13. Obtaining an accurate scenario for TB transmission in the Midlands 
The data presented in this chapter is a large population based study with 5,731 patients from a 
population of almost 9.5 million people over a six year period from between 2004 and 2009. 
MIRU-VNTR data using the 15 loci does correlate well with IS6110 RFLP data when 
epidemiological links are known (Hawkey et al., 2003). However, knowledge of conventional 
epidemiological data across the 5,731 strains was not universal. When epidemiological data is 
not known, caution must be exercised when analysing MIRU-VNTR clusters as IS6110 RFLP 
can still split 15 locus MIRU-VNTR clusters (Garcia de Viedma et al., 2006). Therefore, an 
estimation of transmission rates and proportion of secondary cases generated by different 
strains or clades was not calculated. To improve the accuracy of MIRU-VNTR typing across 
the Midlands, prospective universal 24 loci typing of all strains was introduced in 2010. For 
850 strains typed in 2010, an increase in the number of loci from 15 to 24 reduced the 
clustering rate across the Midlands from 45% to 23% (Evans et al., 2011;Small et al., 1994). 
To obtain an accurate estimation of transmission rates in the Midlands, strains typed between 
2007 and 2009 will have the additional nine loci added to complete the 24 loci and combined 
with prospective typing data from 2010 to obtain an epidemiologically relevant four year time 
period (Vynnycky et al., 2001). 
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Conventional epidemiological data is now analysed on a routine basis across the Midlands 
including the areas of highest incidence in Birmingham and Leicester. As part of a three year 
HPA national 24 locus typing project initiated in 2010 (Health Protection Agency, 2011), 
molecular and epidemiological data are being combined for the first time in the UK on a 
national level. 
 
5.5.14. The use of repetitive sequences to identify phylogeographic associations 
The use of MIRU-VNTR and spoligotype data for phylogenetic analysis has been examined 
in two recent studies that analysed the relative degree of convergent evolution or homoplasy 
when compared to SNP data. Homoplasy occurs when the same molecular epidemiological 
state such as strain type is identified in different lineages using a separate comparator method. 
A comparison of MIRU-VNTR, spoligotype, and SNP showed that SNP data exhibited the 
lowest rate of homoplasy in strains located in different parts of the global phylogeny of M. 
tuberculosis (Comas et al., 2009). The authors recommended that MIRU-VNTR and 
spoligotype data can be used for initial exploratory screening of strains but that to overcome 
the phylogenetic limitations of these markers, complete strain assignment should be 
confirmed with SNP or LSP analysis. The SNP data analysed in this study was generated by 
an 89 gene target multilocus sequence analysis assay which generated 70 kbp of DNA 
sequence per strain. SNPs were detected by direct DNA sequencing of PCR products using 
the Sanger sequencing method (Hershberg et al., 2008). However, the analysis of 89 potential 
SNPs per strain is beyond the realistic aims of most population-based phylogenetic studies of 
M. tuberculosis strains around the world especially in high-burden areas. 
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A subsequent larger study of 950 isolates in San Francisco compared spoligotypes obtained 
and the associated lineages based on LSP data (Kato-Maeda et al., 2011). For 919 strains that 
had both spoligotype and LSP data, all isolates belonging to each of the recognised 
spoligotype families belonged to the same LSP/SNP derived lineage. No evidence of 
homoplasy in the main spoligotype lineages into different LSP/SNP lineages was identified. 
This study examined strains from the Euro-American (481/919, 53%), Indo-Oceanic 
(235/919, 26%), East Asian (198/919, 22%) but only five strains from the East African Indian 
LSP lineage and none from the two West African lineages. 
 
5.5.15. Refinement of current phylogenies using minimal SNP sets 
To overcome the need for massive gene sequencing to construct robust phylogenetic 
scenarios, minimal sets of informative SNPs involved in replication, repair and recombination 
(3R) in M. tuberculosis have been identified that provide accurate phylogenetic data (dos 
Vultos T. et al., 2008). A minimal set of seven SNPs was used to further delineate the 
Haarlem, LAM, and T spoligotype clades which provides data that is almost as informative as 
massive sequencing projects (Abadia et al., 2010) with identification of 30 SNPs in 192 
clinical Beijing strains identified 26 robust sequence types within this clade (Mestre et al., 
2011). 
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5.5.16. Construction of robust global phylogenies using WGS 
Strains analysed in this chapter will be selected for analysis by large-scale whole genome 
sequencing as part of the UK Clinical Research Collaboration Modernising Medical 
Microbiology Consortium which is a UK wide consortium funded by the Wellcome Trust and 
MRC. This will enable the construction of a robust phylogenetic scenario for the M. 
tuberculosis complex in the West and East Midlands. The three collaborative institutions in 
this project are the University of Oxford, HPA and the Wellcome Trust Sanger Institute. The 
aim of this project is to establish how revolutionary new technologies such as high-throughput 
next generation DNA sequencing can be optimally integrated into clinical microbiology. An 
Illumina system will be the primary next-generation platform that will be used for this project 
(Bentley, 2006;Balasubramanian and Bentley, 2001). 
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5.6. CONCLUSIONS 
Many countries now routinely type M. tuberculosis isolates by using MIRU-VNTR typing. 
Our study of over 5,000 isolates shows that Origins data in combination with molecular 
typing data can be used to identify specific associations between lineages and apparent 
transmission into unexpected population groups. By using Origin software for identification 
of CEL groups, public health teams can identify and investigate possible cultural links for 
transmission of M. tuberculosis. We hypothesised that strains present in Southern Asia would 
also be present in the Midlands. This was proven true as the East African Indian clade was 
one of two predominant lineages in the Midlands.  
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6. ANALYSIS OF THE CLONALITY OF                     
M. TUBERCULOSIS STRAINS IN THE MIDLANDS 
AND IDENTIFICATION OF A GEOGRAPHICALLY-
RESTRICTED BUT PREVALENT STRAIN. 
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6.1. INTRODUCTION 
DNA fingerprinting of M. tuberculosis has a key role in TB control and cluster investigation 
as the molecular data obtained can be used to direct and focus public health control efforts 
(Evans et al., 2007;Hawkey et al., 2003). For example, DNA fingerprinting enhanced the 
investigation of a large outbreak in North London where many of the epidemiological links 
would not have been established by routine contact tracing or traditional epidemiological 
investigations alone (Ruddy et al., 2004). Large-scale studies of M. tuberculosis strains have 
also enabled the accurate assessment of strain transmission. In one of the studies of TB 
transmission, a study in San Francisco identified that a third of new cases were the results of 
recent infection even with what was considered an efficient tuberculosis-control programme 
(Small et al., 1994). In the Netherlands, demographic risk factors including male sex, urban 
residence, Dutch and Surinamese nationality, and long-term residence in the Netherlands were 
identified as significant risk factors for active transmission (van Soolingen et al., 1999). More 
recently, a study in England revealed that recent transmission accounted for approximately 
25% of cases and occurred over wide geographic areas, between ethnic groups and among the 
homeless (Love et al., 2009). 
 
6.1.1. TB in the Midlands and the UK 
The geographical distribution of M. tuberculosis strains across health organisation boundaries 
(PCTs) will be described in this chapter (Figure 2.2). There is much variation in the incidence 
of TB across the Midlands (Figure 6.1), with rates highest in one urban area of Birmingham 
(>80 cases per 100,000) and lowest in rural areas such as Worcestershire (Figure 6.2) (Health 
Protection Agency, 2010).  
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Figure 6.1.  Three-year average tuberculosis case rates in the UK by primary care 
organisation between 2007 and 2009. 
 
The primary care organisations are primary care trusts (PCTs) in England, health and social 
services boards in Northern Ireland, NHS boards in Scotland, and local health boards in 
Wales (Health Protection Agency, 2010). 
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Figure 6.2.  Three-year average tuberculosis case reports and rates by Primary Care 
Trusts in the West and East Midlands between 2007 and 2009. 
Office for National Statistics mid-year figures from 2008 were used for population estimates 
(Health Protection Agency, 2010). 
 
Chapter 6 
 210 
6.2. AIMS 
We analysed all M. tuberculosis isolates in the Midlands region of the UK between 2004 and 
2008 by universal prospective DNA fingerprinting with the aim of understanding the 
distribution and clonality of M. tuberculosis strains in the Midlands. The geographical 
distribution and epidemiological characteristics of patients infected with the most prevalent 
strain in the Midlands was analysed. 
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6.3. METHODS 
6.3.1. Study population 
Prospective universal DNA fingerprinting was undertaken between 2004 and 2008 with 
retrospective requested genotyping carried out on strains isolated before 2004. Retrospective 
observational epidemiological investigations were undertaken within one city and on a 
regional scale. 
 
6.3.2. Mycobacterial culture, identification, and DNA fingerprinting 
Primary specimens were processed as described in Section 2.3, cultured using liquid media 
(Section 2.3.2), DNA was extracted (Section 2.3.3) and isolates were identified as M. 
tuberculosis using the HAIN GenoType MTBC assay (Section 2.4). MIRU-VNTR typing of 
the five ETR (ETR-A to -E) and 10 MIRU loci (MIRU-02, -10, -16, -20, -23, -24, -26, -27, -
39, and -40) was carried out using a Transgenomic WAVE® System (Section 2.7). MIRU-04 
and MIRU-31 were removed from the 12 MIRU loci and analysed as ETR-D and ETR-E in 
the five ETR loci.  IS6110 RFLP (Section 2.5) and MIRU-VNTR typing was carried out on 
specific requested M. tuberculosis strains until 2004. A selection of strains were analysed by 
the nine additional loci (VNTR0424, 1955, 2163b, 2347, 2401, 3171, 3690, 4052, and 4156) 
that together with the 15 loci comprise the internationally optimised set of 24 loci (Section 
2.7.4) (Supply et al., 2006). 
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6.3.3. Case definition 
Patients with the MIRU-VNTR profile of the most prevalent M. tuberculosis strain in the 
Midlands were included in further epidemiological investigations. 
 
6.3.4. M. tuberculosis strain clustering analysis  
MIRU-VNTR and IS6110 RFLP data were entered into BioNumerics (Applied Maths, Saint 
Marten-Latem, Belgium) to identify clustered MIRU-VNTR profiles. MIRU-VNTR data was 
also queried against the HPA UK M. tuberculosis Strain Typing Database which contains 
>26,000 typed M. tuberculosis strains from six contributing centres in the United Kingdom 
(Health Protection Agency, 2011). Clustering percentages were calculated using the n-1 
method (Section 2.9.3). The HGDI was used to assess the diversity and clonality of strains in 
the Midlands (2.9.4). 
 
6.3.5. Assignation of global clade lineage 
Spoligotyping was carried out to identify the global strain family that the most prevalent 
strain is part of. Spoligotyping was performed using the Luminex Multianalyte Profiling 
System as previously described  (Cowan et al., 2004) (Section 2.8). Spoligotype families were 
assigned by comparison to the international SpolDB4 database which contains 39,925 entries 
from 122 isolation countries (Section 2.9.6) (Brudey et al., 2006). 
 
6.3.6. West Midlands regional epidemiological analysis 
Patients infected with the single most prevalent M. tuberculosis strain from 2004-2008 were 
compared to all patients with tuberculosis in the West Midlands between 2004 and 2008 in the 
HPA Enhanced Tuberculosis Surveillance System. The HPA Enhanced Tuberculosis 
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Surveillance System contains molecular, pathological, and treatment data on all notified cases 
of tuberculosis in England including culture-confirmed cases and clinically diagnosed cases. 
All patients with strain typing data were selected for comparison. 
 
6.3.7. Patient location 
M. tuberculosis strains referred from laboratories located in the West and East Midlands were 
included in this study. From the patient postcode, three levels of patient residence were 
analyzed: Health Protection Unit (HPU), PCT (Figure 2.2) and LA. Local HPA HPUs work 
alongside the National Health Service in England providing specialist support in 
communicable disease and infection control. There are three HPUs in the West Midlands: 
West Midlands East, West Midlands North, and West Midlands West. The major cities of 
Birmingham and Coventry are located in West Midlands East, Stoke-on-Trent in West 
Midlands North, and Wolverhampton in West Midlands West. More specific analysis of 
patient residence was undertaken by analyzing patient location within PCT or LA regions in 
the West Midlands. Primary Care Trusts provide primary and community services in England. 
LAs are administrative regions that are based on city or county boundaries (Figure 2.1).  
 
6.3.8. Geographical distribution of the Mercian strain in the West Midlands region 
Laboratory records of patients with the most prevalent strain were used to map patient 
residential location using postcode within the West Midlands with MapInfo software (Pitney 
Bowes Software, Watford, UK). 
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6.3.9. City specific epidemiological investigation 
When it became apparent that there was a cohort of patients in Wolverhampton with an 
indistinguishable MIRU-VNTR profile, a retrospective review of patient case notes and 
interview of specialist tuberculosis nurses who were involved with the care of these patients 
was undertaken for culture-positive patients resident in Wolverhampton diagnosed with the 
same indistinguishable MIRU-VNTR profile between June 2003 and February 2006 to 
identify common factors and potential epidemiological links. These patients were compared 
to culture-positive cases diagnosed with other strains in 2004. Chest radiographs of all 
patients were also reviewed for the presence of cavitations. 
 
6.3.10. Statistical analysis 
Proportions calculated from epidemiological data obtained from the West Midlands regional 
and Wolverhampton city datasets were compared using Pearson‟s chi-squared test with 
Fisher's exact test was used where necessary. Univariate and multivariate logistic regression 
modelling was used to test the significance of odds ratios in Stata v10 (Stata Corp, College 
Station, TX, USA). The multivariable model was assembled by adding covariates individually 
in decreasing order of significance and the "goodness of fit" of each model was assessed using 
the likelihood ratio test. All cases with missing values for the variables examined were 
excluded from the multivariate model with 114 patients infected by the Mercian strain and 
1,891 patients in the control group included. A univariate analysis of the epidemiological 
investigation of patients resident in Wolverhampton was undertaken using EpiData Analysis 
v2.2 (EpiData Association, Odense, Denmark). The extent of any association was expressed 
as an odds ratio (OR) with 95% confidence intervals (Section 2.9.9). 
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6.4. RESULTS 
6.4.1. Summary of DNA fingerprinting data 
Between 2001 and 2003, 290 M. tuberculosis strains identified between 1995 and 2002 were 
typed as part of requested retrospective epidemiological investigations (Figure 6.3). In 2003, a 
prospective service to genotype all referred M. tuberculosis strains in the Midlands was 
initiated, with 2004 the first full calendar year of typing. 
 
Between 2004 and 2008, there were 4,830 isolates typed from 31 referring laboratories in the 
West and East Midlands. There were 171 duplicate isolates were removed so that 4,659 
isolates representing the first typed isolate from each patient between 1
st 
January 2004 and 31
st
 
December 2008 were selected. From 4,659 isolates typed, 2,791/4,659 (60%) originated from 
patients resident in the West Midlands and 1,464/4,659 (31%) from patients resident in the 
East Midlands. A summary flowchart of the molecular and epidemiological investigations 
undertaken in this study is shown in Figure 6.3. 
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Figure 6.3.  Flow diagram of DNA fingerprinting and epidemiological investigations. 
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6.4.2. MIRU-VNTR profile distribution across the Midlands 
Across the Midlands, there were 489 molecular clusters that contained ≥2 isolates. Pairs of 
isolates were the most common cluster size with 216/489 (44%) clusters. Most clusters 
contained ≤5 isolates (372/489, 76%). There were three clusters that contained ≥85 isolates. 
The single largest cluster contained 156 isolates (Figure 6.4). 
 
 
 
Figure 6.4.  MIRU-VNTR profile distribution across the Midlands, 2004-2008. 
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6.4.3. Clonality and diversity of M. tuberculosis in regions across the Midlands 
Heart of Birmingham and Leicester City PCTs had the highest number of MIRU-VNTR types 
(430 and 404), clusters (88 and 60), indistinguishable isolates (356 and 210) and total 
numbers of isolates (698 and 554) in the West and East Midlands respectively (Table 6.1). 
Two different areas had the highest proportion of strain clustering by MIRU-VNTR typing, 
Wolverhampton City (43%) and Northamptonshire (29%). Three areas had complete 
differentiation of all strains with 0% clustering and a HGDI value of 1.000 (Herefordshire, 
North Staffordshire, and Bassetlaw). Clustering rates and the HGDI were calculated to assess 
the clonality of strains within each PCT. Wolverhampton City PCT had the highest rate of 
clustering (43%) and a reduced HGDI value (0.948, 0.927 - 0.968), which indicated that in 
this location strains had a higher degree of clustering and clonality than other areas. 
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PCT 
No. of 
MIRU-VNTR 
types 
No. of 
MIRU-VNTR 
clusters 
No. of 
indistinguishable 
isolates 
No. of 
unique 
isolates 
Total 
No. 
isolates 
Clustering 
(%) 
HGDI 
(95% CI) 
West Midlands        
Birmingham East and North 232 35 131 197 328 29 0.994 (0.991 - 0.996) 
Coventry 196 32 121 164 285 31 0.989 (0.983 - 0.994) 
Dudley 60 15 46 45 91 34 0.979 (0.966 - 0.993) 
Heart of Birmingham 430 88 356 342 698 38 0.994 (0.993 - 0.996) 
Herefordshire 16 0 0 16 16 0 1.000 (0.974 - 1.000) 
North Staffordshire 17 0 0 17 17 0 1.000 (0.977 - 1.000) 
Sandwell 187 23 101 164 265 29 0.991 (0.987 - 0.995) 
Shropshire County 25 2 4 23 27 7 0.994 (0.984 - 1.000) 
Solihull 32 2 4 30 34 6 0.996 (0.990 - 1.000) 
South Birmingham 143 16 56 127 183 22 0.993 (0.988 - 0.997) 
South Staffordshire 62 8 23 54 77 19 0.991 (0.984 - 0.998) 
Stoke On Trent 91 9 29 82 111 18 0.994 (0.989 - 0.998) 
Telford and Wrekin 25 1 2 24 26 4 0.997 (0.989 - 1.000) 
Walsall 123 21 62 102 164 25 0.994 (0.991 - 0.997) 
Warwickshire 93 10 35 83 118 21 0.986 (0.975 - 0.997) 
Wolverhampton City 147 22 133 125 258 43 0.948 (0.927 - 0.968) 
Worcestershire 71 10 32 61 93 24 0.989 (0.982 - 0.997) 
East Midlands        
Bassetlaw 3 0 0 3 3 0 1.000 (0.310 - 1.000) 
Derby City 115 16 48 99 147 22 0.993 (0.989 - 0.998) 
Derbyshire County 50 7 19 43 62 19 0.989 (0.980 - 0.999) 
Leicester City 404 60 210 344 554 27 0.996 (0.995 - 0.998) 
Leicestershire County and Rutland 91 11 30 80 110 17 0.994 (0.989 - 0.999) 
Lincolnshire 41 5 15 37 52 19 0.980 (0.958 - 1.000) 
Northamptonshire 154 23 87 131 218 29 0.988 (0.982 - 0.995) 
Nottingham City 180 23 74 157 231 22 0.996 (0.994 - 0.998) 
Nottinghamshire County 69 10 28 59 87 21 0.992 (0.987 - 0.998) 
PCT not assigned 259 37 115 222 337 23 0.997 (0.996 - 0.998) 
West Midlands 1,379 299 1,711 1,080 2,791 51 0.994 (0.993 - 0.995) 
East Midlands 915 164 713 751 1,464 38 0.997 (0.997 - 0.998) 
Midlands 2,195 489 2,953 1,706 4,659 53 0.996 (0.996 - 0.996) 
 
Table 6.1.  MIRU-VNTR profile distribution by PCT. 
 
Profile distribution in shown by the number of distinct MIRU-VNTR profiles, the number of MIRU-VNTR clusters that contain ≥2 
isolates, the number of clustered or indistinguishable isolates, and the number of unique isolates. The clonality or diversity of strains in 
each PCT was assessed by calculated the clustering rate using the n-1 method and the HGDI. 
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6.4.4. Distribution of the most prevalent MIRU-VNTR profile in the Midlands 
The single most prevalent MIRU-VNTR profile was 32333 2432515314, which was 
identified in 156/4,659 (3%) isolates across the West and East Midlands and 155/2,791 (6%) 
isolates in the West Midlands. One isolate with this MIRU-VNTR profile was identified in the 
East Midlands (Table 6.2). The second and third most prevalent profiles were 42235 
2542517333 (117/4,659, 3%) and 42235 2642515333 (88/4,659, 2%).  
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No. 
MIRU-VNTR 
profile 
MIRU-VNTRplus 
Lineage 
Patient residence 
Total West 
Midlands 
(%) 
East 
Midlands 
(%) 
Not 
assigned 
(%) 
Non-Midlands 
(%) 
1 32333 2432515314 Euro-American 149 (96) 1 (1) 6 (4) 0 (0) 156 
2 42235 2542517333 East African Indian 82 (70) 28 (24) 4 (3) 3 (3) 117 
3 42235 2642515333 East African Indian 48 (55) 33 (38) 7 (8) 0 (0) 88 
4 42235 2642516333 East African Indian 55 (86) 7 (11) 2 (3) 0 (0) 64 
5 21433 2412615221 Euro-American 34 (55) 21 (34) 4 (6) 3 (5) 62 
6 32433 2312515322 Euro-American 49 (84) 2 (3) 7 (12) 0 (0) 58 
7 42235 2642517333 East African Indian 37 (64) 18 (31) 3 (5) 0 (0) 58 
8 42234 2642517323 East African Indian 41 (76) 9 (17) 4 (7) 0 (0) 54 
9 32433 2312515324 Euro-American 36 (77) 7 (15) 4 (9) 0 (0) 47 
10 -2235 2542517333 East African Indian 34 (79) 5 (12) 4 (9) 0 (0) 43 
11 32433 2512511322 Euro-American 24 (57) 17 (40) 1 (2) 0 (0) 42 
12 32333 2532515323 Euro-American 17 (41) 21 (51) 3 (7) 0 (0) 41 
13 32433 2432515323 Euro-American 13 (41) 16 (50) 3 (9) 0 (0) 32 
14 42234 2742511334 East African Indian 12 (39) 16 (52) 2 (6) 1 (3) 31 
15 42435 2332517333 East Asian 11 (37) 14 (47) 3 (10) 2 (7) 30 
16 32433 2432515324 Euro-American 18 (67) 6 (22) 3 (11) 0 (0) 27 
17 32333 2432515324 Euro-American 11 (42) 11 (42) 4 (15) 0 (0) 26 
18 42435 2332515333 East Asian 22 (85) 2 (8) 2 (8) 0 (0) 26 
19 32433 2332615321 Euro-American 18 (72) 5 (20) 1 (4) 1 (4) 25 
20 32333 2532315323 Euro-American 14 (58) 10 (42) 0 (0) 0 (0) 24 
21 42433 2331513321 Euro-American 1 (5) 19 (95) 0 (0) 0 (0) 20 
22 22433 2342515322 Euro-American 7 (37) 10 (53) 2 (11) 0 (0) 19 
23 32333 1532515323 Euro-American 16 (84) 1 (5) 1 (5) 1 (5) 19 
24 42235 2642513333 East African Indian 9 (47) 9 (47) 1 (5) 0 (0) 19 
25 61464 2432622334 Indo-Oceanic  14 (78) 4 (22) 0 (0) 0 (0) 18 
26 32333 2531315323 Euro-American 13 (81) 1 (6) 1 (6) 1 (6) 16 
27 42235 2442517333 East African Indian 7 (44) 8 (50) 1 (6) 0 (0) 16 
28 42235 2542516333 East African Indian 10 (67) 3 (20) 2 (13) 0 (0) 15 
29 22434 243251a322 Euro-American 13 (87) 0 (0) 2 (13) 0 (0) 15 
30 21433 2312615221 Euro-American 5 (36) 6 (43) 2 (14) 1 (7) 14 
 459 other profiles  1,008 (58) 550 (32) 147 (8) 26 (2) 1,731 
 Unique profiles  963 (56) 604 (35) 112 (7) 27 (2) 1,706 
 Total  2,791 (60) 1,464 (31) 338 (7) 66 (1) 4,659 
 
Table 6.2.  Most prevalent MIRU-VNTR profiles in the Midlands (2004-2008). 
 
The 30 most prevalent MIRU-VNTR profiles are shown. The MIRU-VNTRplus lineage was 
assigned as described in Chapter 5. The total number and proportion of each lineage in the 
West and East Midlands is also shown. 
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6.4.5. Distribution of the most prevalent MIRU-VNTR profile across the Midlands 
Analysis of the geographical distribution of the most prevalent MIRU-VNTR profile (32333 
2432515314) showed that this strain was identified in 14/17 (83%) PCTs in the West 
Midlands. Wolverhampton had the highest proportion of this strain with 55/258 (21%) of all 
strains in Wolverhampton identified as 32333 2432515314 (Table 6.3). 
 
Overall, 121/156 (78%) isolates of the Mercian strain were identified in patients resident in 
three cities in the West Midlands (Birmingham, Coventry and Wolverhampton) which are 
located within a 25 km radius of each other. There were 55/156 (35%) isolates that originated 
from Wolverhampton, 40/156 (26%) isolates from Birmingham, and 26/156 (17%) isolates 
from Coventry. Figure 6.5 shows the geographical mapping of 32333 2432515314 in the West 
Midlands between 2004 and 2008. 
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PCT 
32333 
2432515314 
(%) 
488 
Other 
profiles 
(%) 
Unique  
strains 
(%) 
Total 
West Midlands     
Birmingham East and North 12 (4) 189 (58) 127 (39) 328 
Coventry 26 (9) 159 (56) 100 (35) 285 
Dudley 10 (11) 61 (67) 20 (22) 91 
Heart of Birmingham 16 (2) 448 (64) 234 (34) 698 
Herefordshire 0 (0) 8 (50) 8 (50) 16 
North Staffordshire 0 (0) 13 (76) 4 (24) 17 
Sandwell 4 (2) 171 (65) 90 (34) 265 
Shropshire County 0 (0) 16 (59) 11 (41) 27 
Solihull 1 (3) 20 (59) 13 (38) 34 
South Birmingham 12 (7) 100 (55) 71 (39) 183 
South Staffordshire 4 (5) 48 (62) 25 (32) 77 
Stoke On Trent 3 (3) 64 (58) 44 (40) 111 
Telford and Wrekin 1 (4) 14 (54) 11 (42) 26 
Walsall 2 (1) 109 (66) 53 (32) 164 
Warwickshire 2 (2) 65 (55) 51 (43) 118 
Wolverhampton City 55 (21) 140 (54) 63 (24) 258 
Worcestershire 1 (1) 54 (58) 38 (41) 93 
East Midlands     
Bassetlaw 0 (0) 3 (100) 0 (0) 3 
Derby City 0 (0) 101 (69) 46 (31) 147 
Derbyshire County 0 (0) 38 (61) 24 (39) 62 
Leicester City 0 (0) 299 (54) 255 (46) 554 
Leicestershire County and Rutland 0 (0) 67 (61) 43 (39) 110 
Lincolnshire 0 (0) 30 (58) 22 (42) 52 
Northamptonshire 0 (0) 132 (61) 86 (39) 218 
Nottingham City 1 (0) 132 (57) 98 (42) 231 
Nottinghamshire County 0 (0) 57 (66) 30 (34) 87 
Not assigned 6 (2) 220 (65) 111 (33) 337 
West Midlands 149 (5) 1,679 (60) 963 (35) 2,791 
East Midlands 1 (0) 859 (59) 604 (41) 1,464 
Non-Midlands 0 (0) 39 (58) 28 (42) 67 
Total 156 (3) 2,797 (60) 1,706 (37) 4,659 
 
Table 6.3.  Distribution of the Mercian strain in PCTs across the Midlands. 
 
The number and proportion of the Mercian strain, all other clustered strains and all unique 
strains in each PCT is shown. 
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Figure 6.5.  Geographical mapping of patients infected with the Mercian strain in the 
West Midlands between 2004 and 2008.  
 
The postcode map was produced under license by ©Crown Copyright and database right 
2010. Ordnance Survey License 100016969/100022432. 
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6.4.6. Temporal distribution of the most prevalent MIRU-VNTR profile 
The Mercian strain has been identified in each year of prospective typing between 2004 and 
2008 with an average of 31 isolates (range 27-37) each year (Figure 6.6). The average annual 
proportion of all strains that are the Mercian strain across the Midlands was 3.35% (range 
2.93%-4.13%). 
 
 
Figure 6.6.  Incidence and cumulative total of the number of patients infected with the 
Mercian strain in the Midlands between 2004 and 2008. 
The total for each six month period is shown in black with the white bars showing the 
cumulative total. The proportion of all strains in the Midlands that are the Mercian strain is 
shown on the right-hand y axis. 
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6.4.7. Distribution of the most prevalent MIRU-VNTR profile in other regions in the 
UK 
The HPA UK M. tuberculosis Strain Typing Database was interrogated to analyze the 
national distribution of the Mercian strain. This database found a total of 176 isolates 
identified as 32333 2432515314 across the UK from 2004-2008. Only 6/176 (3%) of these 
isolates were identified in patients resident outside of the Midlands. The six strains were 
identified by regional laboratories in Cardiff (n=1), London (n=3), Newcastle (n=1) and 
Edinburgh (n=1) with 14 duplicate isolates present in the national database from the 
Midlands. Since this MIRU-VNTR profile appeared to be geographically restricted to the 
West Midlands in the UK, we have named the profile the “Mercian strain”, after the Anglo-
Saxon kingdom of Mercia (Zaluckyj , 2001). 
 
6.4.8. Case definition 
Inclusion of a patient into the Mercian strain profile was based on 15 locus MIRU-VNTR 
typing, with a confirmed case defined as a patient with microbiologically confirmed 
tuberculosis and an isolate that had the 32333 2432515314 MIRU-VNTR profile. 
 
6.4.9. Confirmation of genetic homogeneity of the Mercian strain across the Midlands 
by IS6110 RFLP 
Cluster investigations that involved retrospective typing of stored M. tuberculosis isolates 
originally identified between 1995 and 2003 (before the introduction of universal typing) 
resulted in the identification of an additional 51 isolates from six different locations as 
members of the 32333 2432515314 Mercian strain MIRU-VNTR profile. Upon further 
investigation by IS6110 RFLP, 50/51 (98%) of these strains were still indistinguishable ( 
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Figure 6.7) with a 7-band RFLP pattern. One isolate from Wolverhampton in 2003 possessed 
eight copies of IS6110 but was still considered as part of the same strain and the MIRU-
VNTR profile did not vary in this single isolate. A total of 58 isolates were retrospectively 
identified as the Mercian strain by MIRU-VNTR typing between 1995 and 2003 (Figure 6.3). 
When requested retrospective typing was undertaken prior to 2003, 31/290 (12%) of all 
strains genotyped by MIRU-VNTR were identified as the Mercian strain. 
 
 
 
Figure 6.7.  RFLP analysis of the Mercian strain across the Midlands.  
 
Each horizontal lane is an example individual M. tuberculosis strain from each location and 
year. The molecular sizes of the digested DNA fragments of MT14323 are shown in 
kilobases. The 8
th
 IS6110 fragment was identified in an isolate from Wolverhampton in 2003. 
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6.4.10. West Midlands regional epidemiological analysis 
Since the Mercian strain was restricted to the West Midlands and in particular 
Wolverhampton, regional and city-wide epidemiological analyses were carried out to 
understand the basic epidemiological associations and more in-depth social links within 
Wolverhampton. A total of 124/156 (79%) tuberculosis patients with the Mercian strain were 
successfully matched to notification data in the HPA Enhanced Tuberculosis Surveillance 
system. There were 2,190 tuberculosis patients with other strain types notified in the West 
Midlands between 2004 and 2008.  A univariate analysis identified that patients who were 
resident in the West Midlands West HPU areas and specifically resident in Wolverhampton, 
UK-born, black Caribbean or white ethnic group had a significantly higher risk of disease 
caused by the Mercian strain (Table 6.4 and Table 6.5). Significant negative associations were 
identified with age not greater than 65 years old, the Black African ethnic group or 
extrapulmonary disease. No significant associations with drug resistance were identified 
(p>0.05). The significant variables were then included in a multivariate logistic regression 
which identified that being UK-born (OR 9.03, 95% CI 4.56-17.87), Black Caribbean ethnic 
group (OR 5.68, 95% CI 2.96-10.91), >65 years old (OR 0.25, 95% CI 0.09-0.67), and 
resident in Wolverhampton (OR 9.29, 95% CI 5.69-15.19), were significantly associated with 
the Mercian strain. A significant negative association of the Mercian strain with patient age 
>65 years old was identified. Therefore, age <65 years old is positively associated with the 
Mercian strain. 
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Variable 
No. patients Unadjusted  Adjusted 
Mercian 
(n=124) 
WT 
(n=2,066) 
Odds Ratio 95% CI p  Odds Ratio 95% CI p 
Gender          
Male 77 1,118 1.38 0.95-2.01 0.09  1.03 0.65-1.62 0.91 
Female 47 944 1.00 1.00 Reference     
Age group          
0-14 4 45 1.27 0.45-3.59 0.69  0.35 0.07-1.63 0.18 
15-44 92 1310 1.00 1.00 Reference     
45-64 23 379 0.86 0.54-1.38 0.543  0.77 0.42-1.41 0.40 
>65 5 330 0.22 0.09-0.53 <0.01*  0.25 0.09-0.67 <0.01* 
HPU location in West Midlands          
East 47 1,126 1.00 1.00 Reference     
North 10 206 1.16 0.58-2.34 0.67     
West 67 727 2.21 1.50-3.24 <0.01*     
Local Authority          
Wolverhampton 51 169 7.83 5.30-11.58 <0.01*  9.29 5.69-15.19 <0.01* 
32 other Local Authorities 73 1,895 1.00 1.00 Reference     
Place of birth          
UK-born 100 546 18.03 10.22-31.81 <0.01*  9.03 4.56-17.87 <0.01* 
Non-UK-born 14 1,378 1.00 1.00 Reference     
Ethnic group          
Black Caribbean 32 70 14.84 8.55-25.77 <0.01*  5.68 2.96-10.91 <0.01* 
Black African 1 362 0.09 0.01-0.68 0.02  0.19 0.02-1.51 0.12 
Indian Subcontinent 33 1,102 1.00 1.00 Reference     
Other 6 105 1.57 0.60-4.10 0.36  1.11 0.37-3.37 0.85 
White 49 366 4.47 2.79-7.15 <0.01*  1.75 0.95-3.22 0.07 
 
Table 6.4.  Statistical analysis of sociodemographic data for patients infected with the Mercian strain. 
The wild-type (WT) control group consisted of tuberculosis patients infected with M. tuberculosis strains other than the Mercian strain (n = 
2,066) in the West Midlands between 2004 and 2008. *P-values were considered as statistically significant if <0.05. Significant unadjusted 
values were included in the multivariate model. 
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Variable 
No. patients Unadjusted  Adjusted 
Mercian 
(n=124) 
WT 
(n=2,190) 
Odds Ratio 95% CI P  Odds Ratio 95% CI p 
Site of disease          
Pulmonary sputum smear positive 59 655 1.00 1.00 Reference     
Pulmonary sputum smear other 47 711 0.73 0.49-1.09 0.13  1.06 0.64-1.74 0.83 
Extra pulmonary 18 685 0.29 0.17-0.50 <0.01*  0.62 0.33-1.18 0.15 
Clinical history of TB          
Previous diagnosis of TB 10 85 0.60 0.30-1.20 0.15     
No previous diagnosis of TB 82 1,164 1.00 1.00 Reference     
Treatment          
Patient admitted as in-patient  25 329 1.04 0.64-1.65 0.89     
Patient admitted as out-patient 58 737 1.00 1.00 Reference     
Treatment outcome at 12 months          
Treatment completed 71 1,157 1.00 1.00 Reference     
Died 3 108 0.45 0.14-1.46 0.19     
Lost to follow up 4 72 0.91 0.32-2.55 0.85     
Still on treatment 2 32 1.02 0.24-4.34 0.98     
Treatment stopped 1 6 2.72 0.32-22.87 0.36     
Transferred out 0 18 - - -     
Not completed unknown 2 21 1.55 0.36-6.75 0.56     
Unknown 2 13 2.51 0.56-11.32 0.23     
Treatment outcome at 12 months          
Successful 73 1,189 0.89 0.47-1.66 0.71     
Not successful 12 220 1.00 1.00 Reference     
Drug Sensitivity Testing          
Resistance to any 1
st
 line drug 5 93 0.89 0.35-2.22 0.79     
No resistance to any 1
st
 line drug 119 1,959 1.00 1.00 Reference     
MDR 1 15 1.10 0.14-8.43 0.92     
Not MDR 123 2,037 1.00 1.00 Reference     
 
Table 6.5.  Statistical analysis of clinical and bacteriological data for patients infected with the Mercian strain across the West 
Midlands. 
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6.4.11. Epidemiological investigation in the city with the highest proportion of the 
Mercian strain  
The Mercian strain in Wolverhampton was significantly associated with white UK-born 
patients who presented with cavitations on chest X-ray and produced smear positive 
specimens (Table 6.6 and Table 6.7). Patients with the Mercian strain continued to experience 
weight loss at eight weeks after being started on anti-tubercular chemotherapy (p<0.05). 
However, there was no significant difference between treatment completion rates after 12 
months. 
 
Examination of the epidemiological factors revealed that cases with the Mercian strain were 
more likely to have a previous history of TB (9/35, 26%), and would have had significant 
previous contact with a case of TB (24/35, 69%), and in particular patients with the Mercian 
strain (13/35, 37%). Significant social factors detected were evidence of excess alcohol intake 
(OR 8.78, 95%CI 2.42-41.01, p<0.01) and cannabis use (OR 10.02, 95%CI 1.96-100.33, 
p<0.01). 
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Variable 
Mercian 
(n=35) 
WT 
(n=47) 
Unadjusted  Adjusted 
Odds Ratio 95% CI p  Odds Ratio 95% CI p 
Patient gender          
Female 18 20 1.42 0.54-3.77 0.43     
Male 17 27 1.00 1.00 Reference     
Age group          
0-14 1 1 1.15 0.01-92.99 1.00     
15-44 27 31 1.00 1.00 Reference     
45-64 4 10 0.46 0.10-1.85 0.22     
>65 3 5 0.69 0.10-3.95 0.72     
Ethnic group          
Indian Subcontinent 11 23 1.00 1.00 Reference     
Black African 0 6 - - -     
Black Caribbean 9 6 3.06 0.75-13.46 0.07     
Other 1 5 0.44 0.01-4.71 0.65     
White 14 7 4.06 1.15-15.77 0.01*     
Country of birth          
UK-born 32 12 29.42 7.32-177.18 <0.01*  9.68 2.00-46.78 <0.01* 
Non-UK-born 3 35 1.00 1.00 Reference     
Epidemiological History          
Previous contact  
with TB case 
24 11 6.94 2.42-21.50 <0.01* 
 3.40 0.92-12.59 0.07 
No previous contact  
with TB case 
11 36 1.00 1.00 Reference 
    
Previous contact  
with Mercian strain 
13 0 15.65 4.76-51.48 <0.01* 
    
No previous contact  
with Mercian strain 
13 46 1.00 1.00 Reference 
    
Previous history of TB 9 3 4.97 1.11-31.13 0.01*     
No previous history of 
TB 
26 44 1.00 1.00 Reference 
    
Clinical co-factors          
Malignancy 1 0 10.41 0.20-547.59 0.43*     
No evidence of 
malignancy 
34 47 1.00 1.00 Reference 
    
Diabetes 2 7 0.35 0.03-2.01 0.29     
No evidence of diabetes 33 40 1.00 1.00 Reference     
Social factors          
Excess alcohol use 16 4 8.78 2.42-41.01 <0.01*  6.26** 1.45-27.02 0.01 
No evidence of  
excess alcohol use 
19 43 1.00 1.00 Reference 
    
Cigarette smoking 6 3 2.99 0.58-19.96 0.12     
Non-smoker 29 44 1.00 1.00 Reference     
Cannabis use 11 2 10.02 1.96-100.33 <0.01*     
No evidence of  
cannabis use 
24 45 1.00 1.00 Reference 
    
Employed 14 24 1.00 1.00 Reference     
Unemployed 21 23 1.56 0.59-4.18 0.32     
 
Table 6.6.  Epidemiological associations of patients infected with the Mercian strain 
in Wolverhampton. 
 
P-values were considered as statistically significant if ≤0.05. **OR for excess alcohol use and 
cannabis use was combined. 
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Variable 
Mercian 
(n=35) 
WT 
(n=47) 
Unadjusted  Adjusted 
Odds Ratio 95% CI p  Odds Ratio 95% CI p 
Clinical presentation          
Cavitary disease 22 12 4.83 1.74-14.24 <0.01*  1.57 0.40-6.17 0.52 
Non-cavitary disease 13 35 1.00 1.00 Reference     
Pulmonary disease 31 34 2.93 0.79-13.64 0.07     
Non-pulmonary disease 4 13 1.00 1.00 Reference     
Sputum specimen 25 24 2.37 0.87-6.84 0.06     
No sputum specimen 10 23 1.00 1.00 Reference     
Positive microscopy 22 17 2.94 1.10-8.19 0.02*     
Negative microscopy 13 30 1.00 1.00 Reference     
Treatment          
Therapy adherence 28 44 1.00 1.00 Reference     
Therapy non-adherence 7 3 3.61 0.75-23.42 0.06     
No weight loss after  
initiation of treatment 
27 47 1.00 1.00 Reference     
Weight loss after  
initiation of treatment 
8 0 12.99 3.00-56.28 <0.01*     
Completed treatment  
within 12 months 
26 36 0.64 0.17-2.29 0.43     
Did not complete  
treatment within 12 months 
8 7 1.00 1.00 Reference     
Drug Sensitivity Testing          
Resistance to any 1st line 
drug 
0 1 - - -     
No resistance to any 1st line 
drug 
35 46 1.00 1.00 Reference     
MDR 0 0 - - -     
Not MDR 35 47 1.00 1.00 Reference     
 
Table 6.7.  Clinical and bacteriological associations of patients infected with the 
Mercian strain in Wolverhampton. 
 
P-values were considered as statistically significant if ≤0.05. 
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6.4.12. Additional genotyping by spoligotyping and MIRU-VNTR using the 
internationally optimised set of 24 loci 
A selection of 201 strains identified as the Mercian strain between 1996 and 2008 were 
analysed by spoligotyping and nine additional MIRU-VNTR loci to complete the recently 
described optimal set of 24 loci. This was to identify which global lineage the Mercian strain 
is a member of and to confirm or refute presence of a clone by the current internationally 
recommended set of MIRU-VNTR loci. When compared to the international spoligotyping 
database (SpoldDB4), the predominant spoligotype clade for the Mercian strain (189/201, 
94%) was identified as ST490 (octal code 767776777760771). This shared typed is a member 
of clade X1. There are 13 strains with this spoligotype in the SpolDB4 database, of which 
nine originate from our initial studies and two originate from New York with one strain each 
from London and Washington (date accessed 5th December 2010). Of the 201 strains 
analysed by the complete 24 loci set, 170 (85%) were still indistinguishable (extra nine loci 
profile 434443183). The other 31 isolates contained two single locus variants (23 and five 
isolates), two unique isolates and a double locus variant. The first variant profile was 
identified in a strain originating from 2000 with subsequent variants identified in 2002, 2005, 
and 2006 (Gibson et al., 2010). 
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6.5. DISCUSSION 
This chapter describes the identification of the most prevalent M. tuberculosis strain in the 
West Midlands, which we have termed the Mercian strain. Concordant MIRU-VNTR and 
RFLP data from six different geographical locations across the West Midlands indicated that 
this strain has continued to expand in three major cities. Regional, national, and global 
databases provided evidence that this strain was restricted to the West Midlands region in 
England. Regional epidemiological data showed that this strain primarily infected UK-born, 
Black Caribbean patients less than 65 years old. 
 
6.5.1. Significant epidemiological associations have been identified but the reasons for 
regional transmission are still to be determined 
The regional and Wolverhampton epidemiological investigations presented in this report 
identified significant associations for the Mercian strain. However, they do not provide a full 
explanation as to why the Mercian strain is more prevalent when compared to other strains in 
the West Midlands. Drug and alcohol use were identified as significant social factors in 
Wolverhampton. These two risk factors have been identified as significant associations in 
previously reported tuberculosis outbreaks particularly in low-incidence countries (Jackson et 
al., 2009;Fok et al., 2008;Oeltmann et al., 2006;Perlman et al., 1997). The cumulative 
number of cases and continuing presence of the Mercian strain does not follow a typical 
point-source outbreak pattern. The significant association with younger age suggests that 
cases caused by the Mercian strain have arisen as a result of recent transmission and not re-
activation in older patients. A possible transmission scenario is that after the initial emergence 
of the Mercian strain there have been several independent clusters of transmission each with 
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their own common social link. This has resulted in a large, complex transmission network that 
is still expanding and is yet to be fully elucidated. 
 
6.5.2. The Mercian strain has been present in the Midlands since at least 1995 
Retrospective epidemiological studies have identified the earliest isolate of the Mercian strain 
from 1995 in an archive strain collection. This isolate was part of a cluster of 11 isoniazid 
resistant strains identified between 1995 and 2000 which was reported previously before the 
full regional extent of the Mercian strain was known (Chapter 3) (Hawkey et al., 2003). We 
have typed very few archived M. tuberculosis strains from 1995 so the full extent of drug 
sensitive and drug resistant Mercian strains 15 years ago has not been assessed. The cluster of 
isoniazid resistant Mercian strains was present in one specific location. Between 1995 and 
2000, there was no other investigated instance of increased isoniazid resistance in the rest of 
the West Midlands. 
 
It is likely that the Mercian strain first emerged in the West Midlands well before 2004 and 
perhaps even before 1995. The Mercian strain has been present since prospective DNA 
fingerprinting commenced in 2004 with a median of 30 isolates per year (range 27-37), and 
has represented a consistent proportion of all strains (Figure 6.1),  
 
6.5.3. Wolverhampton is a geographical focus for the Mercian strain 
The distribution of M. tuberculosis strains in Wolverhampton was significantly altered by the 
Mercian strain.  Compared to all other regions, Wolverhampton had a reduced level of strain 
diversity and an increased rate of clustering. The calculation of clustering rates using the 
“classical” 15 locus MIRU-VNTR should be analysed with caution as has been discussed 
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previously in this thesis (Chapter 5, Section 5.5.13). The Wolverhampton epidemiological 
investigation applied a detailed questionnaire that was only used in this location. Patients with 
the Mercian strain in Birmingham and Coventry might differ in their use of drugs and alcohol. 
The results from the Wolverhampton and region-wide analysis do not concord exactly as 
different ethnic population groups were identified as at highest risk: the White population in 
Wolverhampton but the Black Caribbean group across the West Midlands. 
 
6.5.4. The origin of the Mercian strain 
There are three possible scenarios for the emergence of the Mercian strain in the West 
Midlands. The first scenario is that it is an endemic strain that has been present in the West 
Midlands for decades perhaps even centuries. The other two scenarios are based on the 
epidemiological association with Black Caribbean patients. The second scenario is that the 
strain has been recently imported from the Caribbean to the West Midlands by human 
migration in the 20
th
 century. A further extension of the second scenario is that the Mercian 
strain spread from the UK to the Caribbean centuries ago and then back to the UK again more 
recently. The clonality of the Mercian strain even after 24 loci and IS6110 RFLP analysis 
suggests that there was a single original common source for this strain. 
 
The Mercian strain is significantly associated with UK-born Black Caribbean patients. The 
fact that the Mercian strain is associated with UK-born patients may provide some evidence 
for the timeline of emergence of this strain. The Mercian strain is not associated with Black 
Caribbean patients not born in the UK which could represent either recent transmission into 
UK-born patients or transmission between Caribbean-born and UK-born descendents in the 
early part of the 20
th
 Century. 
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Across the UK, there are other areas that have a high proportion of people who originate from 
the Caribbean. This population groups accounts for more than ten per cent of the total 
population in the London boroughs of Lewisham, Lambeth, Brent and Hackney (Office for 
National Statistics, 2003). Yet, only three M. tuberculosis isolates typed in London had the 
same indistinguishable MIRU-VNTR profile as the Mercian strain. In England in 2009, only 
160/8,064 (2%) of all TB cases were patients identified as Black Caribbean. The relative 
paucity of the Mercian strain in other areas of the UK indicates that the Mercian has expanded 
by successful recent transmission in the Midlands and not by importation from a common 
country outside of the UK. 
 
6.5.5. Identification of Clade X and location in the global phylogeny of M. tuberculosis 
The Mercian strain is a member of the Clade X global spoligotype family. A characteristic 
spoligotype signature for Clade X was first identified by data mining of the third international 
spoligotyping database (SpolDB3) that contained 13,008 strains from >90 countries (Sebban 
et al., 2002). Clade X was identified as a family of strains that do not have spacer 18 or 
spacers 33-36. Three subtypes have been identified: X1 (spacer 18 and spacers 33-36 absent); 
X2 (as X1 plus spacers 39-42 deleted as well); and X3 (as X1 with spacers 4-12 deleted) 
(Filliol et al., 2002). IS6110 typing has shown that clade X strains are usually considered as 
strains containing low-copy numbers of IS6110 (Warren et al., 2004;Soini et al., 2000). 
 
The global distribution of Clade X has been associated with English-speaking countries and 
countries with a past history of colonization by Anglo-Saxon populations (Sebban et al., 
2002;Soini et al., 2000). Clade X is most prevalent in North America (14% of all strains) 
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(Filliol et al., 2002), South Africa (19%) (Stavrum et al., 2009a), Southwest Ireland (26.2%) 
(Ojo et al., 2010), and London (9% of UK-born patients) (Brown et al., 2010).  
 
The distribution of spoligotypes on Caribbean islands have been intensively studied and it was 
revealed that clade X is present on both French- and English-speaking islands including 
Guadeloupe (9.3%), Martinique (3.4%) and continental French Guiana (7.6%) (Brudey et al., 
2006;Duchene et al., 2004). Trinidad & Tobago is the only English-speaking Caribbean island 
investigated so far. A novel spoligotype was identified that is a member of Clade X and 
accounted for 56% of all strains (Baboolal et al., 2009;Millet et al., 2009).  
 
Clade X has been rarely detected in Southern (Italy) and Eastern Europe (Poland) (Lari et al., 
2007;Jagielski et al., 2010); Saudi Arabia and Turkey in Western Asia (Al-Hajoj et al., 
2007;Otlu et al., 2009); India in Southern Asia (Gutierrez et al., 2006;Kulkarni et al., 
2005;Singh et al., 2004;Singh et al., 2007); China in Eastern Asia (Dong et al., 2010); 
Honduras and Paraguay in Central and South America (Candia et al., 2007;Rosales et al., 
2010); Gambia in Western Africa (de Jong et al., 2009); and Malawi(Glynn et al., 2010), 
Mozambique (Viegas et al., 2010), and Zambia in Eastern Africa (Mulenga et al., 2010) with 
proportions ranging from 0.9-6.0%. 
 
Clade X strains have been analysed by various phylogenetic techniques to locate their position 
in the global evolution of M. tuberculosis. Essentially, clade X is a modern clade of M. 
tuberculosis that is closely related to other modern strains such as Haarlem, LAM, and T but 
is a distinct spoligotype. Clade X is a member of: the Euro-American lineage based on LSPs 
(Gagneux et al., 2006); PGG 2/3 (Sreevatsan et al., 1997); Lineage 4 (Gagneux and Small, 
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2007); Lineage II (Baker et al., 2004); SNP clusters III-VII (Gutacker et al., 2006); and SNP 
group 3b-6b (Filliol et al., 2006). The link between Anglo-Saxon history and the Caribbean 
fits in with a recent hypothesis that ancestral M. tuberculosis complex strains spread by land 
and modern strains spread by sea travel (Hershberg et al., 2008). 
 
6.5.6. Utility of universal prospective DNA fingerprinting 
Detection of the Mercian strain was only possible with the commencement of universal 
prospective MIRU-VNTR typing of all M. tuberculosis isolates in the West and East 
Midlands. Only with universal prospective DNA fingerprinting was the full extent of the 
Mercian strain in the West Midlands fully characterized. It would only have been possible to 
detect the Mercian strain by obtaining the genotype as it is not a drug-resistant strain and there 
are no other phenotypic properties that could have easily differentiated it from other M. 
tuberculosis complex strains, The patient population that the Mercian strain has been 
identified in is different to the UK-wide situation for TB as the majority of patients diagnosed 
each year in the UK are not born in the UK and originate from the ISC (Health Protection 
Agency, 2010). 
 
The 156 individual patients detected between 2004 and 2008, make the Mercian strain one of 
the largest known community-based clusters in the world. Previous major prevalent strains 
have been identified in New York (Alland et al., 1994;Moss et al., 1997), Rotterdam (de 
Vries et al., 2007), North London (Ruddy et al., 2004), and Rio de Janeiro (Lazzarini et al., 
2007). 
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6.5.7. Comparison to other reported prevalent strains in the UK 
The most prevalent strain detected in the UK was an isoniazid resistant strain in North 
London that was previously reported in 70 patients (Ruddy et al., 2004), with a current total 
of over 300 cases caused by this strain (Ibrahim Abubakar, Consultant Epidemiologist & TB 
Section Head, Respiratory Diseases Department - Tuberculosis Section, HPA, personal 
communication). The 24 locus MIRU-VNTR profile of this strain is 42433 2431515321 
226423-52. Isoniazid resistance acted as a very useful marker for detection of the strain. It 
was noted by the outbreak investigators that without the drug resistance marker only 
prospective typing of all isolates would have detected this large, complex outbreak. The North 
London strain was predominantly found in young White or Black Caribbean UK-born adults 
with drug misuse a common epidemiological factor (Ruddy et al., 2004). It is possible that 
patients in this population group take longer to present clinically as TB may not be suspected 
when initial symptoms develop or they might not seek medical help soon after onset. Both 
factors aid strain transmission and disease progression. 
 
6.5.8. Future investigations 
Both epidemiological investigations presented in this report were retrospective and did not 
involve direct patient interviews. The Mercian strain continues to be identified in the West 
Midlands. Enhanced epidemiological knowledge could be obtained by prospectively 
investigating social links as each new patient is diagnosed. Investigation of potential factors 
which may cause a delay in diagnosis should be investigated as well. The data presented 
identified the infected patient population and also important common social factors. The exact 
interaction of patient population and social factors should be investigated further to identify 
and fully understand any confounding factors.  
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6.5.9. Potential impact of mycobacterial genomic variation on strain transmission 
A strain was identified in 93/314 (30%) patients in Rio de Janeiro that uniquely lacked a 
major region of genomic DNA (>26.3 kb). This region contained 10 genes including two 
potentially immunogenic PPE (proline-proline-glutamic acid) genes (Gibson et al., 
2008;Lazzarini et al., 2007). This strain (RDRio) was associated with a higher frequency of 
cavitary pulmonary disease (Lazzarini et al., 2008). The major deletion identified in the 
RDRio strain has been hypothesized as having a major impact on the virulence properties of 
the RDRio strain. As the genomic content of the Mercian strain has not been characterized, 
further work should determine whether such a deletion or other similar major genomic 
variation has altered the virulence of this strain leading to multiple transmission events in and 
between three cities in the West Midlands. 
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6.6. CONCLUSIONS 
This chapter describes the identification of the most prevalent M. tuberculosis strain in the 
West Midlands region of the UK, with 156 isolates in a five year period between 2004 and 
2008. The Mercian strain has been significantly associated with UK-born patients, appears to 
be geographically restricted to the West Midlands region in the UK with evidence of ongoing 
transmission and specific risk factors for acquisition that require further investigation. 
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7. WHOLE GENOME ANALYSIS SHOWS A 
COMMON EVOLUTIONARY ORIGIN FOR THE 
DOMINANT STRAINS OF M. TUBERCULOSIS IN A UK 
SOUTH ASIAN COMMUNITY. 
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7.1. INTRODUCTION 
7.1.1. TB in the ISC and UK 
One third of the world‟s population is infected by M. tuberculosis. The bacillus causes 1.6 
million deaths each year and more than eight million new cases annually. India has the 
highest burden of TB of any single country in the world with two million new cases in 2009 
with 420,000 new cases in Pakistan and 360,000 in Bangladesh. These three countries in the 
ISC account for 30% of the global burden of all new TB cases with India alone accounting for 
21% (World Health Organisation, 2010b). Within the UK in 2009, the majority of TB patients 
with a known country of birth were not born in the UK (5,793/8,234, 70%). The most 
frequent country of birth in non-UK-born patients was India (1,615/5,793, 28%). Pakistan 
(982/5,793, 17%) and Bangladesh (247/5,793, 4%) were the second and fourth most frequent 
respectively. Collectively, patients born in these three countries accounted for 49% 
(2,844/5,793) of all TB cases in non-UK-born patients (Health Protection Agency, 2010).  
 
7.1.2. The Central Asian Strain 
This strain was initially described as a spoligotype in a UK study in 1997 (Goyal et al., 1997) 
and the association with patients that originate from the ISC was first identified in a cohort of 
patients from South Asia (SA) who were resident in Leeds and Bradford where this clade was 
identified as the most prevalent strain. In all patients in Leeds and Bradford, 23% were 
infected with this clade and all patients infected with this clade originated from the ISC 
(Gascoyne-Binzi et al., 2002). 
 
The identification and definition of a distinctive spoligotype present in Southern Asia was 
concomitantly and independently recognised by two groups in 2002 (Bhanu et al., 2002; 
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Filliol et al., 2002). A study in Delhi that analysed 83 isolates by IS6110 RFLP and 
spoligotyping identified that 60/ 83 (75%) isolates were at least 61% similar on IS6110 RFLP 
typing with two common IS6110-containing PvuII RFLP fragments present at 10.1 and 12.1 
kb, and a distinctive set of spacer sequence patterns. These strains were named the Delhi type 
(Bhanu et al., 2002). This strain was defined as a distinctive spoligotype clade by the absence 
of spacers 4-7 and 23-34 and was named CAS (Filliol et al., 2002). Within the CAS clade, 
there are several global variants including CAS1-Delhi, CAS-Kili identified in Tanzania that 
has additional spacers absent between positions 8-22 (Kibiki et al., 2007;McHugh et al., 
2005); CAS1-DAR in Dar es Salaam (Eldholm et al., 2006); and a separate variant in Sudan 
(Sharaf-Eldin et al., 2002). The initial spoligotype identified as the Delhi type is specifically 
spoligotype Shared Type (ST) 26. CAS encompasses ST26 and other shared spoligotypes, 
including further variants such as CAS2 (additional absent spacers 4-10 and 23-34) (Bhanu et 
al., 2002;Filliol et al., 2002). Subsequent analysis of  M. tuberculosis strains by genomic 
frameworks based on SNP and LSPs have identified CAS as a major phylogenetic clade and 
have assigned it to various global lineages including the East-African-Indian lineage (Table 
7.1) (Gagneux and Small, 2007). 
 
By MIRU-VNTR typing, the CAS spoligotype has characteristic alleles at the five ETR loci 
(A-E) of 42234 or 42235 with some strains possessing a non-amplifiable ETR-A locus 
(Brown et al., 2010;Brudey et al., 2004;Cheah et al., 2010;Freidlin et al., 2009;Gutierrez et 
al., 2006;Gutierrez et al., 2006). 
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Scheme Experimental Data Lineage Reference 
 
TbD1 
 
TbD1 deleted 
 
Modern 
 
Brosch et al. 2002 
 
LSP RD750 East African-Indian 
 
Gagneux et al. 2006 
SNP katG463 CTG (Leu) 
gyrA95 ACC (Thr) 
 
PGG 1 Sreevatsan et al. 1997 
SNP rpoB 2646 G 
ahpC-46 A 
 
Lineage III Baker et al. 2004 
SNP See reference 
 
Cluster II.A Gutacker et al. 2006 
SNP See reference 
 
Cluster group 3a Filliol et al. 2006 
Spoligotyping Spacers absent between 4-7 and 23-34. 
 
CAS Brudey et al. 2006 
ETRs -2234, -2235, 42234, 42235 South Asian strain Gascoyne-Binzi et al. 2002 
Cheah et al. 2010 
 
MIRU-VNTR ETR-C: 2 
MIRU-23: 5 
 
Lineage III/CAS Gibson et al. 2005 
MIRU-VNTR See reference 
 
CAS Brown et al. 2010 
IS6110 RFLP Two common bands at 10.1 and 12.1 kb. 
 
One of most variable IS6110 groups. 
 
 Bhanu et al. 2002 
 
 
Gutacker et al. 2006 
 
Table 7.1.  Molecular markers for the predominant M. tuberculosis clade present in 
Southern Asia.  
 
Table adapted from Gagneux et al. 2007. 
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7.1.3. Global geographic distribution of CAS 
The CAS spoligotype clade is predominantly associated with South Asia and to a lesser 
extent, the Middle-East. The fourth version of the international spoligotype database 
(SpolDB4) identified that 21.2% of all strains in South-Asia were CAS (Brudey et al., 2006). 
One of the initial studies of strain distribution in Delhi identified that 75% of all strains were 
members of the CAS or Delhi-type clade (Bhanu et al., 2002).  
 
Intensive successive studies of M. tuberculosis strains in India have repeatedly identified CAS 
as the most prevalent clade in many cities and states with particular focus on New Delhi 
(Singh et al., 2004;Stavrum et al., 2009b) and Mumbai (Kulkarni et al., 2005;Almeida et al., 
2005). There is a geographical gradient of strain distribution between North and South India. 
CAS is more predominant in the North of India with the ancestral EAI strain more common in 
the South (Gutierrez et al., 2006;Singh et al., 2007). There are instances of other clades 
present in India as there is a prevalent MDR Beijing strain in Mumbai (Almeida et al., 2005). 
A third distinct clade, Manu, was identified as the most prevalent clade in Western India 
(Chatterjee et al., 2010). In the rest of the ISC, CAS has also been identified as the most 
prevalent clade in Karachi, Pakistan (Hasan et al., 2006;Tanveer et al., 2008) but not in 
Bangladesh where Beijing and EAI predominate (Banu et al., 2004;Rahim et al., 2007). CAS 
has been frequently identified in immigrants originating from South Asia in other regions of 
the world (Sola et al., 2001). CAS makes up approximately half of the M. tuberculosis 
isolates circulating in Leicester (Cheah et al., 2010). In 2001, there was a large outbreak 
among people of South Asian origin in a school in Leicester with 70 cases of active 
tuberculosis and 254 cases of latent infection in a total population of 1,208 pupils (Rajakumar 
et al., 2004).  In a recent study of 2,261 isolates in London, CAS was the single most 
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prevalent clade overall (552/2,261, 24%) and in patients originating from the ISC (203/463, 
44%) (Brown et al., 2010). 
 
7.1.4. The post-genomic era in M. tuberculosis 
From the determination of the complete genome sequence of M. tuberculosis H37Rv in 1998, 
a new era of comparative genomics was heralded. M. tuberculosis H37Rv contains 
approximately 4,000 ORFs (Cole et al., 1998). However, the molecular basis of 
pathogenicity, virulence and transmissibility in M. tuberculosis is still not well understood as 
the function of only one-third these 4,000 predicted ORFs can be can be accurately predicted. 
Of the other ORFs, the function of another third can be predicted with some confidence; with 
little or nothing known about the function of the remaining third. Further determination of 
significant deleted regions in the genome of M. tuberculosis by DNA microarrays and whole-
genome sequencing will help to reveal the basis for transmission and pathogenicity especially 
with regards to the interaction between host and pathogen (Barry, III et al., 2000;Cole et al., 
1998).  
 
7.1.5. PPE genes 
One of the major gene families identified in M. tuberculosis are the PE and PPE gene glycine-
rich families which make up 10% of the coding capacity of the genome. There are multiple 
copies of repetitive sequences (PGRS and MPTRs) in each family. The PE family contains 
Pro-Glu (PE) motifs and the PPE family contains Pro-Pro-Glu (PPE) motifs, both usually 
found near the N terminus (Cole et al., 1998). It is hypothesised that both PE and PPE genes 
are involved in antigenic variation. One member (Rv1759) is a fibronectin-binding protein 
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that elicits a variable antibody response (Abou-Zeid et al., 1991) and it these genes are likely 
associated with the mycobacterial cell wall (Sampson et al., 2001). 
 
7.1.6. DNA microarrays: the technique 
For DNA microarray analysis, oligonucleotides are designed to amplify each of the predicted 
ORFs in the reference sequenced genome. Each amplicon is then spotted onto a glass slide. 
Extracted DNA from the strain of interest and reference strain is extracted and fluorescently 
labelled with two different dyes. The labelled DNA from both strains is then hybridised to the 
microarray and scanned by laser excitation. The data obtained for each dye is then combined 
to identify regions that are present or absent in the strain of interest (Figure 7.1). “Deleted” 
regions are confirmed by PCR and DNA sequencing to determine the extent of the deleted 
region (Pym and Brosch, 2000). There are various types of DNA microarrays including: 
printed; in situ-synthesized oligonucleotide; high-density bead; electronic; and suspension 
bead arrays (Miller and Tang, 2009). The study described in this chapter used a printed 
microarray produced by The Bacterial Microarray Group at St George's Hospital (BµG@S), 
University of London. 
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Figure 7.1.  Specimen preparation and printed microarray analysis.  
 
PCR amplicons are generated for each identified ORF in a genome and spotted onto a glass 
slide. DNA from the strain of interest and a suitable control strain are extracted, labelled and 
hybridised to the spotted microarray in a competitive hybridization. The presence or absence 
of ORF regions is then identified by a laser scanner, images combined and a list of deleted 
regions identified. Figure adapted from Miller and Tang, 2009. 
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7.1.7. Delineation of evolution in the M. tuberculosis complex using DNA microarray 
technology 
Comparison of the M. tuberculosis H37Rv and M. bovis BCG vaccine strain genomes 
identified 14 sequences present in M. tuberculosis H37Rv but absent in M. bovis BCG. These 
were called regions of difference (RD1-14) and demonstrated the genomic changes involved 
in the production of the BCG vaccine strain (Gordon et al., 1999). Similarly, six regions were 
identified, that were absent from the M. tuberculosis H37Rv genome relative to other 
members of the M. tuberculosis complex: H37Rv relative deletions (RvD1-5) and M. 
tuberculosis specific deletion 1 (TbD1) which divided global clades into “ancestral” and 
“modern” lineages. These deletions provided evidence that M. africanum, M. microti, and M. 
bovis diverged from the progenitor of M. tuberculosis before a deletion in TbD1 occurred 
which altered the previous hypothesis that M. tuberculosis had evolved from M. bovis.  
(Gordon et al., 1999;Brosch et al., 2002). A global collection of BCG vaccine strains were 
also analysed by DNA microarrays which demonstrated the evolution of BCG strains since 
the original passaged strain (Behr et al., 1999). This study of BCG strains in comparison to 
H37Rv identified 14 regions (RD1-14) absent in BCG Pasteur but present in H37Rv with two 
additional deletions (RD15 and 16) in specific BCG substrains (Behr et al., 1999). DNA-
DNA microarrays have also been used to map IS6110 insertion sites to specific regions or 
genes and the implications for strain virulence examined (Kivi et al., 2002). Evolutionary 
studies have been undertaken to characterize genomic deletions and determine the probable 
evolution in a large number of different clinical isolates of M. tuberculosis. This found that 
deletions in clinical strains are not randomly distributed and tend to be aggregated in related 
lineages but that there were also deletions found in unrelated strains in regions apparently 
vulnerable to disruption (Tsolaki et al., 2004).  
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A comparative study of 100 M. tuberculosis strains revealed that a patient‟s region of origin is 
predictive of the strain that the patient is infected with even when transmission has occurred 
in a geographic location outside the region of the patient‟s origin. Two lineages that 
originated from South-East Asia diverged centuries ago and have remained distinct lineages 
which suggests that the associations between host and pathogen are highly stable (Hirsh et al., 
2004). 
 
DNA-DNA microarrays have been used to assess the varying spectrum of virulence in a 
virulent strain (H37Rv) and a member of the M. tuberculosis complex that is less virulent in 
humans (M. microti). Heterogeneous deletions were identified which make it difficult to 
assign virulence properties to any specific pattern of deletion. Perhaps the most significant 
factors being that ESAT-6 antigens and PE/PPE proteins are frequently deleted in M. microti 
(Garcia-Pelayo et al., 2004;Frota et al., 2004) . 
 
Some of the genomic deletions of strains of M. tuberculosis studied were identified as useful 
markers for defining the Beijing/W family of strains (Tsolaki et al., 2005) and six distinct 
global lineages of M. tuberculosis (Gagneux et al., 2006). Genomic deletions generally 
behave as being unique event polymorphisms that once generated are not regained. Therefore, 
genomic deletions can be used to construct robust, unambiguous phylogenies. 
 
7.1.8. Gene expression profiling microarrays 
In expression microarrays, two populations of cDNA derived from RNA extracted from two 
M. tuberculosis strains exposed to two contrasting environments are labelled with two 
different fluorochromes. The two cDNA populations are then compared by hybridisation. The 
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values for each of the two populations are then compared to calculate the relative degree of 
expression or repression for each ORF (Barry, III et al., 2000). 
 
Whole-genome microarrays were first used in M. tuberculosis for the definition of gene 
expression responses to isoniazid and ethambutol (Wilson et al., 1999).  Subsequent 
expression microarray studies have analysed the response of  M. tuberculosis to various 
environmental conditions and other antibiotics (Betts et al., 2003;Rengarajan et al., 
2005;Voskuil et al., 2003); and survival within the host (Sassetti et al., 2003). Differences in 
human gene expression between infection and active disease have also been identified. Genes 
expressed by monocytes involved in antimicrobial defence, inflammation, chemotaxis, and 
intracellular trafficking were significantly over-expressed with a minimal set of genes that 
included lactoferrin, CD64, and a GTPase were sufficient to distinguish between tuberculosis 
patients, M. tuberculosis-infected health donors and non-infected healthy donors. (Jacobsen et 
al., 2007). 
 
The first large-scale description of the human transcriptional signature of TB infection 
discovered a 393-gene transcript expression signature. This was dominated by IFN-induced 
genes that are specific to individuals with active TB disease when compared to other bacterial 
or inflammatory diseases and correlated with radiographic findings. This signature may also 
be able to identify latently infected individuals who will develop active TB, as 10-25% of 
latently infected patients had similar transcriptional profiles to those with active disease. The 
transcriptional signature decreased after two months of treatment of active disease and 
reverted to being indistinguishable from health controls after completion of treatment. 
Therefore, the transcriptional signature could be used to monitor patient response to infection 
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and treatment. The largest collection of expressed transcripts in active tuberculosis were those 
induced by type I IFNs or IFN-y which were produced by neutrophils and monocytes (Berry 
et al., 2010). 
 
7.1.9. Microbial diagnostic microarrays 
Microarrays have been developed to identify a broad range of pathogenic bacteria including 
M. tuberculosis using gyrB and speciation across the genus (Kostic et al., 2007;Park et al., 
2005). Microarrays have been developed to identify mutations that confer drug resistance to 
rifampicin, isoniazid, and pyrazinamide (Wade et al., 2004;Park et al., 2006).  Five genomic 
deletions were identified by DNA-DNA microarray analysis in the specific strain of CAS that 
caused a large outbreak in Leicester in 2001. These five deletions were restricted to the 
outbreak strain. All strains within Leicester were analysed for the presence of these five 
deletions on a local level to identify outbreak strains using a Genome Level-Informed PCR 
(Rajakumar et al., 2004). A similar approach was applied to the investigation of a TB 
outbreak in Seattle (Freeman et al., 2005). A high-throughput membrane-based hybridisation 
method (deligotyping) that uses a similar principle to spoligotyping has been developed to 
analyse LSPs (Goguet de la Salmoniere YO et al., 2004). Comparative genomic hybridisation 
has also been used to examine a prevalent strain family in Quebec. Two example clinical 
isolates were analysed by microarray and identified deletions were confirmed in 302 clinical 
strains which identified a 11.4 kb “DS6Quebec” deleted region in 143 strains. (Nguyen et al., 
2004).  
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7.2. HYPOTHESIS & AIMS 
In comparison to the Beijing strain (Parwati et al., 2010), little is known about the selective 
advantages that CAS possesses which has enabled it to become the most predominant clade in 
the ISC. Also, global strains exhibit a stable association with the global continental origin of 
the host (Gagneux et al., 2006). Recent studies in San Francisco suggested that patients tend 
to become infected with strains of M. tuberculosis that have similar origin to those associated 
with their region of birth (Hirsh et al., 2004). 
 
The study of genetic variability within natural populations of pathogens can provide insight 
into their evolution and pathogenesis with comparative genomics a powerful tool providing 
important data that can be used to control transmission, and complements the more extensive 
studies of variation using other sequences such as IS6110 (van Soolingen et al., 
1994;Shamputa et al., 2004). 
 
Therefore, it was hypothesized that microbial determinants are likely to play an important role 
in the specificity of strains with certain patient populations. To further understand the host-
pathogen interaction between host and strains originating from the ISC a whole genome 
analysis of strains originating from the ISC was carried out. Analysis of the whole genome 
content of this strain will provide further insights into the evolution and biological properties 
of this strain. 
 
The aim of this chapter was to obtain a further understanding of the diversity, origin, and 
biological properties of the CAS strain from patients originating from the ISC in the UK, by 
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analysing a selection of 10 M. tuberculosis strains by whole-genome DNA-DNA microarray 
analysis. 
 
This particular group of strains were not related epidemiologically to those in the outbreak in 
Leicester despite most of the strains having an indistinguishable VNTR profile 42235 
(Rajakumar et al., 2004). 
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7.3. METHODS 
7.3.1. Selected strains 
Strains were selected on the basis on the five locus ETR profile (Section 2.6.1). Clinical 
strains 8088, 9375, 9866, and isolate 6947 were isolated from patients who originated from 
South Asia and are now resident in Leeds and Bradford. The other clinical strains (0135, 
2566, and 3242) from South Asian patients and two other strains (1339 and 7009) were from 
Birmingham. The VNTR profiles of these clinical strains are shown in Table 7.2. To validate 
the comparison of strains causing disease in a mixed population, additional clinical strains 
representing VNTR profiles that have been associated with patients from different ethnic 
origins were also studied. This included VNTR profile 32433 (strain 6947 from a South Asian 
patient) and VNTR profile 32333. These two VNTR profiles represent strains that are not 
members of the CAS spoligotype clade. Profile 32333 is strongly associated with the 
European Haarlem spoligotype clade (Sola et al., 2005). The South Indian (SI) clinical isolate 
(TMC120) ATCC 35811 was also included in this study with M. tuberculosis H37Rv used as 
the reference strain.  
 
Strain designation ETR Global origin of patient Originating laboratory 
 
8088 
 
42235 
 
South Asia 
 
Leeds, Yorkshire 
0135 42235 South Asia Birmingham, West Midlands 
2566 42235 South Asia Birmingham, West Midlands 
3242 42235 South Asia Birmingham, West Midlands 
9375 02235 South Asia Leeds, Yorkshire 
9866 42234 South Asia Leeds, Yorkshire 
SI (TMC 120) - South India South India 
6947 32433 Europe Leeds, Yorkshire 
1339 32333 Europe Birmingham, West Midlands 
7009
 
 
32333 
 
Europe 
 
Birmingham, West Midlands 
 
Table 7.2.  Strain collection analysed by DNA microarray hybridisation. 
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7.3.2. DNA microarray analysis and confirmation of deleted regions 
Genomic DNA extraction and microarray hybridization procedures were performed as 
previously described (Stewart et al., 2002;Frota et al., 2004) (Section 2.10.1). Briefly, 2-3 mg 
of DNA was labelled by incorporation of Cy3 and Cy5 dCTP during DNA polymerisation 
(Section 2.10.2). DNA microarray hybridisation and detection was carried out as described in 
Section 2.10. 
 
Genes were only considered to be deleted when the p-value was <0.05. Deleted regions were 
compared to those published for the Beijing/W family (Tsolaki et al., 2005;Stavrum et al., 
2008), strain CH (the Leicester outbreak index isolate) (Rajakumar et al., 2004) and those 
reported by Tsolaki and colleagues (Tsolaki et al., 2004). The function of each deleted region 
was identified by comparison to the TubercuList Web Server 
(http://genolist.pasteur.fr/TubercuList/). Clustering of disrupted ORFs was analysed by 
importation of categorical data into BioNumerics (Applied Maths, St Martens-Latem, 
Belgium). 
 
7.3.3. Confirmation of deletions by PCR and sequencing 
PCR and DNA sequencing was used to confirm the relevant deletions (Section 2.10.7 and 
oligonucleotides listed in Table 7.3).  
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Gene or genomic region 
affected by deletion 
Primer Sequence (5’-3’) 
Rv1519 
 
CM1518F 
CM1520R 
CM1518Fb 
CM1520Rb 
 
 
TTCTCACCTGGTTGATCGTG 
GTCCAGTAATCGTCGCCTTC 
CGTTTTGAGGATCCCAGTGT 
GGAATGCCAAATACCGTGAG 
 
RD3 region
* 
 
RD3 intF
 
RD3 intR 
 
 
TTATCTTGGCGTTGACGATG 
CATATAAGGGTGCCCGCTAC 
 
plcD/cut1 and  
Rvd2 region 
 
CM1755exF 
CM1758R 
ORF3Rvd3F 
ORF1Rvd2R 
 
 
CAGTTCGCTGATGTGACGAT 
ATTGCCTCCGCTAGAACAGA 
GATTGCGTTTGTTTTGCTGA 
TGGTCGCAGTGTTTCCAATA  
 
Rv1917c 
 
CM1916F 
CM1917exR 
CM1917R 
CM1917F 
 
 
ATGACCCTGATCCACCTCTG 
TCGATTCCTAAAGCGGCTAA 
CCACCAGAGATCAACTC 
CGCCACTGTTGAAGAAG 
 
Rv3017c22c region 
 
CM3017exF 
CM3022exR 
CM3022R 
CM3019exF 
IS-R 
ISup 
ISdown 
ISdw 
 
 
TGGCTGTTCGTCAGTAGGTG 
GGAACCTTCACTCGTACACCA 
TTGCAGAGTGCGGTGGGGTTT 
CGCTAGCGGAATCAATGTG 
AGTTTGGTCATCAGCCGTTC 
TACCTCCTCGATGAACCACC 
CTCTACCAGTACTGCGGCGACG 
CTGCCTACTACGCTCAAC 
 
Rv3135 
 
CM3135F 
CM3136R 
 
 
CATATCGCTTGACCCACAGA 
TCGCTGTTTGCTGTGTCTTT 
 
Rv3516-17 
 
CM3515F CM3518R 
CM3515Fc 
CM3515Rb 
 
 
CCTTGTGTTTGTGGATCGTG 
TTCGCATGTGTCTCAAGAGG 
ACCTTGTCGTCCTTTTGCAC 
CGAAATCCAAACAGCCACTT 
 
Rv3738c-39c 
 
CM3737F 
CM3739exR 
 
 
GAGTTCCTCGCCTCACCAT 
TCAGTTGACTGACCGGCTTT 
 
 
Table 7.3.  Oligonucleotides used for confirmation by PCR and DNA sequencing of 
deletions detected by DNA microarrays.  
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7.4. RESULTS 
7.4.1. Global lineage assignation 
Deletions were identified in this study that assigned these strains to one of the six main 
phylogenetic global lineages previously described (Table 7.4) (Gagneux et al., 2006). All six 
of the SA-strains possessed a deleted Rv1519 (LSP RD750) which assigned these strains to 
the East-African-Indian lineage. The South Indian clinical isolate ATCC 35811 was assigned 
to the Indo-Oceanic lineage by a deletion in Rv3651 (LSP RD239) which includes 
„„ancestral‟‟ strains (Brosch et al., 2002). The three non-SA strains were all assigned to the 
Euro-American lineage by virtue of deleted Rv2270-80 (LSP RD182) in strains 1339 and 
7009 and deleted Rv2313c-15c (LSP RD183) in strain 6947. 
 
Strain 
designation 
ETR 
Global origin 
of patient 
Lineage assigning 
deletion 
Global lineage 
 
8088 
 
42235 
 
South Asia 
 
Rv1519 (RD750) 
 
East-African-Indian 
0135 42235 South Asia Rv1519 (RD750) East-African-Indian 
2566 42235 South Asia Rv1519 (RD750) East-African-Indian 
3242 42235 South Asia Rv1519 (RD750) East-African-Indian 
9375 02235 South Asia Rv1519 (RD750) East-African-Indian 
9866 42234 South Asia Rv1519 (RD750) East-African-Indian 
SI (TMC 120) - South India Rv3651 (RD239) Indo-Oceanic 
6947 32433 Europe Rv2313c-15c (RD183) Euro-American 
1339 32333 Europe Rv2270-80 (RD182) Euro-American 
7009
 
 
32333 
 
Europe 
 
Rv2270-80 (RD182) 
 
Euro-American 
 
 
Table 7.4.  Assignation of the strains in this collection to previously defined global 
lineages. 
 
Strains were assigned to the LSP framework previous described (Gagneux et al., 2006). 
  
Chapter 7 
 262 
7.4.2. Microarray studies of clinical strains 
The total number of deletions in the analysed SA-strains ranged from 10 to 24 deletions. The 
median number of deleted genes was 12 (range 10-14) when mobile elements were not 
considered. Only one South Asian strain (8088) had an RD3 region deletion (prophage 
phiRV1) accounting for 14 genes. Excluding the RD3 deletion in strain 8088, strain 9375 had 
more deletions (14 genes) than any other SA-strain (Table 7.5). The South Indian reference 
strain (ATCC 35811) and strain 6947 possessed a high number of deletions with 51 and 58 
deleted genes respectively. However, most of the deletions were disruptions caused by mobile 
elements (Figure 7.2). Deleted regions were confirmed by PCR and partial or total sequencing 
in the SA-strains 8088, 9375 and 9866. The validation of the microarray results was extended 
to the rest of the strains of the SA group (0135, 2566 and 3242) to confirm commonly deleted 
genes. 
 
Construction of a clustering dendrogram based on deleted regions revealed that the deletion 
profiles of the South Asian strains are clustered together when compared to the other non-
South Asian strains and that there are two families of disrupted genes within this study 
(Figure 7.3). The first group of deletions is variable between isolates and contains genes that 
are deleted in most of the South Asian strains. The second group is much larger and contains 
two groups of deletions; ones caused by an insertion/mobile element only and non-IS 
mediated deletions. 
 
 
  
Chapter 7 
 263 
Distribution of deletions by function Distribution of disrupted ORFs by function 
 
East-African-Indian  
  
Indo-Oceanic  
  
Euro-American  
  
 
Figure 7.2  Proportions of deleted regions and disrupted ORFs by functional class.  
Functional categories are derived from Tuberculist. Figure A details the number and 
proportion of individual identified deletions. Deleted ORFs (B) are the total numbers of 
deleted ORFs such that one deleted region (A) can disrupt multiple ORFs (B). 
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Global Lineage  East-African-Indian  Indo-Oceanic  Euro-American 
VNTR  profile  42235 02235 42234  -  32433 32333 
Strain 
(Origin) 
 
8088 (L) 
0135 
(B) 
2566 
(B) 
3242 
(B) 
9375 
(L) 
9866 
(L) 
 SI 
(South India) 
 6947 
(L) 
1339 
(B) 
7009 
(B) 
              
Rv0064              
Rv0180c              
Rv0795-96              
Rv0963c              
Rv1354c              
Rv1355c-56c              
Rv1369c-70c              
Rv1519              
Rv1524-25              
Rv157386c              
Rv1735c              
Rv1755c              
Rv1756c-57c              
Rv1758              
Rv1759              
Rv176062              
Rv1763-64              
Rv1802              
Rv1895              
Rv1917c              
Rv1947              
Rv2105-06              
Rv2167c-68c              
Rv227177c              
Rv2278-79              
Rv2314c-15c              
Rv2354-55              
Rv2479c-80c              
Rv2595              
Rv26452647c              
Rv2648-49              
Rv2650 59c              
Rv2814c-15c              
Rv3017c              
Rv3018c              
Rv3019c              
Rv3020c              
Rv3021c              
Rv3022c              
Rv3135              
Rv318487              
Rv3203              
Rv3325              
Rv3381c              
Rv3382c84c              
Rv3424c28c              
Rv3474-75              
Rv3516-17              
Rv3651              
Rv3738c-39c              
Rv3741              
Rv3786c              
Rv3887c 89c              
              
 
Table 7.5.  Distribution of deleted genes identified by microarray experiments.  
 
The deleted sequences belonging to insertion or mobile elements are shown in grey. The 
VNTR profiles of the strains and Rv number, corresponding to M. tuberculosis H37Rv 
genome, are indicated. Only significant deletions are shown (p<0.05). Isolates were either 
isolated in Birmingham (B) or Leeds (L) in the UK.  
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Figure 7.3.  Deleted regions in the ten M. tuberculosis strains analysed.  
The dendrogram was constructed by the unweighted pair group method (UPGMA) clustering 
using a categorical co-efficient. Red squares indicate deleted regions and green squares 
indicate regions disrupted by mobile elements. 
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7.4.3. Common deletions within this study and strain CH 
The analysis of the deletion events in the SA-strains investigated showed that these strains 
possessed some common deletions present in all SA-strains (Rv1519, Rv3516-Rv3517 and 
Rv3738c-Rv3739c). PCR and sequencing showed that these deletions were indistinguishable 
to some of the deletions reported in the Leicester CH strain (Rajakumar et al., 2004). Deletion 
Rv3738c-Rv3739c (PPE66-PPE67) was identified in all the SA-strains except 9866 (Table 
7.5 and Table 7.6). None of these common deletions have been described in Beijing/W strains 
(Tsolaki et al., 2005;Stavrum et al., 2008) or in a collection of 100 clinical strains (Tsolaki et 
al., 2004). 
 
  
South Asian strains (East African Indian lineage) 
 CH 8088
 
0135 2566 3242 9375
 
9866
 
VNTR 42235 42235 42235 42235 42235 02235 42234 
Deleted genes        
Rv0180c - + + + + - + 
Rv1519
 
(RD750) - - - - - - - 
Rv1995-96 - + + + + + + 
Rv3017c + + + + + + - 
Rv3018c + + + + + + - 
Rv3019c - - - - + - - 
Rv3020c - - - - - - - 
Rv3021c + - + + - + + 
Rv3022c + - + + - + + 
Rv3135 + - - - - - - 
Rv3516-17 - - - - - - - 
Rv3738c-39c - - - - - - + 
 
Table 7.6.  Genes disrupted by deletions in SA-strains and the CH strain.  
 
Deletions in the CH strain were previously reported by (Rajakumar et al., 2004). Plus (+): 
gene present. Minus (-): gene deleted. 
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7.4.4. Polymorphic deletions 
The SA-strains also showed additional deletions which distinguished them from the CH strain 
and from other strain families (Rajakumar et al., 2004;Tsolaki et al., 2004). These additional 
deletions provided genetic variability in this specific group of strains (Table 7.5 and Table 
7.6). The sites of genetic variation among M. tuberculosis isolates could contribute to putative 
differences in the phenotypic and biological properties of the strains. 
 
Previous studies have shown polymorphism in the deletions of some PE/PPE genes and were 
also found in the M. tuberculosis isolates studied here (Marmiesse et al., 2004;Musser et al., 
2000). Four polymorphic deletions in genes or regions were analysed in the SA strains: 
Rv3135 (PPE50), Rv1917c (PPE34), Rv1755c-Rv1758 (plcC-cut1) region, and Rv3017c-
Rv3022c region (esxQPPE46-PE27A-esxR-esxS-PPE47-PPE48). Deletions in Rv3135 were 
observed in all of the strains examined in this study. A characteristic partial deletion was 
identified in all of the SA strains studied and the deletion differed from those present in other 
strains (Figure 7.4). This deletion was not found in the strain CH (Rajakumar et al., 2004).  
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Figure 7.4.  Variation in the Rv3135 PPE gene.  
 
A. The gene in H37Rv is shown with a grey box and the orientation of the gene is indicated 
by an arrow. The line with dots represents the deleted sequence in the strains compared to 
H37Rv. The new sequence in some of the strains is shown as a black box. 
 
B. Sequence comparison of different Rv3135 variants: 1. H37Rv; 2. South Asian strains 
(clinical strains: 8088, 0135, 2566, 3242, 9375 and 9866); and 3. SI-ATCC; and 4. 6947-
Erdman (Acc. no. AE007137)-CDC1551 (Acc. no. Y17598). The deleted nucleotides are 
indicated by dashes. The new sequence with respect to H37Rv is in lower case. The deleted 
amino acids in SA-strains are indicated by a box in the sequence of H37Rv. Figure created by 
Carmen Menéndez 
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The p-value obtained for this deletion was variable among SA-strains (p=0.0271-0.168) but 
presence of the deletion was validated by PCR and sequencing which revealed the identical 
partial deletion in all of the strains. The deletion of 135 nucleotides in the sequence of this 
gene caused the loss of 45 amino acids in the sequence of the protein (Figure 7.4). In order to 
confirm the variability of this gene, the deletion of Rv3135 was also confirmed in the three 
Euro-American strains and the South Indian strain ATCC 35811, both of them with consistent 
statistical significance (p<0.05). The Rv3135 gene in the three Euro-American strains had an 
insertion of 20 nucleotides at the 5‟ end of the deleted genomic sequence. The sequences in 
these strains were 100% homologous with those in the Erdman and CDC1551 strains of M. 
tuberculosis. The clinical isolate South Indian ATCC 35811 possessed a large deletion in 
Rv3135 with almost the entire region deleted including the promoter sequences for this 
region. 
 
Isolate 9375 (VNTR profile 02235) was the only isolate that possessed a partial deletion in 
Rv1917c (PPE34) that was detected by the microarray. Rv1917c encodes a surface exposed 
protein, which is highly polymorphic in clinical isolates (Sampson et al., 2001). Most of the 
polymorphism detected in this gene is caused by variation in VNTR loci present in this region  
(Sampson et al., 2001). However, no evidence of the ETR-A region was detected in Rv1917c 
of the 02235 strain with the deleted region replaced by IS6110. Subsequent analyses by PCR 
and sequencing also showed disruption of this region in SA-strains 8088 (VNTR profile 
42235) and 9866 (VNTR profile 42234) that was not detected by microarray (Figure 7.5). The 
orientation of IS6110 in all three strains was opposite that of the direction of gene 
transcription. The insertion of an IS6110 element in the Rv1917c was not detected in the CH 
strain (Yesilkaya et al., 2006;Rajakumar et al., 2004). 
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Figure 7.5.   Polymorphism in the Rv1917c gene. 
 
A. Rv1917c region amplified by PCR. H, H37Rv; (a) clinical strain 8088; (b) clinical strain 
9375 and (c) clinical strain 9866. 
 
B. Graphical representation of the location of the insertion of IS6110 in Rv1917c. The gene is 
represented by a dark grey box and the IS6110 are indicated by a light grey box. The insertion 
points are indicated with lines. The scale in base pairs is indicated. Figure created by Carmen 
Menéndez.  
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A polymorphic region was identified between Rv3017c and Rv3022c in the three SA-strains. 
All three SA strains have at least esxR (Rv3019c) and esxS (Rv3020c) deleted, with the 
deletion of adjacent genes in this region variable between strains (Figure 7.6). This region 
also contains PE/PPE genes with highly repetitive sequences (Rv3018c (PPE46), Rv3018A 
(PE27A), Rv3021c (PPE47), Rv3022c (PPE48), and Rv3022a (PE29)), and three genes 
encoding ESAT-6 like genes esxQ (Rv3017c), esxR (Rv3019c) and esxS (Rv3020c). One 
IS6110 sequence was inserted in the intergenic region of Rv3018c and Rv3019c of the CH 
strain but the deletion of Rv3019c-Rv3020c located by microarrays was not confirmed 
(Rajakumar et al., 2004;Yesilkaya et al., 2006). The variability of the deletions in this 
genomic region has previously been shown in some M. tuberculosis and M. microti strains but 
this chapter was the first report of replacement by an insertion element or transposase in this 
region (Figure 7.6) in closely related strains (Marmiesse et al., 2004).  
 
 
 
Figure 7.6.  Polymorphism between Rv3017c and Rv3022c.  
 
The orientation of the genes and the genes are shown. The insertion of IS6110 is indicated by 
a black arrow, the insertion of the transposase (second ORF of the IS6110) is represented by a 
striped arrow. The scale in base pairs is indicated. Figure created by Carmen Menéndez. 
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The region between Rv1755c (plcD, phospholipase) and Rv1758 (cut1, cutinase) was 
analysed by PCR and DNA sequencing. These genes are interrupted by a single IS6110 
element in H37Rv and corresponded to the RvD2 region that is deleted in H37Rv but present 
in M. bovis, H37Ra and other clinical strains (Gordon et al., 1999;Brosch et al., 1999). 
Insertion and deletion events in this region have resulted in notably high diversity among 
strains (Ho et al., 2000). The region Rvd2 is located downstream of the plcD gene (Rv1755c) 
and is present in strains 9375 and 9866 but not in 8088. In strains 8088 and 9866, plcD 
(Rv1755c) and cut1 (Rv1758) genes were not interrupted by a copy of IS6110, whereas they 
are in the M. tuberculosis H37Rv genome (Figure 7.7). 
 
 
 
Figure 7.7.  Rv1755c-Rv1765c region. 
 
The orientation of the genes is represented by arrows. The IS6110 in H37Rv are shown by 
black arrows. The deleted sequences in each strain were confirmed by PCR. The assumed 
substitution by Rvd2 in the strains 9375 and 9866 is shown in the figure. The asterisks 
indicate the truncated genes in H37Rv by IS6110 insertion. (B) Region amplified by PCR. H, 
H37Rv; (a) clinical strain 8088; (b) clinical strain 9866 and L, ladder. Figure created by 
Carmen Menéndez. 
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The plcD (Rv1755c) gene is also interrupted by a copy of IS6110 in the genome of the CH 
strain (Yesilkaya et al., 2006). Rv1759c (wag22, member of the PE-Polymorphic GC-rich 
Repetitive Sequence (PGRS) family) is only absent in isolate 9375 where the deletion extends 
to the adjacent genes. The size of the PCR fragment seems to indicate the presence of the 
region Rvd2 in this strain and sequencing using the internal primers of Rvd2 confirmed its 
presence. The deletion or presence of prophages is variable in clinical strains of M. 
tuberculosis. Strain 8088 possessed a deletion in the RD3 region (phiRV1 prophage). This 
prophage is present in the genome of M. tuberculosis H37Rv but deleted in M. bovis BCG and 
some strains of M. tuberculosis (Gordon et al., 1999). This deletion also appeared in the Euro-
American strain 6947 and in the South Indian clinical isolate ATCC 35811 (our data) and has 
been described in Beijing/W strains (Tsolaki et al., 2005). 
 
7.4.5. Accession numbers 
The nucleotide sequences of deleted regions of SA-strains are in the EMBL Data Bank with 
the accession numbers: AJ878456; AJ878457; AJ878458; AJ878459; AJ878460; AJ878461; 
AJ879166; AJ879167; AJ879168; AJ879169; AJ879170; AJ879171; AJ879172; AJ879173; 
AJ879174; AJ879175; AJ879176; AJ879177; AJ879178; AJ879179; AJ879180; and 
AJ879181. 
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7.5. DISCUSSION 
In this chapter, microarray-based comparative genomics were utilised to analyse the 
distribution of deleted regions in the genome of six clinical strains of M. tuberculosis that 
originated from South Asia in comparison to the previously reported CH strain that also 
originates from South Asia. Examples of other common clades were also included. Our results 
indicate that strains of the South Asian group have a common evolutionary origin similar to 
the strain CH but are distinct from members of the Beijing clade. 
 
7.5.1. Global phylogeny of strains in this study 
There were characteristic deletions in each of the 10 strains in our study that assigned each 
strain to one of six global phylogenetic lineages as previously described (Gagneux et al., 
2006). All six of the SA-strains were assigned to the East-African-Indian lineage. The South 
Indian clinical isolate ATCC 35811 was assigned to the Indo-Oceanic lineage and the three 
non-SA strains were all assigned to the Euro-American lineage. These deletion based lineages 
equate to various spoligotype clades: East-African-Indian equates to CAS; Indo-Oceanic is 
the ancestral EAI spoligotype; and the Euro-American lineage contains Haarlem, LAM, T, 
and X (Gagneux and Small, 2007). 
 
Presence of the RD750 deletion defined SA-strains as members of the East-African-Indian 
global lineage (Gagneux et al., 2006). Recent studies examined the immunological relevance 
of this deleted region in the CH strain and found that the deletion in RD750 conferred a 
phenotype that could subvert the host immune response (Newton et al., 2006). 
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A subsequent microarray study examined Beijing and non-Beijing strains (including one 
CAS) present in Myanmar. Comparison of our data with the data from Myanmar identified 
three common deletions between Beijing strains in Myanmar and CAS strains studied in this 
chapter with multiple other variable deletions identified as well (Stavrum et al., 2008). 
Comparative genomics and population-based spoligotyping studies indicate that Beijing and 
CAS may share a common ancestry but have evolved into two currently distinct clades. 
 
7.5.2. The origin of two major global clades: CAS and the Beijing strain 
CAS is a member of PGG 1 (Sreevatsan et al., 1997;Kulkarni et al., 2005) but does not 
possess the TbD1 (TbD1-) region (Gutierrez et al., 2006). The Beijing and EAI families are 
also located in PGG1 but Beijing is TbD1- with EAI TbD1+ (Gutierrez et al., 2006). 
Therefore, the EAI clade was present before the appearance of CAS and Beijing. Both Beijing 
and CAS are located in the same principal phylogenetic group and share the presence of 
spacers 35-43. However, the Beijing clade has lost spacers 1-22 that are present in CAS (Banu 
et al., 2004). Therefore, the CAS family could have been one of the possible ancestors of the 
Beijing strain (Sola et al., 2003;Stavrum et al., 2008). It is hypothesised that the Manu 
spoligotype (with only two deleted spacers at 33 and 34) is the probable ancestor of both the 
CAS and EAI clade (Singh et al., 2004). 
 
Spoligotyping has been widely used for population-based phylogenetic studies. However, it 
has been shown that spoligotyping is not as robust for constructing phylogenetic frameworks 
when compared to large-scale LSP or SNP-based data as significant homoplasy may exist 
(Comas et al., 2009;Kato-Maeda et al., 2011). Studies using a minimal number of SNPs 
further strengthened the early spoligotype evidence that EAI is an ancestral clade followed by 
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CAS (Filliol et al., 2006). More recent studies have refined spoligotype clades using minimal 
SNP sets whilst almost being as informative as large-scale sequencing projects (Abadia et al., 
2010). The ancestral EAI clade is more predominant in the South of India with the CAS clade 
more predominant in the North of India (Gutierrez et al., 2006;Singh et al., 2007). 
 
There may be a striking correlation between the distribution of the human population in North 
and South India and the distribution of M. tuberculosis strains. This may indicate that M. 
tuberculosis has co-evolved with the human population within India. A recent study of human 
genetics in North and South India (and two Pakistani populations) studied the distribution of 
560,000 SNPs in the whole genomes of 132 individuals from 25 groups representing the 
breadth of social, language and geographic variation in India. Most of the Indian populations 
sampled are mixtures of two groups which were named the Ancestral North Indians (ANI) 
and Ancestral South Indians (ASI).  The ratio of ANI:ASI varies from 39% to 79% in a cline 
from south to north.  The ANI human population represents an older clade displaced from the 
North by the Indo-European speaking ANI in approximately 1500BC (Reich et al., 2009). 
This geographical distribution of human populations closely resembles the distribution of the 
EAI and CAS clades in India. 
 
Specific human genotyping studies examining the relationship between M. tuberculosis and 
host genotypes in India have not yet been undertaken. However, human genetic studies in 
other geographical areas have shown that there are associations between both the genotypes of 
the host immune system and M. tuberculosis strain (Ma et al., 2007). Moreover, specificity 
host-mycobacterial interactions have been identified in Toll-Like Receptors of patients 
infected with Mycobacterium leprae in the ISC (Wong et al., 2010). 
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7.5.3. Functional implications of identified deletions 
It is interesting to note that some of the deleted regions in the SA-strains studied here were 
also found in the index strain CH from the outbreak in Leicester in 2001, where the strains 
were isolated from patients that were also of predominantly South Asia origin (Rajakumar et 
al., 2004). The deletion of LSP designated RD750 involved the Rv1519 and Rv1520 genes 
that encode conserved hypothetical proteins with unknown function. This deletion has been 
found to be associated with the persistence in human populations of the CH strain (Newton et 
al., 2006). An understanding of the pathogenicity of this group of strains might be aided by an 
in-depth study of genetic similarities and differences of an expanded collection of strains with 
similar epidemiological and genomic characteristics.  
 
7.5.4. Variability in PE/PPE genes 
The results in this chapter show major variability in some of the PE/PPE genes of SA-strains 
that represent a major portion of the M. tuberculosis H37Rv genome (Cole et al., 1998). The 
biological function of most of these proteins is unknown. It has been suggested that they are 
involved in antigenic variation or interfere with host immune responses (Cole et al., 
1998;Banu et al., 2002;Brennan et al., 2001). Moreover, genes of the ESAT-6 family (Cole et 
al., 1998), which are closely linked in the genome to genes encoding PE/PPEs (Tekaia et al., 
1999), have been demonstrated to encode several immunodominant molecules that are 
strongly recognized by the immune system in different animal models of TB as well as by T-
cells from humans exposed to M. tuberculosis (Skjot et al., 2002). This family of proteins has 
also been shown to be immunogenic in a human peripheral blood mononuclear cell model 
(Skeiky et al., 2000). Some cell-surface proteins present in M. tuberculosis, such as PE/PPE 
genes, can influence the type of host response and can alter the composition of the infiltrates 
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and the cellular composition of lesions (Cosma et al., 2003). These potential antigens for host 
immunity may play an important role during host-pathogen interactions. The antigenic 
variability in the analysed strains could contribute, with a combination of other factors, to a 
special interaction with specific hosts, in this case people originating from South Asia.  
 
Another major source of polymorphism among M. tuberculosis isolates appears to be defined 
by deletions in Rv3135, as the gene is larger in Beijing strains than in H37Rv (Musser et al., 
2000;Mokrousov et al., 2002). The commonly deleted regions of Beijing/W strains do not 
extend to this family of proteins (Tsolaki et al., 2005). The Rv3135 gene, which encodes the 
PPE50 protein, was found to be uniquely variable and could be a useful marker to 
differentiate epidemiologically related groups of strains, since there was a common deletion 
of this gene in the SA-strains (Musser et al., 2000). However, the full extent of variability 
within this region needs to be determined in a larger collection of isolates as this gene was not 
affected by deletion in the CH strain (Rajakumar et al., 2004). Despite having an unknown 
function, Rv3135 is considered an essential gene and is closely linked to a two-component 
system (dosR/dosS) in the genome of H37Rv (Sassetti et al., 2003). However, the effect of 
this deletion in these strains remains unknown, as a defect in this PPE gene may be 
complemented by another gene absent in the reference strain H37Rv or by another PPE due to 
the functional similarities among these members.  
 
The presence of an insertion in Rv1917c (PPE34) could contribute to genetic variability, 
which is not only important in genomic evolution but also in the expression of these genes 
and in antigenic variation. The similar point of insertion of the IS6110 among our SA-strains 
and the CH strain suggest the presence of a hot spot in this gene. Polymorphisms in this gene 
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are used as an epidemiological tool because it contains one of the more discriminatory loci 
(ETR-A) in VNTR typing (Sola et al., 2003). 
 
From the five years of prospective typing presented in Chapter 5, 530/5,731 (9%) strains 
possessed a non-amplifiable ETR-A locus. Of the six global clades, the East African Indian 
Clade had the highest number of strains with non-amplifiable ETR-A (217/1,888) which 
equates to 11% of all strains in this clade. Confirmation of disruption caused by IS6110 would 
need to be carried out by PCR and DNA sequencing. 
 
7.5.5. Variability in ESAT-6-like genes 
A notable microarray result was the detection of one polymorphic region from Rv3017c to 
Rv3022c among the three SA-strains which encodes for ESAT-6-like genes. Deletion of 
ESAT-6-like genes might confer a selective advantage during certain stages of infection or 
transmission. The role provided by the selective pressure of the host‟s immunological system 
in the deletion of some genes is not well understood; however it has been suggested that there 
is limited selective pressure because of little genetic diversity in a large number of genes 
encoding essential antigens which are recognized by the host immune system (Musser et al., 
2000). The tight binding capability of the closely related ESAT-6 proteins has been reported 
(Lightbody et al., 2004), but the loss of two of these genes (Rv3019c and Rv3020c) could 
decrease the opportunity for plasticity in the SA-strains. Rv3019 was also identified as a 
deletion in a comparative genomic hybridisation study of Beijing and non-Beijing strains in 
Myanmar. This region was identified as being present in all of the LAM strains tested, present 
in 15/28 Beijing strains tested, present in 5/9 EAI strains tested but deleted in the single CAS 
isolate tested (Stavrum et al., 2008). The strain 9866 (with VNTR 42234) is the only strain 
Chapter 7 
 280 
that possessed a deletion in three of the esx genes (Rv3017c, Rv3019c and Rv3020c). Further 
analysis is necessary to understand the implications that this deletion may have.  
 
The insertion elements that replaced deletions in SA-strains could modify the expression of 
adjacent PE/PPE genes in the region from Rv3017c to Rv3022c. Taking into account that 
IS6110 can upregulate downstream genes (Safi et al., 2004;Soto et al., 2004), the replacement 
event in this region demonstrated the important role of insertion elements in the evolution of 
the genome and in the contribution to phenotypic diversity. The presence of insertion 
elements could contribute to this variability, which is not only important in genomic evolution 
but also in expression of these genes and in antigenic variation. In M. microti the deletion 
MiD4 removes the esx genes Rv3019c and Rv3020c, but the strains which possess this 
deletion and RD5 (deletion in the plcC region) were still able to produce disease (Garcia-
Pelayo et al., 2004). However, the protective efficacy of Rv3019c and its suitability as 
promising candidate TB vaccine suggests that the deficiency of members of the ESAT-6 gene 
family may affect the immunological response in the patient (Hogarth et al., 2005). In strain 
8088, one IS6110 element was inserted in the plcC gene (data not shown) but this gene was 
not interrupted by insertion elements as was the case in strains 9375 or 9866. Mutations in the 
plcC gene attenuates strains (Raynaud et al., 2002), with further studies required to confirm 
this effect in SA-strains. In addition, the Rvd2 region has been found in two of the SA strains 
in this study. Located close to this region is Rv1759c (wag22), which encodes a member of 
the PE-PGRS glycine rich protein family (Espitia et al., 1999). This gene is expressed in 
tuberculosis infections and the protein is recognized by sera from patients and seems to have a 
biological role in the interaction of the bacillus with the host (Espitia et al., 1999). The 
phospholipase genomic region has already been shown to be a preferential locus for IS6110 
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transposition (Vera-Cabrera et al., 2001). However, in the SA-strains Rv1755c (plcD) was not 
interrupted by IS6110. The polymorphic deletions detected in SA-strains in this study 
(Rv3135, Rv1917c, Rv1755c-Rv1758 and Rv3017c-Rv3022c) were also polymorphic among 
previously analysed clinical strains of M. tuberculosis and are not specific to the SA-strains 
(Brosch et al., 1999;Marmiesse et al., 2004;Musser et al., 2000;Sampson et al., 2001). 
Rv3135 has been recently assigned to a group of large-sequence polymorphisms (LSP Group 
C) by Alland and colleagues in which it has been suggested that sequence alterations in this 
region occur under selective pressure (Alland et al., 2007). 
 
This chapter indicates that both SA strains 8088 and 9375 (VNTRs 42235 and 02235, 
respectively) showed the same deletion in the Rv3738-Rv3739c region which was not present 
in strain 9866 (VNTR profile 42234). This genomic deletion involved a partial removal of the 
Rv3737 gene, a probable conserved transmembrane protein close to a transcriptional 
regulatory protein (Rv3736) belonging to the AraC/XylS family (Cole et al., 1998). The 
implication that deletions of Rv3737, Rv3738 and Rv3739 affect expression of Rv3736 will 
require further investigation. 
 
7.5.6. Phenotypic and clinical associations identified by comparative genomics in 
previous studies 
It may be that further studies of the deletions identified in this chapter may reveal significant 
associations with phenotypic and clinical characteristics of M. tuberculosis. The 
aforementioned RD750 deletion in the CH strain enables this strain to subvert the host 
immune response which could contribute to the transmission of this strain (Newton et al., 
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2006). Since this deletion defines a global lineage, all strains within the East-African-Indian 
lineage may exhibit the same immune subverting phenotype as the CH strain. 
 
An initial study of 19 clinical strains identified an association between the amount of deleted 
genomic DNA and cavitary disease. As the amount of deleted genomic DNA sequence 
increased, the probability of pulmonary cavitations decreased; suggesting that the 
accumulation of mutations diminished strain pathogenicity (Kato-Maeda et al., 2001). Within 
specific clades such as the Beijing strain, the presence of deletions in five specific RDs were 
significantly associated with extrathoracic tuberculosis (Kong et al., 2006).  
 
7.5.7. Limitations of microarrays 
There are two principal limitations of microarray-based deletion analysis. Microarrays will 
only identify deletions relative to the reference strain which will not contain all of the genome 
of all members of that particular species. M. tuberculosis H37Rv lacks at least five regions 
that are present in clinical isolates of and other members of the  M. tuberculosis complex 
(Brosch et al., 1999). This limitation has been overcome with the latest array designs which 
also include regions from M. tuberculosis H37Rv, M. tuberculosis CDC1551, and M. bovis 
2122/97 (Stavrum et al., 2008).  
 
Microarrays also cannot detect genetic rearrangements involving duplication of DNA which 
has been shown to have played a significant part in the evolution of M. tuberculosis. An in 
silico analysis of the M. tuberculosis proteome showed that at least 50% of mycobacterial 
proteins arose from gene duplications or rearrangement including genes involved in fatty acid 
metabolism, regulation of gene expression, and PE/PPE proteins (Tekaia et al., 1999). 
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DNA microarrays only provide data on large gene disruptions within specific ORFs. Further 
resolution on a genome-wide scale can now be provided by WGS, which is able to provide 
data on variations caused by SNPs and insertions or deletions. Through the analysis of read 
coverage, the presence or absence of RDs/LSPs can be inferred. 
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7.6. CONCLUSIONS 
Variability in the genome of strains of M. tuberculosis which are associated with patients of 
South Asian origin has been demonstrated in this chapter. The reasons for the host selection 
of this group of strains cannot be explained only by the deletion pattern, but are probably a 
combination of events which are involved in the interaction with the cell and the host. Other 
studies have shown the presence of deleted genes in strain families present around the world, 
but it has been shown that the Beijing/W strain lack the deletion in genes involved in 
antigenic variation such as PE/PPE members or ESAT-6 like proteins (Tsolaki et al., 2005). 
Some of these genes, such as Rv3135 or Rv3738-Rv3739, are very closely linked to genes 
known to be important during infection. The high levels of variability in particular regions 
like Rv3017c-Rv3022c in the M. tuberculosis SA strains need further investigation by 
analysis of multiple strains within the CAS lineage and examination of protein expression in 
order to understand the differences in the pathogenesis, virulence and development of this 
prevalent global strain. 
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8. SUMMARY AND FUTURE WORK 
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8.1. SUMMARY AND CONCLUSIONS 
This project was an investigation of M. tuberculosis genotypes in the West and East 
Midlands. The main aim of this project was to improve our knowledge and understanding of 
the molecular epidemiology and transmission of M. tuberculosis in the Midlands.  
 
The specific objectives of this PhD were to: 
 Evaluate IS6110 RFLP data in comparison to MIRU-VNTR data to identify if 
MIRU-VNTR typing could be a rapid alternative method to IS6110 RFLP. 
 Develop automated analysis of MIRU-VNTR loci using non-dHPLC which would 
enable the analysis of all M. tuberculosis strains in the Midlands and enhanced the 
knowledge and understanding of the epidemiology and transmission of M. 
tuberculosis in the Midlands. 
 Identify the prevalent global lineages present in the Midlands and the continental 
origin of infected patients using non-dHPLC, MIRU-VNTR, and a novel computer 
software programme called Origins. 
 Identify, confirm, and analyse the distribution of the single most prevalent MIRU-
VNTR profile in the Midlands. 
 Undertake a whole-genome analysis of prevalent strains in the Midlands using 
DNA-DNA microarray hybridisation to identify properties unique to those strains 
and the genetic origin of these strains. 
 
For these objectives, MIRU-VNTR typing was evaluated against IS6110 typing and shown to 
provide comparable clustering when epidemiological links were known. Non-dHPLC was 
shown to be a feasible automated option of MIRU-VNTR typing. The distribution of all 
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global clades present in the Midlands were analysed and the predominance of two global 
clades was shown. Finally, whole genome array analysis of strains that originated from the 
Indian-Subcontinent showed that strains within the East African Indian lineage do have a 
common origin. 
 
The clonality of all strains in the Midlands was analysed and from this, the single most 
prevalent strain was identified and investigated further by conventional epidemiological 
methods. The Mercian strain represents one of the world‟s longest running and largest TB 
outbreaks. Within the study period analysed in this thesis, the Mercian strains was identified 
in a total of 214 patients between 1995 and 2008. M. tuberculosis causes active disease in 
only 10% of patients infected (Sutherland, 1976). From the 214 patients diagnosed with active 
disease and infected with the Mercian strain, there could be more than 2,000 individuals 
latently infected with the Mercian strain in the West Midlands. 
 
8.1.1. Limitations 
The main limitation of this research is that the presented genotyping data between 2004 and 
2009 used 15 MIRU-VNTR loci and the optimal 24 loci set was used only on selected strains. 
This was mainly due to the additional funding required to analyse the additional nine loci 
which was not obtained until the end of 2009. This has enabled the commencement of 24 loci 
typing of all isolates at the start of 2010 with 1,376 strains analysed prospectively by 24 loci 
so far. 
 
As part of the previously published evaluation of IS6110 RFLP, candidate MIRU-VNTR loci, 
and spoligotyping (Supply et al., 2006), it was identified that optimal performance for cluster 
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identification was provided by the combination of data from all three methods. For this thesis, 
RFLP and spoligotyping was carried out on selected strains. Alternative methods for IS6110 
RFLP and spoligotyping were developed and evaluated during this thesis. Selected M. 
tuberculosis strains analysed by IS6110 RFLP within the Birmingham Laboratory were 
analysed by an alternative method (IS6110 fAFLP) which has been developed by Dr Cath 
Arnold (HPA Centre for Infections, London). fAFLP determines the insertion position and 
copy number of IS6110 in M. tuberculosis strains using a DNA sequencer which generates a 
digital sequence that details the position of each IS6110 element. This method has been 
shown to generate comparable clustering when compared to IS6110 fingerprints obtained 
using the conventional Southern hybridisation method (Thorne et al., 2007a). IS6110 fAFLP 
analysis of all available Mercian strains is currently being carried out. Spoligotyping using a 
liquid suspension array system was evaluated using a system available at the University of 
Birmingham as part of another PhD project and further implementation of this method awaits 
the procurement of a Luminex system by the HPA laboratory. 
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8.2. HYPOTHESES GENERATED AND FUTURE WORK 
The data obtained from DNA fingerprinting of all M. tuberculosis isolates in the Midlands 
from 2004 onwards as part of this thesis will form the basis for multiple future projects. 
 
8.2.1. In-depth molecular characterisation of the Mercian strain 
The widespread transmission of the Mercian strain may be caused by bacterial, host, or 
environmental factors. Various epidemiological investigations have been undertaken and the 
only environmental factors identified so far were a significant association with alcohol or drug 
use in Wolverhampton. No specific location has been identified. The only putative host factor 
identified so far was that a cohort of eight patients infected with the Mercian strain in 
Wolverhampton continued to experience weight loss even after initiation of therapy with no 
treatment adherence issues. However, patients infected with the Mercian strain completed 
treatment with a similar rate as the rest of the patient population. A further hypothesis to test 
from this data would be that the Mercian strain interacts differently with the host immune 
response. This could be tested by analysing the response of an in vitro THP-1 macrophage 
model to infection with the Mercian strain. 
 
From the 24 locus MIRU-VNTR and IS6110 RFLP data, it appears that the Mercian strain has 
spread by clonal expansion in three different cities across the West Midlands. What we do not 
know is whether the Mercian strain appeared in one city with two subsequent major 
transmission events to the other cities and subsequent transmission contained to those cities or 
whether continuous transmission between the three cities is still occurring. The hypothesis 
that the Mercian strain is truly clonal will be tested by whole genome sequencing which has 
been has been used to elucidate the transmission route of the Harlingen strain in the 
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Netherlands (Schurch et al., 2010a). The hypothesis that the Mercian strain has transmitted 
widely because it possesses unique genetic properties that enhances virulence and 
transmission will be tested by analysis of the whole genomic content by DNA microarrays. 
 
8.2.2. Prospective national 24 locus typing 
Prior to 2010, typing was funded on a regional level which resulted in variation in the 
proportion of M. tuberculosis strains typed. The HPA has funded a National TB Typing 
Service initially for three years (2010-2012) which includes universal, prospective typing of 
all M. tuberculosis isolates in England by 24 MIRU-VNTR loci (Health Protection Agency, 
2011). The impact of 24 loci typing on a national scale will be evaluated by various 
parameters including the number of false positive cultures identified and the enhancement of 
conventional epidemiological data when combined with molecular data. 
 
From Chapter 5 and the identification of two predominant global clades in the Midlands, the 
next hypothesis to accurately determine would be the determination of what proportion of 
strains that originate from Southern Asia are directly imported and what proportion are the 
result of recent transmission within the Midlands. This will be determined by adding the extra 
nine loci retrospectively to clusters in Birmingham and the West Midlands that were 
identified using 15 loci between 2007 and 2009. This will create a four year period of 24 
locus strain typing data (2007-2010) that achieves the temporal requirements for the 
construction of an epidemiologically relevant transmission model for the city of Birmingham 
(Vynnycky et al., 2001). This would be the first such long-term transmission model 
constructed for in England and will identify in which population groups transmission (UK-
born and non-UK-born) is occurring and associations between clinical presentation, 
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clustering, and strain genotype. There have been two previous studies in England that have 
estimated transmission rates (Love et al., 2009;Maguire et al., 2002). However, the durations 
of these studies were only 12 and 24 months respectively. 
 
8.2.3. Social Network Analysis 
Currently, clusters identified by 24 loci data obtained prospectively are analysed on a monthly 
basis by the Birmingham Chest Clinic led by Dr. Martin Dedicoat. The aim is to confirm or 
identify social links between patients. These cluster reviews also determine if further 
screening for latent TB infection is required. To improve the identification of links between 
patients, structured social network analysis using a standardised patient questionnaire and 
epidemiological analysis software such as UCINet will be carried out (Borgatti et al., 1999). 
Social network analysis identifies patients or locations (nodes) that have the highest centrality 
scores between all nodes within a cluster. This would enable the identification of patients that 
have exhibited the highest rate of contact with all other patients in a cluster and could 
potentially be a “super-spreader”. A location or social activity may be identified as a central 
node which could focus further screening for latent infection onto that particular location. The 
Mercian strain will be investigated by social network analysis with the aim of uncovering 
previously identified social links and evaluate the hypothesis that the Mercian strain is the 
most prevalent strain because there is a significant environmental factor associated with 
transmission. 
 
8.2.4. In vitro infection of THP-1 monocytes 
As part of a PhD project carried out by Helen Smith at Birmingham University, phenotypic 
differences within and between clades that originate from the ISC are currently being 
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analysed by investigating the interaction with THP-1 macrophages in an in vitro infection 
model.  
 
8.2.5. Whole Genome Sequencing 
Strains analysed in this thesis will be selected for analysis by large-scale WGS as part of the 
UK Clinical Research Collaboration Modernising Medical Microbiology Consortium which is 
funded by the Wellcome Trust and MRC. The three collaborative institutions in this project 
are the University of Oxford, HPA and the Wellcome Trust Sanger Institute. The aim of this 
project is to establish how new technologies such as high-throughput next generation WGS 
can be optimally integrated into clinical microbiology. To calibrate the rate of variation in the 
DNA sequence of M. tuberculosis, clusters ranging in size from two or more isolates from the 
same patient to large complex clusters with linking conventional epidemiological data will be 
sequenced. After the retrospective analysis of isolates, it is planned to undertake prospective 
WGS as patients are identified with active TB disease. It is anticipated that WGS will be able 
to provide even greater resolution in defining epidemiological links between patients and 
could determine the exact transmission routes of large, complex outbreaks. 
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APPENDIX I. REAGENTS AND SOLUTIONS 
CTAB/NaCl: 
 4.1 g NaCl in 80 ml sterile distilled H2O 
 10 g N-cetyl-N,N,N,-trimethyl ammonium bromide (CTAB) 
 80 ml sterile distilled H2O 
 Heat the solution to 65°C and adjust the volume to 100 ml with sterile distilled H2O  
 
20X SSC: 
 3 M NaCl  
 0.3 M Na-citrate  
 1 L sterile distilled H2O 
 Adjust the pH to 7.0 with 5 M NaOH 
 
Stringency Wash Solution 1: 
 100 ml 2X SSC 
 0.1% SDS 
 
Stringency Wash Solution 2: 
 100 ml 0.1X SSC 
 0.1% SDS 
 
50X TAE: 
 2 M tris 
 0.05 M EDTA 
 Adjust to pH 8.0 with ~57 ml glacial acetic acid. 
 Make up to 1 l with sterile distilled H2O 
 
1X TBE: 
 89 mM tris 
 89 mM boric acid 
 2.5 mM EDTA 
 Adjust the pH to 8.2. 
 1 l sterile distilled H2O 
 
10X TE: 
 100 mM Tris-HCl, pH 8.0 
 10 mM EDTA 
 1 l sterile distilled H2O 
 
1.5X TMAC Hybridisation Solution: 
 4.5 M TMAC 
 0.15% sarkosyl solution 
 75 mM Tris-HCl, pH 8.0 
 6 mM EDTA, pH 8.0 
 250 ml sterile distilled H2O 
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1X TMAC Hybridisation Solution: 
 3 M TMAC 
 0.1% sarkosyl solution 
 50 mM Tris-HCl, pH 8.0 
 4 mM EDTA, pH 8.0 
 250 ml sterile distilled H2O 
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APPENDIX II. EPIDEMIOLOGY FOR TABLE 3.4 
Cluster Patient 
Conventional Epidemiological 
Data of each Patient 
Extra nine 
loci profile 
Concordance between 
molecular and conventional 
epidemiological data using 
ETR+MIRU VNTR+ 
1 
1 Same county as C5 but different town. Orphan No Yes 
2 
Same county as C5 but different town. 
Same town as P3. 
344423692 No Yes 
3 
Same county as C5 but different town. 
Same town as P2. 
344423692 No Yes 
4 Same county as C5 but different town. Orphan No Yes 
2 
1 No known links. Orphan No Yes 
2 No known links. Different city from P8. 442423384 No No 
3 No known links. Orphan No Yes 
4 No known links. Orphan No Yes 
5 No known links. Orphan No Yes 
6 No known links. Orphan No Yes 
7 No known links. Orphan No Yes 
8 No known links. Different city from P2. 442423384 No No 
9 No known links. Orphan No Yes 
3 
1 Member of family 1 456443362 Yes Yes 
2 No known links Orphan No Yes 
3 Contact with Family 1 456443362 Yes Yes 
4 Public bars, no contact with family 1. Orphan No Yes 
5 Contact with family 1 456443362 Yes Yes 
6 Public bars, no contact with family 1. Orphan No Yes 
7 Previous TB outside UK. Orphan No Yes 
8 
Public bars, known secondary 
contact with family 1. 
456443362 Yes Yes 
4 
1 Contact with three families. 434443183 Yes Yes 
2 Contact with two patients. 434443183 Yes Yes 
3 Hospital worker - no known links. 434443183 No No 
4 Public bars, no specific contacts. 434443183 No No 
5 Contact with patient. 434443183 Yes Yes 
6 Contact with patient. 434443183 Yes Yes 
7 No known links. 434443183 No No 
8 Contact of family. 434443183 Yes Yes 
9 Contact with P5. 434443183 Yes Yes 
10 No known links. Orphan No Yes 
11 No known links. 434443183 No No 
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Cluster Patient 
Conventional Epidemiological 
Data of each Patient 
Extra nine 
loci profile 
Concordance between 
molecular and conventional 
epidemiological data using 
ETR+MIRU VNTR+ 
5 
1 Member of family 2 443443153 Yes Yes 
2 Hostel 443443153 Yes Yes 
3 Hostel 443443153 Yes Yes 
4 Hostel 443443153 Yes Yes 
5 Member of family 2 443443153 Yes Yes 
6 Member of family 2 443443153 Yes Yes 
7 Public bar and partner was culture +ve 443443153 Yes Yes 
8 Hostel 443443153 Yes Yes 
9 Elderly patient 443443153 No No 
10 Hostel – family 3 443443153 Yes Yes 
11 Public bars – no specific links Orphan No Yes 
12 Hostel 443443153 Yes Yes 
13 Member of family 3 443443153 Yes Yes 
14 Member of family 3 443443153 Yes Yes 
15 Father was culture positive 443443153 Yes Yes 
16 Household contact of P22 and P24. 443443153 Yes Yes 
17 
Contact of culture positive 
 patient in same public bar. 
443443153 Yes Yes 
18 Hostel 443443153 Yes Yes 
19 No known links Orphan No Yes 
20 No known links Orphan No Yes 
21 
Worked with P23& ex-partner 
was culture positive. 
442443151 Yes Yes 
22 Household contact of P16+P24 443443153 Yes Yes 
23 Worked with P21. 442443151 Yes Yes 
24 Household contact of P16+P22. 443443153 Yes Yes 
6 
1 Warehouse 236423252 Yes Yes 
2 Warehouse 236423252 Yes Yes 
3 Warehouse 236423252 Yes Yes 
4 Warehouse 236423252 Yes Yes 
7 
1 No known link Orphan No Yes 
2 Pubs 442423382 Yes Yes 
3 Prison 442423382 Yes Yes 
4 No known link Orphan No Yes 
5 Member of family 4. 442423382 Yes Yes 
6 Known contact of family 4 442423382 Yes Yes 
Concordance between molecular and 
conventional epidemiological data for all seven clusters 
Yes 37 59 
No 27 7 
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